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Abstract 
Within the wall of the native artery the endothelial cells (EC) and smooth muscle cells 
(SMC) are functionally indispensable and interact to a large degree. The vascular EC are 
known to profoundly effect the proliferative, synthetic and motor functions of the 
underlying SMC. In a like manner the SMC have been found to contribute to the 
maintenance and survival of the endothelium by the release of soluble factors. One of the 
most significant and specific endothelial cell survival factors is vascular endothelial 
growth factor (VEGF). SMC are the chief vascular source of VEGF and constitutively 
produce VEGF in vivo. The anti-apoptotic action of VEGF for EC occurs via the 
phosphorylation of the VEGF receptor KDR. Thus, in a healthy state the artery resides in 
a balanced way with the absence of unrestrained cellular loss or proliferation. However, 
if the artery has to be replaced due to blockage or damage, and a suitable autologous 
vessel graft is unavailable, a prosthetic vascular graft may be used. 
Increased understanding of the molecular mechanisms involved in vessel function and 
development has permitted great advances in prosthetic vascular graft design. However, 
present synthetic grafts remain a last resort in peripheral arterial reconstructions. The key 
reason for their failure is the absence of host-derived EC which are paramount to 
synthetic graft patency. Although the fibrin matrix within the graft wall formed during 
implantation is initially highly favourable to cell integration, healing patterns show the 
EC and SMC to be excluded from presently available grafts. This may be due to 
prolonged inflammation, limited porosity and compliance mismatch with the native 
vessel. Compliance plays a role because cells within an incompliant graft do not 
experience the appropriate blood flow-related biomechanical forces experienced by cells 
in the artery. These forces are fluid shear stress on the EC and cyclic stretch on both the 
EC and SMC due to the rhythmic expansion of the artery wall. Cyclic stretch has been 
shown to be imperative for normal cell function in both cell types in vivo. Therefore, 
prosthetic vascular grafts should possess a degree of elasticity approaching the natural 
artery if it is to resemble the function of the natural artery. The development of novel 
compliant graft materials accompanied by advances in anti-inflammatory treatment and 
porous graft design may allow EC accompanied by pericytes / SMC to integrate into the 
graft structure to a greater extent. In this case the challenge will be to retain the 
functional endothelial layer after endothelial cell invasion without the apoptotic 
regression normally associated with scar formation. 
Vl 
In the light of studies which show the upregulation of VEGF in contractile cells 
subjected to cyclic stretch and the profound effects which cyclic stretch has been shown 
to have on the release of other cytokines by SMC, this study investigates the role which 
cyclic stretch might play in VEGF expression by SMC in a compliant environment. 
Furthermore, following observations of receptor phosphorylation in response to cyclic 
stretch in vascular cells, the effect of cyclic strain on the KDR-mediated endothelial 
response to locally-released VEGF was also investigated. 
Low passage number bovine aortic SMC and EC were plated on collagen-coated 
elastomer plates and subjected to 10% repetitive strain at 1 Hz. The mRNA expression of 
VEGF in SMC and the phosphorylation of KDR on EC were determined by northern 
blotting and western blotting respectively. The biological activity on EC and levels of 
VEGF secreted into the medium by SMC under cyclic stretch were investigated using a 
migration assay and ELISA respectively. Cyclic stretch was found to cause a 3.3 (±1.5 p 
< 0.005) fold increase in VEGF mRNA levels over unstretched controls at 4 hours. This 
biomechanically-induced expression was found to drop slightly by 24 hours and to be 
approximately equivalent to expression induced by the cytokine bFGF over the same 
time course. These results correlated with an increase in VEGF levels in media from 
stretched SMC capable of inducing migration of EC by 1.6 fold although additional EC 
chemotactic factors appear to be released by stretch. Furthermore, although the levels of 
KDR remained constant under cyclic stretch, average KDR phosphorylation was found 
to increase weakly over time due to cyclic stretch. These results show that cyclic stretch 
affects the VEGF communication between SMC and EC at both the level of VEGF 
expression by SMC and at the level of VEGF recognition by the KDR receptor on EC. It 
is possible that through the nitric oxide (NO) pathway, VEGF release may alleviate 
abnormally high levels of cyclic strain. It is hoped that a better understanding of the role 
of VEGF communication between stretched SMC and EC will enable the design of a 
graft in which the level of compliance encourages SMC to maintain a functional 
endothelium. Following this it is hoped that the low levels of SMC and pericytes 
invading the graft, pacified by endothelial cell mediation, will not result in intimal 
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The techniques and knowledge developed in molecular biology over the last 20 years 
have provided considerable insight into the biology of the vasculature. Breakthroughs as 
diverse as the construction of rudimentary vessels from cells in culture and strides to halt 
the progression of cancer have emerged from research involving vascular cells. However, 
despite great advances in understanding the molecular mechanisms involved in vessel 
development and function, a successfully lasting replacement of damaged vessels with a 
synthetic structure has eluded researchers for over four decades in the face of growing 
need for such technology. During this time, cardiovascular disease has emerged as a 
leading cause of mortality to the extent that according to the World Health Organisation 
(WHO) by the year 2020 40% of deaths worldwide will be related to cardiovascular 
disease. A common surgical solution to cardiovascular diseases - which often manifest 
themselves in an occlusion or symptomatic narrowing of vessels - is to bypass the 
blocked or stenosed vessels. Typically, the graft links the inflow portion to the distal part 
of the occluded artery and acts as a parallel auxiliary supply to the affected area. It is 
attached by sutures along the junction known as the anastomosis. According to the 
increasing worldwide trend towards a higher incidence in coronary artery disease, the 
coronary artery bypass graft operation has become the single most performed operation in 
the majority of hospitals. Bypass of the coronary arteries may be achieved by diversion of 
the internal thoracic or gastro-epiploic arteries in the chest cavity or insertion of an 
autologous vein graft. These grafts commonly use a saphenous vein from the legs. If 
either of these alternatives were not available, due to damage to the vessels or prior 
operation, the coronary artery would need to be bypassed by a synthetic vascular 
prosthesis. However, the poor performance of contemporary synthetic grafts make them 
obsolete in life-threatening positions such as coronary artery bypass grafts. Peripheral 
arterial reconstructions, such as those in the leg, are equally important. While in coronary 
artery bypass grafting the preferred conduit is an autologous artery graft, autologous vein 
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grafts are the conduits of choice for peripheral bypass surgery. However, if no autologous 
conduit is available, peripheral bypass surgery uses synthetic arterial prostheses as a last 
resort. The performance of these grafts is, however, poor (Veith et al. , 1986) with a 5 
year patency of 38% for synthetic bypass grafts versus 68% for autologous vein grafts. 
One key reason for failure in these grafts is a lack of an endothelium on its surface and 
thus a lack of normal function. Typically, the pores of contemporary synthetic grafts are 
initially filled by seeping blood which forms a loose fibrin clot. Ideally, during the course 
of healing, endothelial and smooth muscle cells would degrade and replace the fibrin 
matrix in the interstices of the graft and the porous structures would be populated by a 
healthy, layered cellular structure resembling a native artery (Figure 1). At present, 
however, the healing responses of prosthetic grafts are characterised by chronic 
inflammation, often rendering them non-functional by thrombus formation and 
anastomotic intimal hyperplasia (Davids et al., 1999). Therefore, the goal remains to 
populate a prosthetic graft with functional vascular cells. This has previously been partly 
achieved through in vitro lining of the synthetic graft surface with cultured, host-derived 
endothelial cells (Zilla et al., 1999). However, this technique requires sophisticated 
laboratory infrastructures and is thus limited to major centres. In order to provide all 
vascular surgeons with a synthetic arterial prosthesis which at least equals the 
performance of autologous vein grafts, a spontaneously healing graft would be needed. 
Unfortunately, contemporary prosthetic grafts fail to elicit a spontaneous healing 
response due to a variety of reasons, amongst them the stiffness of grafts, the lack of 
porosity and an ongoing chronic inflammatory reaction. In order to understand why 
vascular cells fail to elicit a spontaneous healing response in presently available synthetic 
grafts, one needs to understand both the structure and environment of the natural artery 
and the specifics of the unfavourable environment that contemporary synthetic grafts 
provide for ingrowing cells. In this study I seek to better understand the influence of the 
mechanical environment of the vessel on cellular communication in order to allow for 
both muscular components and vascularity within the design of the synthetic vascular 
graft. 
2 
A. The Cellular Physiology of Native Arteries 
1. Cells and Structure 
The function of the coronary artery, and other large arteries, is reflected in the structure 
and cellular components of its wall which consists of three layers: the tunica intima the 
tunica media and the adventitia (Figure 1 ). 
The tunica intima consists of a flat monolayer of endothelial cells (EC) which provides a 
smooth interface with the blood flowing through the lumen of the vessel, while allowing 
diffusion of nutrients and chemical messengers from the blood to the cells in the aortic 
wall. A smooth luminal lining to the vessel prevents thrombus formation and tight 
intercellular junctions maintain the integrity of the lining under the high flow conditions 
found in the arteries (Stevens and Lowe, 1992). These junctions also form a barrier 
between the blood and cells underlying the endothelial layer (Schnittler, 1998). 
Communication between the blood and the cells in the vessel wall is thus limited to either 
diffusion via opened junctions or tightly controlled active transcellular transport of 
pinocytic vesicles across the EC. Endothelial cells are equipped to function as the 
interface between the vessel and the blood because of many diverse receptors on their 
luminal surfaces (Stevens and Lowe, 1992). The high specificity of these receptors allows 
the EC to respond to changes in levels of metabolites such as glucose (Hempel et al., 
1997); ions like Na+ (Wigham et al., 1994); molecules such as nitric oxide (NO) (Gerol et 
al., 1998); cytokines like vascular endothelial growth factor (VEGF) (Neufeld et al., 
1999); and hormones such as insulin (Milton and Knutson, 1993) within the blood 
stream. Thus EC are pivotal in communicating signals in the blood to cells lying within 
the wall of the vessel (Brophy et al., 1997). On the abluminal side of the monolayer the 
EC secrete and adhere to a specialised extracellular matrix (ECM), the basement 
membrane, consisting of type IV collagen, laminin, heparan sulphate proteoglycans, 
entactin, fibronectin and other glycosaminoglycans (Stevens and Lowe, 1992). The 
basement membrane allows attachment of the EC to the underlying ECM, forms a 
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filtration barrier for substances passing from the blood and controls cellular organisation 
and differentiation. In large vessels, the basement membrane lies on a distinct layer of 
collagen and elastin fibres forming the internal elastic lamina, which separates the intima 
from the underlying second layer, the media (Stevens and Lowe, 1992). 
The tunica media is most prominent in larger vessels and has distinct morphology in each 
of the two types of artery, elastic and muscular. Elastic arteries, of which the aorta is an 
example, have the thickest media consisting of concentric layers of elastin running 
circumferentially throughout the media (Stevens and Lowe, 1992). These are interposed 
with collagen and irregular smooth muscle cells (SMC) with numerous branching 
processes (Cliff, 1967). The extensive fibrous network of elastin allows the vessel wall to 
absorb the pressure pulse as the blood leaves the left ventricle of the heart during systole 
by a rapid and dramatic expansion of the vessel diameter (Stevens and Lowe, 1992). 
During diastole in the heart, the aortic valve between the aorta and the heart closes, 
preventing back-flow of blood into the heart before the wall of the aorta returns to its 
original diameter propelling the blood onward into the circulatory system. This serves to 
smooth the pulsatile flow in the proximal arteries, maintaining an adequate diastolic 
pressure and helping to equilibrate the pulsatile output of the heart. This protects the 
smaller vessels and especially the capillaries from damage by peaks of pressure and high 
flow. The elastic arteries gradually merge into the muscular arteries. These are 
distinguished from the elastic arteries by a decrease in elastin in their medias, as the need 
for elastic recoil diminishes (Stevens and Lowe, 1992). The media of the muscular artery, 
of which the coronary artery is an example, consists mainly of spindle-shaped SMC 
arranged circumferentially and perpendicularly to the long axis of the vessel (Mills and 
Sumpio, 1997). 
The vascular SMC are the principal cell type in the media of muscular arteries and are 
unique to this layer (Stevens and Lowe, 1992). The function of vascular SMC is dynamic 
and is the result of two interconvertible phenotypic states: a contractile and a synthetic 
state (Mills and Sumpio, 1997). In the normal adult media, the majority of SMC are 
contractile. These SMC are highly differentiated and mitotically quiescent with large 
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centrally located nuclei and plentiful tracts of myofibrils in the cytoplasm, which are 
involved in the contraction of the cells (Mills and Sumpio, 1997). Contraction of these 
SMC, under the control of the autonomic nervous system as well as through local 
signalling mediated by EC, allows fine-tuning of the blood flow in the muscular arteries. 
In addition, SMC respond to agonists that either cause vasoconstriction or vasodilatation 
(Ross, 1993). Another important trait of vascular smooth muscle is the continued 
maintenance of tension in the vessel wall after stimulation (Adelstein and Sellers, 1987; 
Cooke et al., 1987) despite a dissipation of the signalling cascade molecules involved 
with contraction. This tension is important in the preservation of a consistent level of 
vascular tone (Brophy et al., 1997). If the structure of the artery wall needs readjustment 
to cope with changes in flow the vessel SMC may be found in the synthetic state (Mills 
and Sumpio, 1997). Smooth muscle cells involved in remodelling, repair and 
development of the artery as well as those found in some pathological conditions, such as 
atherosclerosis and intimal hyperplasia, have a synthetic phenotype. Cytokines or injury 
may induce the SMC to adopt this state. In the synthetic state, SMC are proliferative, 
produce a variety of growth factors / cytokines and have an increased production of ECM 
molecules such as collagen and sulphated glycosaminoglycans (Mills and Sumpio, 1997). 
Each of these activities enables synthetic SMC to remodel the vessel wall structure in 
response to changing structural requirements. The metabolic requirements for such active 
cells are high and require constant nutrients and oxygen from the blood. Although cells in 
the wall of smaller vessels obtain their oxygen and nutrients by diffusion from the lumen, 
the energy requirements for SMC embedded within larger vessel walls are met by small 
blood vessels, the vasa vasorum, which are branches of vessels originating in the 
underlying adventitia (Stevens and Lowe, 1992). 
The adventitia forms the third and outermost layer of blood vessels. It is separated from 
the media in large vessels by a condensation of elastin fibres forming the external elastic 
lamina and is composed largely of collagen fibres interspersed with SMC and fibroblasts 
(Stevens and Lowe, 1992). These fibres serve to connect the circulatory system to the 
other organs. An additional function of the adventitia, as mentioned above, is to provide a 
blood supply for the cells of the media. The mature microvasculature, such as that found 
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in the adventitia of large vessels, consists of EC flanked abluminally by pericytes 
(D'Amore, 1992a). Pericytes, also known as mural cells, are a morphologically, 
biochemically, and physiologically heterogeneous group of cells defined in vivo by their 
location within and on the outer side of the basement membrane of microvessels (Shepro 
and Morel, 1993). As the vascular tree progresses from arteries to arterioles and finally to 
capillaries, the contractile cell layer adjacent to the endothelium dwindles from a thick 
media of SMC in the artery to a single pericyte lying adjacent to the EC in the 
microvasculature (Stevens and Lowe, 1992). Although the pericytes play a more 
important role in development (Benjamin et al., 1998), there appears to be a functional 
plasticity and developmental relationship (Hirschi and D' Amore, 1996; Nicosia and 
Villaschi, 1995) between pericytes and SMC in the vasculature and conversion between 
the two phenotypes may occur during remodeling (Nicosia and Villaschi, 1995). Co-
culture experiments suggest that EC and pericytes interact by means of soluble factors 
(Hirschi and D' Amore, 1996), integrins and gap junctions (D'Amore, 1992a) and both 
cell types play a role in vessel assembly, growth control and normal capillary function 
(Hirschi and D' Amore, 1997; Nehls et al. , 1994). For example, pericytes are contractile 
(Schlondorff, 1987) and contraction in the pericytes allows fine control of blood flow in 
the capillary and adjusts junctional permeability in EC (Shepro and Morel, 1993). In 
addition, the pericyte releases basement membrane components (Shepro and Morel, 
1993) and cytokines such as transforming growth factor beta {TGF-~) (Antonelli-Orlidge 
et al. , 1989) which maintain the endothelium in a quiescent state (D'Amore and Smith, 
1993; Grant and Kleinman, 1997). Such cross-talk between cells in the vasculature is 




Figure 1. Structure of artery. A. Photomicrograph of an elastic artery wall showing the 
triple layered structure. The endothelial layer of the tunica intima provides an 
antithrombotic interface with the blood in the lumen and is separated from the tunica 
media by the undulating, black internal elastic lamina. The smooth muscle cells of the 
tunica media are stained yellow and are interspersed with black elastic fibres. The black 
external lamina separating the tunica media and the adventitia can be clearly seen. The 
collagen-rich adventitia is stained red in this preparation (Stevens and Lowe, 1992). B. 
Schematic diagram of ideal healing. The pink endothelial cells and yellow smooth muscle 
cells from native microvessels at left would populate the porous graft structure at right 
without overt proliferation to create a functional prosthesis. 
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2. Stimuli Effecting Vascular Wall Cells 
a. Cytokines 
Although the layered vessel may appear to remain quiescent over many years, the cellular 
environment of the arterial wall is far from insentient. Changing conditions of flow 
within the vessel require constant adaptation of the vessel structure (Nicosia and 
Villaschi, 1999) even in the absence of dramatic short-term vascular remodelling such as 
angiogenesis. This is brought about by abundant interactions between the two main cell 
types present: SMC, EC and their ECM. 
EC and SMC in the wall of the artery undergo a large number of interactions. Although 
gap junctions between adjacent SMC and EC may allow the transfer of ions and small 
molecules (Lash et al. , 1990), the major mode of communication between the cell types is 
through the release of cytokines. Endothelial cells and SMC both contribute to the 
cytokine cross talk in the coronary artery wall making the in vivo milieu at once 
interdependent and complex (Brophy et al., 1997; Mills and Sumpio, 1997). For 
simplicity, a brief review of the contributions of endothelial cell cytokine production on 
SMC and smooth muscle cell cytokine production on EC is considered. 
As mentioned above, EC are responsive to levels of diverse blood components especially 
cytokines. Such stimulation may induce the subsequent endothelial cell production of 
cytokines I growth factors including platelet-derived growth factor (PDGF); basic 
fibroblast growth factor (bFGF); transforming growth factor-beta (TGF-~) interleukin-I 
(IL-1) (Ross, 1993) and vasoactive substances such as nitric oxide (NO) (Li et al., 1995, 
Wennmalm, 1994; Busse, 1995) and endothelin (Estrada et al., 1995; Luscher, 1990; 
Yamagishi et al. , 1993). Many of these molecules are capable of affecting proliferation 
and contractile response in vascular SMC. Thus, it would appear that the presence of an 
intact endothelium also mediates signals from the blood to the SMC in a paracrine 
fashion (Brophy et al. , 1997). In this way, the maintenance of an intact endothelial layer 
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may maintain the SMC in the contractile phenotype (Mills and Sumpio, 1997) and act as 
an inherent brake on smooth muscle cell proliferation (Couffinhal et al., 1997; 
Doornekamp et al., 1996). This is supported by the finding that smooth muscle cell 
proliferative, synthetic and contractile responses to many agents on their luminal surface 
depend on whether the endothelial layer is intact or damaged (Loscalzo, 1995; Peiro et 
al., 1995; Shimokawa and Takeshita, 1995). Damage to the endothelial layer, by toxins in 
the blood (Painter, 1991) or surgical manipulation, (Quist and LoGerfo, 1992) can result 
in phenotypic modulation of SMC to a synthetic and proliferative state (Mills and 
Everson, 1995; Painter, 1991) and participate in the pathogenesis of all the major 
vascular disorders. The upset of the normal balanced situation between the cells may lead 
to unrestrained cellular proliferation in vivo such as underlying the pathological 
proliferation of SMC forming hyperplasia of the intima and vessel occlusion (Allen et al., 
1994; Chervu, 1990). 
Cytokines or hypoxia may also switch the phenotypic state of the SMC from the 
quiescent contractile state to the synthetic state (Mills and Sumpio, 1997). As mentioned 
above, SMC in the synthetic state can express a variety of growth factors / cytokines 
(Ross, 1993) including PDGF (Holt et al., 1994); bFGF; TGF-~; IL-1; vascular 
endothelial growth factor (VEGF) and heparin-binding epidermal growth factor (HB-
EGF) (Abramovitch et al., 1998) and thus contribute to the cytokine cross talk in the 
vessel wall (Mills and Sumpio, 1997). The secretion of many of these factors, such as 
PDGF-B, acts in both an autocrine manner to affect smooth muscle cell proliferation and 
in a paracrine fashion on the neighbouring endothelium (Ross, 1993). Other factors such 
as VEGF are specific for the EC and result in selective migration and proliferation of 
these cells (Ferrara and Davis, 1997). Thus, the complex local cytokine environment in 
the artery will to a large extent define any adjustment of the vessel wall. In addition to the 
short-term release of cytokines associated with fine tuning the vessel structure, cytokines 
may also contribute to the structure of the vessel in a more long-term fashion. For 
example, in addition to its role in proliferation and migration, VEGF produced by the 
SMC has also been proposed to have a role in the continued maintenance and repair of 
the mature endothelium (Couffinhal et al., 1997) as covered below. As the SMC are the 
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chief source of VEGF in the vessel wall (Williams et al., 1995), it is reasonable to assume 
that damage to SMC in the media would affect this upkeep. Due to the interdependence 
of the two cell types, the maintenance of an intact endothelium will in tum act as an 
inherent brake on smooth muscle cell proliferation (Couffinhal et al., 1997) as mentioned 
above. Although cytokines have a specific and potent affect on EC and smooth muscle 
cell activities in the arterial wall this is not the only contributing factor. The ECM 
released by these cells also influences their activities in the vessel wall. 
b. Extracellular Matrix 
Firstly, the composition of the underlying ECM has been shown to increase or attenuate 
the responses to cytokines by the EC and SMC (Powell et al., 1996) and hence may 
contextualise the cellular responses to cytokine stimuli. Secondly, ECM components have 
been shown to have a variety of effects on the remodelling (Liu et al., 1990; Nehls and 
Herrmann, 1996) and other phenotypic characteristics of EC and SMC. For example, EC 
are held in a quiescent state in vivo by the presence of collagen IV and laminin in their 
basement membranes (Grant and Kleinman, 1997) and they may be protected from 
apoptosis by vitronectin (Isik et al., 1998). In a similar fashion, a heparin-like 
glycosaminoglycan in the basal lamina of SMC maintains the cells in the contractile 
phenotype (Campbell et al., 1988) in vitro. It would be reasonable to assume that 
disruption of ECM contacts, such as those associated with injury to the vessel, would 
result in modulations of the phenotype. Thus, it seems that the ECM influences the 
cellular response in a less dramatic but more lasting way than cytokines. 
c. Biomechanical Forces 
In addition to humoral and matrix stimuli, another sustained influence on endothelial cell 
and smooth muscle cell physiology in the vessel wall is the biomechanical environment 
(Ziegler and Nerem, 1994; Gimbrone, 1997). This has been found to have profound 
effects on vascular cell physiology and a consideration of the forces involved in the 
design of a synthetic vascular graft may be key to the design of a more natural cellular 
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responses in these prostheses. The flow of blood in the vessel results in two major 
haemodynamic forces acting on the EC and SMC (Figure 2). Namely: shear stress from 
the flow of blood and cyclic stress from the blood pressure. 
• Shear Stress 
Firstly, the flow of the blood across the luminal surface of the vessel produces a tractive 
force known as shear stress (Dewey, 1984). The magnitude of shear stress oscillates with 
the cycles of systole and diastole in the heart. Only those EC lining the wall are subjected 
to this force and they respond by elongating and aligning with the direction of flow 
(Malek et al., 1993; Zhao et al., 1995). This reduces the tractive force on the cells and 
prevents detachment of the endothelial layer by extremes of shear (Ballermann and Ott, 
1995; Franke et al. , 1984). At the ultrastructural level, the re-orientation of intracellular 
actin and myosin filaments accompanies this response (Franke et al., 1984; Ives et al., 
1986). However, it is not known if the parallel alignment of EC (Dewey, 1984) is an 
active response by the cell to reduce the shear force experienced or a passive adaptation 
due to the flow. Shear stress also induces a spectrum of functional responses in the EC 
(Nerem et al., 1993) including regulation of angiogenesis (Ando and Kamiya, 1993); 
modulation of the production of vasoactive substances (Nerem et al., 1993) like NO 
(Uematsu et al., 1995) and endothelin (Malek and Izumo, 1992) as well as the alteration 
of signal transduction pathways (Ando and Kamiya, 1993; Papadaki and Eskin, 1997; 
Ando and Kamiya, 1996). Co-culture studies have demonstrated that many of the effects 
of shear on the EC are translated to the SMC by the release of soluble factors (Cucina et 
al., 1998; Nackman et al., 1998; Traub and Berk, 1998). Shear stress may thus play a role 
in the normal communication between the cells mentioned above. Damage to the 
endothelial cell layer disrupts this regulatory interaction and subjects the SMC to shear 
stress, both of which may lead to uncontrolled proliferation in the SMC (Kraiss et al., 
1991; Sterpetti et al., 1993). It was hypothesised that shear stress may be used to 
precondition endothelialised vascular grafts prior to implant, following the observation 
that EC exposed to shear stress adhere more tightly to a surface (Ballermann and Ott, 
1995). In the light of this observation, it was hoped that this would result in improved 
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retention of the endothelial layer in situ. In addition, the expansion of the elastic artery to 
accommodate the pulse of blood keeps the blood velocity and thus the level of shear 
stress from peaking to elevated levels (Fung and Liu, 1993). Due to the relationship 
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between flow and expansion (Fung and Liu, 1993), if the wall is able to expand to 10% of 
its diameter during systolic pulse, the pulsatile increase in blood velocity will lead to an 
increase in shear force 25% lower than experiences by EC in an inelastic vessel which 
does not expand with each pulse. Thus, it may be equally important for a synthetic 
arterial graft to possess some of the elastic properties of the artery if it is to mimic the 
physiological levels of shears stress experienced in the artery. This material-dependent 
property is known as graft compliance. 
• Cyclic Stress 
The above mentioned expansion stems from the pressure waveform on the artery wall 
created by the increased volume of blood in the aorta during systole and results in the 
second force acting on the EC and SMC. Although experiments to determine the effect of 
pulsatile pressure on SMC (Watase et al., 1997) have shown to cause an increase in 
proliferation and cell alignment, direct pressure may have limited effects on EC and 
SMC. This is explained by the fact that cells consist mostly of incompressible water. 
Thus, physiological levels of pressure exerted on cells cultured on a rigid substrate should 
have little effect on cell morphology but will be equilibrated across the cell (Ives et al., 
1986). However, in the elastic artery, pressure creates an oscillating variation in the 
vessel circumference. This fluctuation results in a cyclic stretch on the cells of the vessel 
wall in the circumferential direction (Sumpio, 1989) (Figure 2) which affects the cell-cell 
junctions, cell membrane and cytoplasm of both EC and SMC in vivo. 
Effects of Cyclic Stress on Endothelial Cells 
Because it is situated on the internal surface of the vessel, the luminal endothelium is 
subject to the lowest cyclic stretch in vivo. However, a number of experiments in culture 
have shown this cyclic stretch to have important influences on EC (Sumpio et al., 1988a). 
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The translation of a mechanical signal, such as pulsatile stretch, into cellular events is a 
complex and poorly understood process and the precise means by which EC detect and 
respond to cyclic stretch is not known. Possible stretch receptor candidates include the 
integrins a5~ 1 and <Xz~, (Yano et al., 1997) which physically link the ECM substratum and 
the cell (Shattil and Ginsberg, 1997) via condensations of cytoskeletal proteins known as 
focal adhesion plaques (Albelda and Buck, 1990). This hypothesis is supported by the 
observation that integrins are redistributed at the periphery of the cell during cyclic 
stretch (Y ano et al., 1997). Concurrent cytoskeletal remodelling aligns the EC 
perpendicularly to the strain. Thus, although EC receive their primary orientation cues 
from shear stress, as mentioned above, the two forces work in harmony to orientate the 
EC in the vessel wall (Ives et al., 1986; Zhao et al., 1995). Further mechanosensor 
candidates include two cytoskeletal proteins within the focal adhesion plaque, paxillin 
and focal adhesion kinase (F AK), and platelet endothelial cell adhesion molecule- I 
(PECAM-1). PECAM is a receptor which is concentrated at the region of cell apposition 
between adjacent EC (DeLisser et al., 1993) which has been shown to be activated by 
phosphorylation in response to shear stress (Osawa et al., 1997). The demonstration of 
activation of the PDGF receptor-a in SMC by cyclic stretch (Hu et al., 1998) raises the 
possibility of ligand-free physical-force-induced activation of a variety of cytokine 
receptors on other cell types including EC although the effect which such activation has 
on ligand binding is unknown. Finally, the highly-expressed VEGF receptor kinase insert 
domain-containing receptor (KDR) (Quinn et al., 1993), which is discussed in detail 
below, plays a role in the detection of shear stress by EC (Chen et al., 1999) and it is 
interesting to postulate whether it is also important as a stretch receptor. 
Cyclic strain is also found to affect cellular signalling intermediates downstream of the 
initial mechanoreceptor (Letsou et al., 1990; Brophy et al., 1993; Segurola et al., 1997; 
Sumpio and Banes, 1988a; Yano et al., 1996b). Although much is left to elucidate about 
the role of cyclic stretch in the pathways which involve these molecules, modulation of 
their function may bring about many of the altered cellular responses seen in EC under 
cyclic stretch. These include changes in gene expression (Iba and Sumpio, 1992; Sumpio 
et al., 1988a); proliferation (Sumpio et al., 1987); matrix secretion (Sumpio, 1989) and 
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the release of factors capable of affecting smooth muscle cell contractile function 
(Awolesi et al., 1995; Macarthur et al., 1994; Popp et al., 1998; Sumpio and Widen, 
1990). 
Effects of Cyclic Stress on Smooth Muscle Cells 
In addition to any influences from the adjacent EC, SMC are affected directly by cyclic 
stretch in a distinct way to EC (Mills et al., 1993). Stretch is the contributory factor for 
orientation in SMC as compared to EC, which prefer fluid flow as a stimulus for 
alignment. SMC are seen to align perpendicularly to the direction of cyclic strain in vitro 
(Sumpio and Banes, 1988b ). This may be due to breakdown of cell attachments or a 
cellular response to migrate and rotate in order to minimise the strain on the cell. The 
aligning effect of stretch noted in vitro is mirrored in vivo where histological observations 
show a spiral orientation of the SMC parallel to the longitudinal axis of the vessel (Peters 
et al., 1983; Stevens and Lowe, 1992). The cells may align spirally rather than 
circumferentially due to a secondary alignment response to the minor cyclic stresses 
experienced along the length of the vessel (Figure 2) (Deng et al., 1994). The aligning 
response in SMC is paralleled by changes in cell phenotype (Birukov et al., 1995; Reusch 
et al., 1996). 
Cyclic mechanical stimulation in vitro has dual effects on phenotypic characteristics of 
SMC depending on the regimen of stretching. In different models cyclic stretch induces 
the production of ECM (Sumpio et al., 1988b) and growth factors such as PDGF-B 
(Wilson et al., 1993), both characteristic of a synthetic phenotype, and induces increased 
expression of the contraction regulating protein h-caldesmon (Birukov et al., 1995), 
considered a marker of the differentiated contractile smooth muscle state (Glukhova et 
al., 1988). Overall cyclic stretch appears to induce the maintenance of the differentiated 
contractile phenotype based on myosin isoforms expressed (Reusch et al., 1996). 
However, the varied response by SMC under stretch (Reusch et al., 1996) may be due to 
distinct sub-populations of SMC (Lindner et al., 1995; Villaschi et al., 1994) or due to the 
heterogeneous strain profile produced by the strain apparatus used (Gilbert et al., 1994). 
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Alternatively, growth and differentiation in SMC may not be mutually exclusive (Owens, 
1996). In vivo differences in mechanical stimulation of arterial vascular SMC may 
maintain the vascular SMC in the contractile phenotype or a predominantly biosynthetic 
mode (Sottiurai et al. , 1983). At the ultrastructural level, characteristic features of 
contractile smooth muscle cell morphology such as myofilaments became less distinct 
(Sottiurai et al. , 1983) and rough endoplasmic reticulum (RER) profiles were more 
abundant in cyclically stretched cells (Sottiurai et al., 1983). This observation is 
consonant with an increase in ECM synthesis (Leung et al., 1976). 
Collagen production has been found previously in SMC in static culture (Burke et al. , 
1977) and within a vascular graft (Mesh et al. , 1995) but synthesis of collagen, 
noncollagenous ECM protein (Sumpio et al. , 1988b) and other ECM components (Leung 
et al. , 1976) by SMC has been shown to increase under cyclic stretch. These observations 
may represent an adaptive response to increased cyclic stretch by the SMC to strengthen 
the artery by releasing ECM proteins (Leung et al., 1976) although they also parallel the 
composition changes of stiffened artery walls associated with increased medial tensile 
stress (Leung et al. , 1976) such as associated with intimal hyperplasia (Shrestha et al. , 
1992). However, other studies have shown a decrease (Kulik and Alvarado, 1993) or an 
increase (Grande et al. , 1989) in collagen production depending on the nature of stretch 
applied (Sottiurai et al., 1983). Furthermore, in vivo production of ECM by SMC under 
cyclic stretch may be curbed by ECM components in the artery wall (Akita et al., 1993; 
Sakata et al. , 1990; Campbell et al., 1988), the adjacent EC (Powell et al. , 1997) and the 
reduction of ECM production accompanying the promotion of some of the characteristics 
of the contractile state in SMC by cyclic stretch (Reusch et al. , 1996). Thus the precise 
effect of cyclic stretch on ECM production has yet to be determined. In addition to ECM 
production, cells under cyclic stretch form numerous attachments to their moving ECM 
substrate and each other (Leung et al., 1976). 
Attachments with the nascent ECM are important in alignment of SMC in response to 
stretch. These attachment sites are also responsible for transmission of mechanical force 
signals to the cells (Wilson et al. , 1995) and studies in which cells were stretched on 
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different substrates have shown them to be very specific (Ingber, 1991). As was the case 
with EC, SMC have been shown to sense mechanical strain through interactions of 
integrin receptors in the plasma membrane with matrix sites fixed to the moving substrate 
(Wilson et al., 1995). However, different mechanoreceptors may communicate the varied 
responses of SMC to cyclic stretch such as proliferation and differentiation (Reusch et al., 
1996) and the mechanisms by which forces are transmitted across the cell surface and 
transduced into a cytoskeletal response are largely unknown. A number of intracellular 
signalling mechanisms are found to take part during the smooth muscle cell response to 
cyclic stretch (Kulik et al., 1991; Mills et al., 1990; Wiersbitzky et al., 1994; Davis et al., 
1994; Davis et al., 1992; Bialecki et al., 1992). 
In addition to direct stimulation by cyclic stretch, SMC may by stimulated by cytokines 
released autocrinely under cyclic stretch. This is supported by the observation in some 
cell stretching experiments that cells were initially slower to proliferate in lower 
concentrations of foetal bovine serum (FBS) suggesting a switch to autocrine growth 
stimulation by low levels of growth factors (Birukov et al., 1995). The production of 
cytokines, despite the observation of some differentiating effects of cyclic stretch on 
SMC (Reusch et al., 1996), which should diminish the production of cytokines (Mills and 
Sumpio, 1997), once again demonstrates the dual effects of cyclic stretch on smooth 
muscle cell phenotype. One candidate cytokine for the role of growth stimulation is the 
potent smooth muscle cell mitogen PDGF, which has been shown to be released by SMC 
(Ross, 1993). Cyclic strain appears to induce the production and secretion of PDGF-BB 
and PDGF-AA, which act in an autocrine manner (Wilson et al., 1993). In addition, 
cyclic strain has been shown to cause activation of the PDGF receptor-a. on vascular 
SMC (Hu et al., 1998). At present it is not certain whether stretch modulates the activity 
of PDGF on SMC by affecting the production of the cytokine (Birukov et al., 1995), the 
response of the receptor (Hu et al., 1998) or both. Although a potential autocrine 
mediator of smooth muscle cell proliferation under stretch (Brogi et al., 1994; Ross, 
1993; Klagsbrun and Edelman, 1989), bFGF appears not be involved in the proliferative 
response of SMC to stretching (Wilson et al., 1993). TGF-p is a further cytokine secreted 
by SMC (Ross, 1993) that is capable of enhancing both smooth muscle cell proliferation 
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and migration (Bell and Madri, 1989). In the heart, myocardial stretch is associated with 
rapid induction of VEGF gene expression in the related cardiocyte under the mediation of 
TGF-P produced by the cardiocyte (Li et al., 1997a; Seko et al., 1999). However, whether 
TGF-p is released during cyclic stretch by SMC and whether this has any effect on 
smooth muscle cell proliferation has yet to be determined. VEGF itself has also been 
shown to be released under cyclic stretch by the contractile cell lying adjacent to the 
endothelium in the kidney, the mesangial cell (Groden et al., 1997). The mesangial cell is 
the pericyte of the kidney (Schlondorff, 1987; Stevens and Lowe, 1992) and is very 
similar to the vascular SMC in terms of embryonic origin, position in the vasculature and 
function. Although VEGF may have dramatic effects on the underlying endothelial cell 
physiology, as covered below, VEGF has not been shown to have any dramatic effect on 
smooth muscle cell behaviour. Despite evidence of basal levels of VEGF expression by 
vascular SMC in vitro (Ferrara et al., 1991) and in vivo (Couffinhal et al., 1997), to date 
no work has looked into the release ofVEGF by vascular SMC under cyclic stretch. 
The role of the cytokines released due to cyclic stretch on smooth muscle cell 
proliferation may be of secondary importance to the origin of the SMC. Smooth muscle 
cell proliferation under cyclic stretch has been found to be increased, unchanged or 
decreased in various studies (Birukov et al., 1995; Sumpio, 1989). Discrepancies may 
result from experimental differences (Sumpio and Banes, 1988b; Yang et al., 1993) or 
variation in the effectiveness of pulsatile stretch as a proliferative stimulus in SMC from 
different blood vessels. For example, stretching proved inefficient in stimulating 
proliferation in cultured SMC obtained from the human mammary artery (Predel et al., 
1992) but induced proliferative responses in cultured human coronary SMC (Birukov et 
al., 1995). In a similar way, SMC from the relatively inelastic saphenous vein are seen to 
proliferate under cyclic stretch while those of the more elastic aorta were not (Dethlefsen 
et al., 1996). This may explain the hyperproliferative response, which may be found in 
these cells after implant of saphenous vein in the arterial circulation, and the lack of this 
response in bypasses using the internal mammary artery. It therefore appears that the 
proliferative response to cyclic stretch is dependent on the source of the SMC. Thus, if 
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one is aiming at the spontaneous growth of SMC into porous synthetic grafts, the source 
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Figure 2. Haemodynamic forces acting on the cells of the artery wall (after Ives et al., 
1986). A. Schematic diagram displaying effects of blood flow on the artery B Schematic 
diagram showing how the forces are experienced by cells on a flat surf ace. Blood flow 
across the lumen in A results in a shear force shown in B which effects the physiology 
and alignment of the endothelial cells lining the lumen. The rhythmic expansion of the 
artery wall shown in A can be visualised as a linear cyclic stretch in B. Although the 
major direction of stretch (thick curved arrows) is perpendicular to the long axis of the 
artery, a minor component of stretch (thin curved arrows) acts parallel to the long axis of 
the artery. Both EC and SMC have been shown to align due to cyclic stretch and this 
force influences many other functions in both cell types. 
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B. Pathophysiology of Prosthetic Graft Healing 
1. Healing Response in Present Grafts 
As can be seen above, both EC and SMC have properties vital to the proper function of 
blood vessels. In the same way, their presence in a graft is imperative to its proper 
healing and function. Based on the normal structure and function of the artery, the goal in 
the complete healing of prosthetic grafts remains three-fold: Firstly, the formation of an 
antithrombotic endothelial layer / neointima on the luminal surface which is maintained 
over time. Secondly, well-healed interstices containing both a muscular component and 
functional vasa vasora. The SMC strengthen the wall of the graft and provide the 
contractile and controlling function found in the artery. Finally, these cellular 
components should be resident in a material whose surface characteristics, structure and 
mechanical properties are optimal to both the physical demands on the graft and mature 
healing of the cellular components. However, currently available synthetic arterial grafts 
fail to heal (Davids et al. , 1999). Neither surface healing in the form of endothelialisation 
nor complete wall healing through thorough population with SMC occurs, even after 
decades of implantation. On the contrary, these grafts are rather typified by a long-term 
inflammatory response and generally acellular structures (Davids et al. , 1999). A brief 
synopsis of the cellular response and healing patterns observed in these materials is 
presented. Presently two materials are widely used in small diameter vascular prostheses: 
expanded polytetrafluoroethylene and polyethylene terephthalate. 
The first of these is expanded polytetrafluoroethylene (ePTFE), which is used 
commercially in a form resulting from the stretching of the extruded polymer. This 
results in a characteristic structure of nodes with fine fibres bridging intemodal spaces of 
between 30µm and 60µm (Figure 3A). The initial interstitial fibrin matrix formed after 
implant of this material becomes ordered over time into a chronically inflamed triple 
layered biological structure (Davids et al., 1999). Firstly, the blood interface portion of 
the graft is often populated by macrophages and lies adjacent to a distinct and largely 
20 
acellular central protein matrix layer (Joos and Sandra, 1990). The final outer adventitial 
layer of the graft is also rich in macrophages and later becomes populated with foreign 
body giant cells (FBGC) characteristic of unresolved healing (Davids et al., 1999). 
An alternative substance for graft manufacture is polyethylene terephthalate (PET). This 
polyester is manufactured for grafts as a yarn commercially known as Dacron (Figure 
3B). This yarn may be woven or knit, with varying warp and weave into a tubular graft or 
fibres may be pressed into a felt resulting in a more random arrangement of fibres. The 
cellular response to Dacron implants is characterised by macrophages, a prevailing 
absence of SMC and, in the more porous woven or felt structures, the presence of large 
FBGC-associated endothelial sinuses which fail to penetrate the persistent luminal fibrin 
matrix lining the blood surface (Davids et al., 1999; Herring et al., 1984). If used as a 
small diameter bypass graft, this poor healing pattern leads to a disappointing patency 
(Berger et al., 1972). 
The poor cellular response to these two graft materials may in part also be due to their 
structural and physical properties. At present, the non-healing response in these grafts, 
which is generally accepted to be characterised by the prolonged presence of FBGC and 
macrophages, may curtail the appropriate ingrowth of EC and SMC (Davids et al., 1999). 
The adhesion of macrophages to the graft wall is mediated by the absorption of blood 
proteins onto the graft structure, which is in turn dependent on the chemical groups 
available on the polymer surface (Davids et al., 1999). As new surface treatments for 
polymers arise and anti-inflammatory therapies improve, it is hoped that the degree of 
chronic inflammation will diminish. In this case, the primary challenge to graft healing 
will be the achievement of a sustained ingrowth of EC and SMC. However, the pore sizes 
in contemporary ePTFE and PET grafts are ill defined and too narrow to allow the 
ingrowth of EC transmurally (Golden et al., 1990b). Even in high porosity ePTFE 
(internodal distance 1 OOµm), EC in the graft wall seem to originate primarily from the 
adjacent vessel wall and transmural ingrowth may be restricted by the network of fine 
internodal fibres (Tsuchida et al., 1997) (Figure 3A). In addition, grafts of these materials 
are inelastic and this rigidity may present the cells with an environment foreign to that 
21 
found in the natural compliant artery (Ziegler and Nerem, 1994; Gimbrone, 1997; 
Brossollet, 1992). The replacement of a relatively inelastic wound fibrin ECM following 
implant with more elastic cellular components during cellular ingrowth (Greisler et al., 
1992) means that in the end, the mechanical properties of the polymer are the limiting 
factor for the ability of the healing graft to undergo cyclic deformation in situ. Although 
compliance may not act alone (Uchida et al., 1989; Uchida et al., 1993), it has an 
important effect on vascular cell physiology (Zenni et al., 1993). If the walls of the graft 
do not expand to accommodate the pulse of blood, the flow rate past the EC will oscillate 
to abnormally high levels. This will have an effect on the alignment (Ives et al., 1986) 
and function of these cells, as shown above, and may be destructive to the endothelium. 
Similarly, the SMC in the walls of these grafts can be assumed to not be subject to 
sufficient cyclic deformation due to the non-expansion of the wall. This force has also 
been shown to have an effect on the alignment and physiology of the SMC, as discussed 
above (Sumpio and Banes, 1988b). It is possible that altered production of cytokines such 
as PDGF-A and-Band TGF-~ in intimal EC (Sapienza et al., 1998) and SMC (Golden et 
al., 1990a) within some present inelastic prosthetic grafts, which is thought to be 
responsible for proliferation associated with intimal hyperplasia, may stem from an 
abnormal mechanical environment. Although this adverse development will only affect 
the central graft portion once it is populated by SMC, it may seriously enhance the 
luminal narrowing of the anastomosis (Shrestha et al., 1992). This hyperplastic intimal 
reaction (Bryan and Angelini, 1994) is the second most important reason for the failure of 
synthetic vascular grafts. 
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Figure 3. Scanning electronmicrographs of polymers used in prosthetic vascular grafts. 
A. Expanded polytetrafluoroethylene (ePTFE) (Courtesy of D. Bezuidenhout, Medtronic 
Institute for Biomedical Research, University of Cape Town Medical School, Cape 
Town, South Africa). Note the characteristic structure of nodes (thick arrow) separated by 
fine fibres (thin arrow). Although the intemodal distances (45 - 60 µm) are large enough 
to allow cellular infiltration into the graft structure, successful integration is minimised 
by the intemodal fibres. B. Polyethylene terephthalate (PET) (Dacron) (Guidoin et al., 
1987). Dacron fibres (10 µm) joined into approximately 300 µm bundles and woven 
together to form the wall of a tubular graft. Once again the structure is highly 
impenetrable to cells and highly inelastic. 
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2. Facilitated Healing through Vascular Cell 
Transplantation 
As can be seen from healing patterns in presently available grafts, EC don't 
spontaneously cover the graft surface further than one centimeter from the anastomosis 
(Poole et al., 1996). In a first step to actively achieve this goal, autologous endothelial 
cell transplantation has been shown to significantly improve graft performance (Zilla et 
al., 1999). The clinically most successful approach was in vitro endothelialisation prior to 
implant (Zilla and et al., 1987). This involves culture of EC harvested from the patient 
followed by protein coating of the prosthesis and rotation of a suspension of these cells 
onto the graft surface (Meinhart et al., 1997). Alternatively, other studies have used 
venous (Noishiki et al., 1992) and microvascular EC from fat (Jarrell et al., 1986; 
Schmidt et al., 1988) to seed synthetic vascular grafts of Dacron (Matsuda and Miwa, 
1995) and ePTFE (Stansby et al., 1994). 
The role of SMC in graft healing has been largely overlooked in cell transplantation 
because of their pathological role in intimal hyperplasia (Bryan and Angelini, 1994; 
Painter, 1991 ). This uncontrolled proliferative response to a number of factors has been a 
leading cause in graft failure and many strategies have therefore aimed at smooth muscle 
cell exclusion (Pitsch et al., 1996; Powell et al., 1996). Nevertheless, seeding with SMC 
alone (Oene et al., 1987) and accompanying endothelial cell seeding (Noishiki et al., 
1993; Kanda et al., 1993a) has been carried out in some studies and SMC in these grafts 
have been shown to mature over time and demonstrate the contractile characteristics of 
SMC of the native artery (Noishiki et al., 1993; Baitella et al., 1993; Kanda et al., 1993b; 
Kanda et al., 1995). Although their long-term function in vivo has still to be tested, some 
particularly ambitious studies report formation of an entire functional artery from 
cultured EC and SMC (L'Heureux et al., 1998; Niklason et al., 1999) subjected to 
appropriate biomechanical forces. It therefore appears that, rather than excluding SMC, a 
balance between the EC and SMC is important for functional healing in the graft wall. 
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This is in concordance with the situation in the artery wall, in which SMC and EC reside 
in a balanced and interdependent way without overt proliferation. 
Although grafts with cellular constituents have been found to have better long-term 
prospects in animal models and clinical use, the endothelial lining of synthetic grafts 
involves technically demanding and costly cell culture facilities. Furthermore, adequate, 
healthy cells are not always available for seeding in surgical situations and therefore the 
design of a graft in which the spontaneous transmural ingrowth of the EC occurs, would 
be preferable. 
3. Components for a Spontaneously Healing Graft 
SMC and EC populating the pores of a vascular graft originate from tissue adjacent to the 
graft and are enticed to enter the graft by stimuli specific to each cell. A brief 
consideration of the mechanisms of recruitment of each of these cells is presented. 
EC populating the graft wall have been shown to originate from a variety of different 
sources in different models, ranging from transanastomotic ingrowth from the natural 
artery (Clowes et al., 1986a), circulating endothelial cell stem cells (Hollier et al., 1986; 
Scott et al., 1994; Shi et al., 1998) or transmural ingrowth from microvessels of the 
adventitial tissue (Clowes et al., 1986b; Wu et al., 1996). As transanastomotic ingrowth is 
limited in humans (Sauvage et al., 1971; Szilagyi et al., 1965) and the importance of 
blood-borne endothelial precursors in the human model is controversial and uncertain, the 
most promising source of luminal EC is from transmural ingrowth (Wu et al., 1996). The 
importance of this source of EC is demonstrated by the way that endothelial cell 
infiltration depends on the tissue surrounding the vessel in canine experiments (Sterpetti 
et al., 1992). As the capillary sprout from the adventitia faces the abluminal surface of the 
graft, it is confronted with a network of fibrin within the pores and a mildly hypoxic 
environment which is initially highly promigratory (Davids et al., 1999; Liu et al., 1990). 
Both in terms of peptide sequences in the matrix (Nicosia and Bonanno, 1991) and 
cytokines such as PDGF (Green et al., 1997) and VEGF (Weatherford et al., 1996) 
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embedded during the formation of the clot (Devine and Carter, 1995), fibrin provides an 
ideal structural scaffold for neovascularisation and EC have been shown to infiltrate 
fibrin matrices such as those in the interstices of the graft wall in vitro (Hiraoka et al., 
1998; Nehls and Herrmann, 1996). Although EC have been found to migrate on both 
loose and dense fibrin matrices, the formation of differentiated capillaries needs matrices 
with a lower fibre density (Nehls and Herrmann, 1996). Over time, due to the continued 
presence of clotting factors, platelets and macrophages in the blood, the fibrin matrix on 
the blood surface of the graft becomes progressively denser and more saturated with 
ingrowth inhibitory cytokines, making it more imp~netrable to EC migrating towards the 
lumen, thus creating a window of time available for such invasion (Davids et al., 1999). 
Endothelial cells invade the graft by degrading and replacing the fibrin matrix in the 
interstices of the implanted graft by a process known as angiogenesis (Liu et al., 1990). 
a. Angiogenesis 
Blood vessels develop by two processes: vasculogenesis and angiogenesis (Sage, 1997). 
Vasculogenesis is the embryonic formation of the larger vessels from primordial EC in 
the mesoderm (Beck and D'Amore, 1997). Angiogenesis is the growth of new vessels 
from pre-existing ones (Folkman and Shing, 1992). Angiogenesis is fundamental to 
development, reproduction, wound repair in response to injury and augmenting existing 
vessels in response to tissue hypoxia (Ferrara and Davis, 1997; Pepper, 1996a). It is also 
found in a number of pathological conditions including arthritis, diabetic proliferative 
retinopathy, haemangioma and the recruitment of capillaries by solid tumours (Ferrara 
and Davis, 1997). Much of the knowledge of the process of angiogenesis stems from 
studies involving these conditions and the cellular mechanics are well characterised 
(Figure 4). In a spontaneously healing graft angiogenesis is important for the 
development of capillaries from vessels in the adventitia to infiltrate the graft by 
transmural ingrowth. These capillaries will hopefully provide the luminal surface with 
EC and establish the vasa vasorum within the vessel wall (Davids et al., 1999). 
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To bring about such dramatic remodelling requires activation of the quiescent EC in the 
adventitial vessels (Folkman and Shing, 1992). The microvasculature is typically 
quiescent, with a very low cellular turnover (D'Amore, 1992b; Folkman and Shing, 
1992). It is held in this state by specific inhibitory molecules in the basement membrane 
such as collagen IV (Grant and Kleinman, 1997) and cytokines such as TGF-~ 
(Antonelli-Orlidge et al., 1989) and angiopoietin-1 (Darland and D'Amore, 1999; Goede 
et al. , 1998) released by adjacent pericytes. Due to this maintenance, the presence of pro-
angiogenic molecules does not necessarily result in angiogenesis. Rather, a balanced 
concentration-dependent situation exists between positive and negative regulatory factors 
in vivo, which allows fine control of the process (Pepper, 1997a). A large variety of 
cytokines, peptide fragments, signalling molecules, vasoactive peptides and ions have 
been shown to activate EC to angiogenesis (Bussolino et al. , 1997). Activation involves 
the conversion from a quiescent phenotype to an invasive and proliferative morphology. 
A dramatic alteration of cell physiology and upregulation of gene expression in the 
activated EC accompany this switch (Vernon and Sage, 1995). Many of the genes 
expressed are involved in the disruption of cell adhesion and migration of the EC such as 
proteases (Mignatti and Rifkin, 1996) which act locally to degrade the basement 
membrane of the parent vessel underlying the endothelial layer. EC then migrate, as a 
capillary sprout, through the basement membrane into the surrounding matrix towards the 
angiogenic stimulus (Sage, 1997). The cells at the front of this sprout continue to release 
surface-bound proteolytic enzymes as they progress through the interstitial ECM (Pepper 
et al. , 1996b ). Elongation of the capillary ingrowth is accompanied by cell proliferation in 
the portion nearest to the migratory front (Sage, 1997). In the region immediately 
posterior to this a lumen is formed - by the expansion of the intercellular space to form 
vacuoles (Meyer et al., 1997) - as the migration continues (Sage, 1997). Two contiguous 
tubular sprouts fuse to form a new functional capillary loop (Sage, 1997). As the nascent 
tube of EC forms, EC release factors to attract pericytes to accompany them (Benjamin et 
al. , 1998). In fact, EC are seldom found free of pericytes and cultured EC in the absence 
of pericytes have been shown to release endothelin-1, which promotes the proliferation of 
pericytes (Yamagishi et al., 1993) and PDGF-BB, which may recruit and induce 
differentiation of pericytes / SMC (Hirschi et al., 1999). As mentioned above, once 
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beckoned, the pericyte plays an active role in endothelial cell maintenance and regulation 
of the capillary function. After fusion of two endothelial sprouts to form a new capillary, 
pericytes migrate to the apex of the new capillary loop and halt angiogenesis in a contact 
dependent manner (Schott and Morrow, 1993). This may involve the release of TGF-~ 
which inhibits endothelial cell proliferation and maintains the differentiated state 
(Antonelli-Orlidge et al., 1989). Vessel maturation is completed by secretion of a novel 
basement membrane (Sage, 1997). The components of the basement membrane and 
endogenous negative regulators of angiogenesis return the new vessel to a quiescent state. 
The angiogenic progression of capillaries arising from outside of the adventitia and 
entering the wall of the graft is affected by stimuli from the fibrin matrix, inflammatory 
cells and angiogenic cytokines which are released by these cells and embedded in the 
matrix during clotting. 
• Matrix 
The maintaining function which collagen IV and laminin in the basement membrane have 
on endothelial cell physiology (Grant and Kleinman, 1997) demonstrates the potent effect 
which proteins in the ECM have on EC which are dependent on adhesion for the 
completion of the cell cycle (Stromblad and Cheresh, 1996; Watanabe and Dvorak, 1997) 
ECM constituents, or their degraded fragments, may affect each stage of angiogenesis 
(Sage, 1997) including proliferation and guidance of migration. EC undergoing 
angiogenesis in an implanted prosthetic vascular graft use proteins like thrombospondin-1 
(Adams, 1997; Sage and Bornstein, 1991) which originate from the blood and 
macrophages (Sunderkotter et al., 1994) and are bound in the fibrin matrix within the 
pores of the graft. As mentioned above, fibrin provides an ideal scaffold for EC 
undergoing transmural angiogenesis and although the fibrin matrix within the pores of the 
graft is largely acellular, EC may come into contact with inflammatory cells associated 
with the graft. 
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Basement membrane Endothelial cell 
Figure 4. Schematic representation of the process of angiogenesis (after Sage, 1997). 1. 
Basement membrane degradation followed by 2. Directed endothelial cell migration with 
associated extracellular matrix degradation. 3. Endothelial proliferation. 4. Lumen 




Macrophages are ubiquitous in normal and especially inflamed tissues (Sunderkotter et 
al. , 1994). After implant of a prosthetic vascular graft macrophages degrade and enter the 
fibrin within the graft pores from the luminal blood and from capillaries in the adventitia 
in a similar way to normal wound healing (Leibovich and Wiseman, 1988). Macrophages 
are activated by hypoxia, such as found in wounds and in proximity to tumors, chemical 
stimuli or by cytokines in the matrix or released by other cells (Folkman and Shing, 
1992). Activated macrophages can produce a plethora of proteases, and growth factors 
including bFGF; PDGF; VEGF; TGF-P; thrombospondin-1 (Cavaillon, 1994; 
Sunderkotter et al. , 1991) and tumour necrosis factor -alpha (TNF-a) (Leibovich et al., 
1987). This diversity (Takemura and Werb, 1984) and the additional release of 
angiogenic cytokines (Sunderkotter et al., 1991) - incorporated during clotting - by 
fibrinolysis associated with macrophage migration allows activated macrophages to 
influence each phase of the angiogenic process. In this way, the angiogenic capabilities of 
macrophages are comprehensive and unsurpassed by any other cell and their initial 
presence within the graft may stimulate capillary ingrowth such as is found in wound 
healing (Hunt et al. , 1984; Leibovich and Wiseman, 1988). However, on encountering the 
material surface of the graft macrophages tend to adhere to the graft or fuse with other 
macrophages to form FBGC in a material-dependant fashion (Davids et al., 1999). The 
inability of these cells to remove the inflammatory stimulus of the graft results in their 
continued presence with the concomitant production of partly antiangiogenic cytokines 
which, as described before, may halt endothelial cell ingrowth and attenuate the 
recruitment of pericytes, leading to disappointing cellular ingrowth (Davids et al., 1999). 
• Cytokines 
During the course of angiogenesis, EC encounter a variety of cytokines derived from the 
blood, platelets, neighbouring cells and ECM-bound reserves. Cytokines involved in the 
process of angiogenesis may be classified as either direct or indirect (Folkman and Shing, 
1992). Direct cytokines, such as VEGF and bFGF, can trigger migration and / or 
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proliferation of EC. Indirect cytokines, such as TGF-~ (Hanney et al., 1998) and TNF-a 
(Frater et al. , 1987), cannot directly promote migration and / or proliferation of EC but 
have an effect on the angiogenic process which is modulated through other cells or 
cytokines (Sunderkotter et al. , 1991). The angiogenic cytokines can also be classified into 
those capable of driving the whole process of angiogenesis such as VEGF (Thomas, 
1996) and those capable of promoting only discrete sections of the angiogenic process. 
For example, TNF-a only induces the production of proteases in EC (Niedbala, 1993 ). 
The effects of these individual factors on the EC are contextualised in vivo by interactions 
between the cytokines (Rifkin et al. , 1990); ECM (Powell et al., 1996); cytokine 
receptors (Mandriota et al., 1996) and other cells. Thus the effect of individual cytokines 
on the process of angiogenesis is difficult to dissect. Despite this complexity, a brief 
overview of some of the key cytokines involved in angiogenesis is helpful to 
understanding the process more fully (Schott and Morrow, 1993). 
Basic fibroblast growth factor (bFGF) and the related acidic fibroblast growth factor 
(aFGF) are ubiquitous cytokines found in many tissues (Schott and Morrow, 1993). Basic 
FGF production is induced in EC, SMC and nonvascular cells by a variety of stimuli such 
as hypoxia and other cytokines (Brogi et al., 1994). Basic FGF and aFGF are released 
into the ECM by the cells and bind to heparan sulphate proteoglycans in the basement 
membrane (Baird and Ling, 1987). Such binding increases the stability of the cytokines 
and forms a reservoir of the factors that may be released by degradation of the basement 
membrane during invasion of migrating EC regulating angiogenesis in a paracrine 
fashion (Klagsbrun, 1992). Basic FGF has been shown to induce mitogenesis in multiple 
cell types including SMC and EC (Slavin, 1995). This effect coupled with a promotion of 
protease production (Presta et al. , 1986), migration and tube formation (Montesano et al. , 
1986) in EC makes it a potent direct inducer of angiogenesis. Furthermore, the 
upregulation of production of the angiogenic cytokine VEGF in SMC (Stavri et al. , 
1995a) and the co-ordinate upregulation of the VEGF receptor KDR expression in EC 
(Pepper and Mandriota, 1998) are brought about by bFGF. These interactions are capable 
of multiplying the initial angiogenic signal. 
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Another angiogenic growth factor released from the matrix during endothelial sprout 
invasion is TGF-P (Cox and Maurer, 1997; Rifkin et al., 1990). In contrast to the role of 
bFGF, TGF-P inhibits proteolysis (Rifkin et al., 1990); halts endothelial cell proliferation 
(Baird and Durkin, 1986; Frater et al., 1986); downregulates expression of receptors for 
other angiogenic cytokine (Mandriota and Pepper, 1997) and stimulates ECM production 
(Pepper, 1997b) in vitro. These anti-angiogenic properties of TGF-P may serve to balance 
the angiogenic effect of bFGF (Saksela et al., 1987). Following angiogenesis, pericytes in 
contact with EC have been shown to release TGF-P which has been implicated in 
maintaining the quiescent differentiated state in EC (RayChaudhury and D'Amore, 1991) 
without inhibiting pericyte proliferation (D'Amore and Smith, 1993). Preliminary 
evidence indicates that some of the components of the ECM released by EC in response 
to TGF-p may play a part in this anti-proliferative effect of TGF-P (RayChaudhury and 
D'Amore, 1991). However, despite these diverse inhibitory effects on angiogenesis in 
vitro, TGF-p is angiogenic in vivo (Madri et al., 1988). This may be due to the 
modulation of the in vivo angiogenic response by other cell types such as SMC (Brogi et 
al., 1994), macrophages and monocytes (Cavaillon, 1994). For example, TGF-P is 
chemotactic for macrophages and may induce the production of direct angiogenic 
molecules such as VEGF in these cells (Harmey et al., 1998). A direct pro-angiogenic 
effect on EC by TGF-P is that of tube formation. TGF-P has been shown to induce 
formation of a branching tubular structure in EC in vitro (Madri et al., 1988) and its 
functions in capillary remodelling are possibly more consistent with the completion of 
angiogenesis and the establishment of mature neocapillaries. 
Another cytokine shown to play a role in endothelial cell tube formation during 
angiogenesis is PDGF-B (Battegay et al., 1994). PDGF is composed of homologous 
polypeptide chains, termed A and B, that are expressed as mitogenically active homo- or 
hetero-dimers with different roles and cellular specificities (Schott and Morrow, 1993). 
Of these, PDGF-BB is the most potent inducer of mitosis for EC (Marx et al., 1994). 
Production may be induced in a variety of cells including SMC and EC in response to 
injury (Ross et al., 1990) or cytokines, such as TGF-P (Starksen et al., 1987) and TNF-a 
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(Li et al., 1997b ). In addition to its role in tube formation and mitogenic activity for EC in 
vitro (Marx et al., 1994), its effect on EC in vivo may be mediated through the release of 
VEGF and bFGF by vascular SMC (Brogi et al., 1994). Following angiogenesis, the 
endothelial cell sprout may also direct the recruitment and differentiation of pericytes / 
SMC by the mediation of PDGF-BB (Hirschi et al., 1999). Thus PDGF-BB plays a part 
in the recruitment of both components of the capillary (D'Amore, 1992a). 
In contrast to the multi-cellular responses elicited by the above cytokines, the response to 
VEGF is potently and specifically mitogenic for micro- and macro-vascular EC (Shibuya, 
1995). It may exist as one of four different molecular species: VEGF 121 ; VEGF, 65 ; 
VEGF, 89 and VEGF206, which are distinguished by the number of amino acids in each 
molecule. These isoforms arise from alternative splicing of a single gene and have 
different physical properties (Ferrara and Davis, 1997). VEGF 121 is a free soluble form; 
VEGF165 is found both free and bound to the cell surface and ECM; VEGF, 89 and 
VEGF206 are completely sequestered by the ECM (Ferrara and Davis, 1997). The 
differences in ECM binding by the isoforms are due to variations in heparin affinity and 
directly affect their bioavailability (Park et al., 1993). The heparin-bound VEGF, 89 and 
VEGF206 isoforms in the basement membrane have limited access to and thus little effect 
on the EC (Ferrara and Davis, 1997) and the non-heparin binding VEGF 121 isoform is 
considerably less mitogenic than the VEGF, 65 species (Ferrara and Davis, 1997). This 
may be due to mediation of VEGF-receptor binding by the interaction of VEGF, 65 with 
heparan sulphate on the cell surface which may orientate and localise the cytokine to its 
receptor and thus contribute to effective signal transduction and stimulation of EC 
(Dougher et al., 1997; Tessler et al., 1994). VEGF165 is the predominant molecule 
released by a variety of normal and transformed cells (Ferrara and Davis, 1997). As the 
majority of the research into this cytokine has dealt with this major isoform (hereafter 
referred to as VEGF), this work will focus on its role in angiogenesis. 
VEGF is produced throughout the body by a variety of normal embryonic or adult tissues 
and abnormal or tumour cells which require the recruitment of capillaries (Shibuya, 
1995). The chief source ofVEGF in the vasculature is the SMC / pericytes (Couffinhal et 
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al., 1997; Ferrara et al., 1991; Williams et al., 1995) although temporally activated 
macrophages may be responsible for VEGF production (Harmey et al., 1998) and recent 
reports indicate the possibility of autocrine production of VEGF by stimulated EC 
(Namiki et al., 1995; Wang et al., 1999). VEGF production in SMC/ pericytes (Ferrara et 
al., 1991), as with many cells in the body (Ferrara and Davis, 1997), can be induced by 
hypoxia (Brogi et al., 1996; Shweiki et al., 1992), a variety of hormones (Shibuya, 1995) 
and notably by other angiogenic cytokines (Williams, 1997) including the above 
mentioned bFGF (Stavri et al., 1995a), PDGF-BB (Stavri et al., 1995b; Williams et al., 
1995) and TGF-~ (Brogi et al., 1994). The centrality of VEGF in the smooth muscle cell-
mediated interactions of other angiogenic cytokines with EC emphasises its importance 
in the process of angiogenesis. The specificity of VEGF activity for EC in the absence of 
a smooth muscle cell response (Ferrara and Davis, 1997) also makes it stand out from the 
other angiogenic cytokines. 
The specificity of VEGF for EC is defined by the presence of the two predominantly 
endothelial cell specific VEGF receptors (Thomas, 1996): fms-like tyrosine kinase-I (Flt-
1) and kinase insert domain-containing receptor (KDR). (Although Flt-1 has recently 
been identified to induce protease release in SMC (Wang and Keiser, 1998) and to 
mediate the mitogenic activity of VEGF for pericytes (Takagi et al., 1996; Yamagishi et 
al., 1999), both of which may contribute to angiogenesis, the activity of VEGF receptors 
in other cells is rare (Neufeld et al., 1999; Shibuya, 1995).) Both of the receptors are 
tyrosine kinases and respond to binding of VEGF by dimerising and autophosphorylating 
(Hanahan, 1997; Heldin, 1995; Mustonen and Alitalo, 1995). Although present on the 
mature endothelium, Flt-1 (also known as VEGF receptor-I (VEGFR-1)) is unable to 
drive proliferation and chemotaxis alone and appears to play more of a role in 
developmental vasculogenesis (Kroll and Waltenberger, 1997; Weatherford et al., 1996). 
The function of Flt-1 in the adult vasculature remains unclear (Waltenberger et al., 1996) 
but may be associated with ongoing vascular repair and maintenance of permeability 
(Peters et al., 1993). By contrast, KDR (also know as foetal liver kinase-I (Flk-1) and 
VEGF receptor-2 (VEGFR-2)) can transduce signals for mitogenicity, chemotaxis and 
cytoskeletal organisation (Neufeld et al., 1999). The difference in cellular response to the 
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activation of each of the receptors is reflected in their distinct signal transduction 
pathways following phosphorylation (Waltenberger et al., 1994). While little is known of 
the signal transduction events following Flt-1 activation, in the case of KDR, the diverse, 
and in some cases unique (Doanes et al., 1999), signal transduction cascades triggered by 
phosphorylation correlate with the diversity of endothelial cell functions associated with 
this receptor (Kroll and Waltenberger, 1997). 
The level of the VEGF receptors on the endothelial cell surface is regulated by many of 
the same factors affecting the expression of VEGF in other cells (Shibuya, 1995). This 
parallel regulation of the ligand and its receptor may tighten the control of angiogenesis 
by co-ordinating the release of VEGF with the expression of its receptor. Cytokines such 
as bFGF increase both the levels of KDR on the endothelial cell surface (Pepper and 
Mandriota, 1998) and VEGF secreted by adjacent SMC (Stavri et al., 1995a). Similarly, 
hypoxia, shown to induce production of VEGF in many cell types (Brogi et al., 1996; 
Shweiki et al., 1992) - and recently in EC (Liu et al., 1995) - has been demonstrated to 
upregulate the expression of the KDR receptor on EC in some studies (Brogi et al., 1996; 
Waltenberger et al., 1996) although it is unaffected in others (Gerber et al., 1997). This 
regulation of receptor expression may enable VEGF produced by hypoxic EC to act in a 
paracrine fashion during angiogenesis. 
The role of VEGF in angiogenesis is not limited to proliferation. VEGF also induces 
migration by its potent and endothelial cell-specific chemotactic nature (Abramovitch et 
al., 1998; Neufeld et al., 1999°; Senger et al., 1996; Visweswaran et al., 1997). In parallel 
to the induction of endothelial cell migration, VEGF can also induce the production of 
proteases in microvascular (Lamoreaux et al., 1998; Mandriota and Pepper, 1997) and 
lymphatic (Pepper et al., 1994) EC. These proteases are involved in the migration of the 
EC during angiogenesis (Mignatti and Rifkin, 1996) in conjunction with VEGF-
upregulated adhesion molecules (Senger, 1996; Senger et al., 1996). Early research 
focussed on the ability of VEGF to increase the permeability of the endothelial layer 
(hence the synonym vascular permeability factor (VPF) (Senger et al., 1983)). An 
increase in vascular permeability, mediated by a loosening of intercellular connections or 
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the induction of fenestrations (Shibuya, 1995), may be a crucial step in angiogenesis 
(Dvorak et al., 1995). It has been proposed that plasma escaping through the 
permeabilised endothelial layer may form an extravascular fibrin gel ideal for migration 
of EC (Senger et al., 1993). In addition, VEGF can induce the formation of tubular 
structures in vitro (Goto et al., 1993). 
A further crucial function of VEGF is that of endothelial cell survival and maintenance. 
During vasculogenesis in vivo, VEGF (Alon et al., 1995; Gerber et al., 1999) and both of 
its receptors (Fong et al., 1995; Millauer et al., 1993; Shalaby et al., 1995) have been 
shown to be essential for vessel maturation. However, the widespread presence of VEGF 
in postnatal vessels after development (Couffinhal et al., 1997) has led to investigations 
into a "housekeeping" function for VEGF. Quiescent EC expressing both the KDR 
(Quinn et al., 1993) and Flt-1 (Peters et al., 1993) receptors may be exposed to this 
constitutive VEGF stimulus without the induction of angiogenesis (Couffinhal et al., 
1997). The expression of these receptors in mature vessels suggests a role in ongoing 
repair and "housekeeping" (Jakeman et al., 1992). In a similar fashion, although it may 
not be the only survival factor necessary for EC from all tissues (Etoh et al., 1989; Karsan 
et al., 1997), VEGF has been found to improve endothelial cell survival on polystyrene 
culture dishes (Watanabe and Dvorak, 1997) and to be imperative for synovial 
endothelial cell survival in vitro (Yamane et al., 1994). A number of studies have 
elucidated the nature of the signalling pathways involved in maintenance and repair of 
the luminal endothelium by VEGF (Gerber et al., 1998; Nor et al., 1999). The survival 
function ofVEGF seems to be mediated by the KDR receptor rather than Flt-1 (Gerber et 
al., 1998; Meeson et al., 1999). This is in contrast with the proposed roles of Flt-1 as the 
dominant receptor in maintenance of the quiescent endothelium (Peters et al., 1993) and 
KDR as the dynamic mediator of angiogenesis (Millauer et al., 1993; Quinn et al., 1993). 
VEGF seems to promote cell survival by halting apoptosis (Nor et al., 1999) 
experimentally-induced in EC by anchorage disruption (Watanabe and Dvorak, 1997) or 
cytokines (Spyridopoulos et al., 1997) or in haematopoietic cells by radiation (Katoh et 
al., 1995). In addition to its function in survival, VEGF may also play a long-term role in 
maintenance of correct permeability of the endothelium (Shibuya, 1995). In adult wound 
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healing, EC invading the fibrin matrix (Liu et al., 1990) may regress by apoptosis as the 
local levels of angiogenic cytokines diminish. This leaves a collagenous and acellular 
scar. Thus, the continued maintenance of the EC appears to be as important to healing of 
the vascular graft as the recruitment of EC during angiogenesis (Desmouliere et al., 1997; 
Kischer, 1992). 
Due to the specificity of the endothelial cell response in the absence of overt smooth 
muscle cell proliferation, a number of groups have proposed strategies to use the VEGF-
KDR ligand-receptor signalling system to improve healing of vascular grafts. One in 
vitro strategy employed VEGF and heparin embedded in fibrin glue to selectively 
increase endothelial cell proli~eration while avoiding smooth muscle cell growth 
(Weatherford et al., 1996). It is hypothesised that this approach will increase patency of 
the graft in vivo by encouraging the development of an antithrombotic endothelium in the 
absence of unrestrained smooth muscle cell proliferation associated with intimal 
hyperplasia. Masuda et al (1997) used VEGF alone attached to the graft to improve the 
transmural and transanastomotic endothelialisation of vascular grafts. As discussed 
above, the presence of an antithrombotic endothelium has been shown to improve graft 
patency (Zilla et al., 1999). A further study used transfection of vascular SMC with the 
VEGF gene in vitro in the hope that increased production of VEGF by such SMC seeded 
on the graft will promote the growth of an endogenous endothelium in vivo 
(Visweswaran et al., 1997). If these or similar strategies are successful in promoting the 
endothelialisation of the graft the challenge remains to populate the wall of the graft with 
a functional muscular component. 
b. Musculogenesis 
Following the ingrowth of capillaries from the adventitia, a number of scenarios exist for 
the accompanying migration of SMC into the graft wall. Despite isolated evidence of 
SMC originating from the blood (Feigl et al., 1985; Kouchi et al., 1998) and 
differentiated myofibroblasts (Okahara et al., 1995; Greisler et al., 1992) these scenarios 
seem unlikely to provide the bulk of the SMC and the most likely source for proposed 
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contractile cells in the pores of a graft is by attraction via cytokines released by the EC, 
the fibrin matrix and macrophages. 
As mentioned above, angiogenic EC migrating into a matrix are usually accompanied by 
pericytes (D'Amore, 1992a). Pericytes have been shown to be precursors for SMC and 
may be recruited and induced to mature under the mediation of PDGF-BB and other 
factors released by the EC (Darland and D'Amore, 1999; Swinscoe and Carlson, 1992). 
Recent work has also shown the pericytes to be subject to the mitogenic effects of VEGF 
in parallel to the endothelial cell response (Y amagishi et al. , 1999) allowing the 
simultaneous migration of the whole capillary in response to this cytokine. Ingrowing 
SMC may also originate from the media of the adjacent vessel at the anastomosis 
(Clowes et al. , 1986a; Okahara et al., 1995). There appears to be some phenotypic 
plasticity between the related SMC and pericytes and a sub-population of SMC in the 
vessel wall may be recruited as pericytes by EC during angiogenesis (Nicosia and 
Villaschi, 1995). These findings have been supported in vivo (Zacharias et al., 1988), 
where EC have been shown to promote infiltration and proliferation of SMC in a number 
of histological observations (Allen et al., 1994). 
Chemotactic cytokines for SMC ,/, pericytes may also be incorporated during the 
formation of the fibrin matrix within the interstices of a prosthetic graft and thus induce 
smooth muscle cell invasion (D'Amore, 1992b) into the wall of the structure. During 
proteolytic migration, the SMC or pericyte may utilise the sequences within the fibrin 
matrix (Yee et al. , 1998) and protein components (Naito et al., 1992; Patel et al., 1997) as 
a scaffold in a similar way to migratory EC. However, despite these potential sources of 
SMC it is the observation that they are conspicuous by their absence in most implanted 
vascular grafts (Davids et al. , 1999). 
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4. The Possible Role of Compliance in a Spontaneously 
Healing Prosthetic Vascular Graft 
Developments in cell seeding have been paralleled by improvements in the materials 
involved in vascular grafts. One amongst many materials which shows promise in small 
diameter vascular prostheses is biostable polyurethane (PU) (Coury, 1999). This is a 
thermoplastic polymer into which pores of a larger size than those found in ePTFE and 
PET can be fashioned by the addition of a soluble filler to the polymer while it is still in 
solution (Deon Bezuidenhout, University of Cape Town Medical School, Cape Town, 
South Africa, personal communication). The filler is then dissolved out of the structure 
leaving a network of interconnecting pores with sizes up to the 60-1 OOµm diameter range. 
This pore size is sufficient for the ingrowth of whole capillaries; bundles of SMC; the 
secretion of an elastin- and collagen-rich matrix and the rearrangement of EC and SMC 
involved in healing. It is hoped that this will facilitate the integration of the cellular 
components of the graft wall including SMC (Hess et al., 1983) and vasa vasorum. In 
addition to larger pore sizes, a chemically modified surface of the PU may reduce the 
absorption of blood proteins and thus lower the adhesion of macrophages to the graft 
(Coury, 1999). It is hoped that this will in tum attenuate the prolonged inflammatory 
response seen in present grafts which precludes successful integration. In the absence of 
inflammation the main goal for mature healing in the graft is that of maintenance of the 
cellular components without regression or hyperproliferation. In this case, the 
biomechanical properties of the graft may significantly contribute in a more sustained 
way to the long-term cellular responses. PU is also distinguished from ePTFE and Dacron 
as a graft material by its physical properties (Coury, 1999). Some porous PUs are 
elastomeric and as such may better approximate the mechanical environment found in the 
natural artery. As mentioned above, such matching of compliance has been shown to 
improve healing (van der Lei et al., 1987) and has been shown to reduce 
hyperproliferation of SMC (Miwa et al., 1993). Although little is known about the long-
term healing patterns in compliant grafts, the material qualities of thermoplastic 
elastomers set them aside from the other polymers currently used in vascular prostheses. 
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Considering the manifold effects of cyclic deformation on vascular SMC, the presence of 
SMC within the interstices of a compliant graft brings with it some intriguing 
possibilities. Smooth muscle cells have been shown to produce ECM, alter proliferation 
and produce growth factors in response to cyclic stretch in vitro (Mills et al., 1993; 
Reusch et al., 1996; Sumpio and Banes, 1988b ). If these responses are mirrored in situ, 
the possibility exists that, in addition to a structural and functional role, SMC stretched 
within the graft wall might play a major part in maintaining EC and altering their activity 
by release of ECM and cytokines as observed above. 
EC have been shown to be paramount with regards to the patency of synthetic grafts. 
Although the fibrin matrix within the graft wall is initially highly favourable to 
endothelial cell migration, EC fail to achieve full thickness transmural ingrowth into most 
of the contemporary vascular prostheses, most likely due to prolonged inflammation, 
limited porosity and the build-up of a hostile ingrowth matrix. However, as soon as these 
obstacles are overcome, by advances in anti-inflammatory treatment and graft design, the 
challenge will not be so much to induce endothelial cell invasion as to retain the 
functional endothelial layer. In light of the intense interrelation between EC and SMC in 
the vessel wall and the maintaining role of VEGF in the vasculature, SMC appear to be 
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important players in endothelial cell maintenance. The low levels of SMC and pericytes 
potentially invading a graft are not likely to become a bulk of SMC resembling the 
natural vessel wall Therefore, it is unlikely that SMC - pacified by endothelial cell 
mediation - will become the villains of intimal hyperplasia. On the contrary, it is more 
likely that they will complete a physiological healing pattern of synthetic vascular grafts 
by avoiding a stiff collagen matrix and facilitating the maintenance of functional 
capillaries and endothelial coverage through their secretion of VEGF. 
In typical wound healing, decreasing tissue levels of VEGF lead to a purposeful 
regression of the abundant microvessels of granulation tissue. As the oxygen supply to a 
wound matrix improves due to the new vessels, the production of VEGF decreases 
(Benjamin et al., 1998). Due to the survival role which VEGF has on EC this decrease in 
40 
VEGF concentrations results in cell apoptosis (Benjamin et al., 1998). In addition, 
macrophages may mediate the apoptosis of capillary loops by deprivation of VEGF in the 
plasma (Meeson et al. , 1999). These mechanisms result in a trimming of the vascular tree 
based on oxygen demand prior to pericyte recruitment. Pericytes, recruited in parallel by 
VEGF (Yamagishi et al., 1999) or by PDGF-BB (D'Amore, 1992a) released by the EC, 
establish contact with the endothelial cell tube. Establishment of pericyte contact with the 
EC results in an abrogation of the survival dependence on VEGF and the establishment of 
a quiescent phenotype in the EC (Benjamin et al., 1999). This is consistent with the 
observation of lower endothelial cell turnover in vascular beds in which the pericyte: 
endothelial cell ratio approaches 1: 1 such as the brain microvasculature (Stevens and 
Lowe, 1992) and the observed vulnerability of EC supplying tumours, which lack 
pericytes, to apoptosis in the absence of high concentrations of VEGF (Benjamin et al. , 
1999). The maintenance of the endothelial cell by the pericyte may be mediated by the 
contact-dependent production of collagen IV into the basement membrane and TGF-~, 
which maintains the EC in a quiescent state, lowers the expression of the VEGF receptor 
KDR (Mandriota et al. , 1996) and stimulates the production of further basement 
membrane components responsible for inducing quiescence in EC (Darland and 
D'Amore, 1999; RayChaudhury and D'Amore, 1991 ). Pericytes also release the related 
angiopoietin-1 and angiopoietin-2 in a paracrine fashion (Darland and D'Amore, 1999). 
Angiopoietin-1 has been show to be important for endothelial cell survival during 
development and to reduce apoptosis and increase stability of mature capillaries (Kwak et 
al. , 1999; Papapetropoulos et al. , 1999) in conjunction with VEGF (Asahara et al., 1998). 
While VEGF may be important in early capillary formation, the maintaining role of 
angiopoietin-1 seems to be limited to later stabilisation of the capillary (Peters, 1998). In 
contrast, angiopoietin-2 destabilises capillaries and appears to be involved in migration of 
EC during angiogenesis (Asahara et al. , 1998). In this way a balance between 
destabilising factors and inhibitors is established which results in a capillary which is not 
dependant on high concentrations of cytokines for survival (Darland and D'Amore, 1999; 
Hanahan, 1997). Finally, pericytes have been demonstrated to produce angiopoietin and 
VEGF as a survival factors in stable capillaries in the corpus luteum (Goede et al. , 1998; 
Reynolds and Redmer, 1998) and in response to many of the same stimuli inducing 
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VEGF production in the SMC (Kim et al., 1998). It appears therefore that, although the 
dependence on VEGF for endothelial cell survival decreases with the arrival of pericytes 
in the mature capillary (Benjamin et al., 1998), low levels of VEGF are still produced by 
the pericyte in a similar way to that observed by SMC in vivo (Couffinhal et al., 1997; 
Ferrara et al, 1991). Given the similarities in function and response between the two cell 
types (Nicosia and Villaschi, 1995), the production of VEGF by mesangial pericytes 
(Gruden et al., 1997) and other contractile vascular cells (Seko et al, 1999) under stretch 
and the profound effects of cyclic stretch on SMC including cytokine production (Mills et 
al., 1993), it seemed worthwhile investigating the role which cyclic stretch might play in 
VEGF expression in SMC potentially populating a compliant graft. To date no other 
study has addressed this question. 
I hypothesised that SMC under physiological levels of cyclic stretch will express and 
release VEGF. The first aim of this work was to determine the extent and time course of 
VEGF expression by SMC due to these levels of cyclic stretch using an in vitro model. In 
addition, if any VEGF was expressed by SMC under cyclic stretch it would be useful to 
determine whether it was released by the cells at sufficient levels into the cultured media 
to affect endothelial cell physiology. Following this, I wished to determine whether cyclic 
stretch induced VEGF expression in other mammalian species and if cyclic stretch could 
influence the expression of other cytokines such as PDGF, bFGF and TGF-~. 
Although VEGF released by stretched SMC may be capable of inducing a response in EC 
it is additionally possible that VEGF receptors on stretched EC may be affected by cyclic 
stretch. Studies showing the phosphorylation of cytokine receptors under cyclic stretch in 
the absence of their respective ligands (Hu et al., 1998; Osawa et al., 1997) raise the 
possibility that similar activation of the VEGF receptors on EC by stretch alone may 
occur in vivo. This may alter the endothelial cell response to locally-released VEGF from 
stretched SMC. Of the two constitutively expressed VEGF receptors on EC, KDR 
appears to play the predominant role in mediating endothelial cell survival due to VEGF. 
In addition, KDR has also been recently demonstrated to be phosphorylated by shear 
stress and thus act as a mechanoreceptor for this force (Chen et al., 1999). Therefore, a 
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further aim of this work was to determine the effect of cyclic stretch on KDR expression 
and phosphorylation on EC. I aimed to outline the timecourse and magnitude of any 
response compared to the response from VEGF stimulation. This information should give 
an indication of how cyclic stretch will effect EC response to VEGF released by SMC 
under cyclic stretch. It is hoped that a better understanding of the role of VEGF 
communication between stretched SMC and EC will enable the design of a graft in which 
the level of compliance encourages the maintenance of a functional endothelium and 
more complete healing. 
In order to investigate this relationship in vitro EC and SMC must be cultured under 
cyclic stretch. In light of accumulating evidence that cells residing in a dynamic system 
in vivo may be affected by the stresses to which they are subjected, a number of culture 
systems have been developed to grow cells under stretched conditions. Their use has led 







Flex I plate 
Vacuum 
manifold 
Figure 5. Schematic diagram of in vitro application of cyclic stretch to cells (after 
Sumpio et al., 1987). A. Cells seeded in Flex I plate placed in vacuum manifold in neutral 
position. B. Vacuum is applied to base of Flex I plate resulting in deformation. Cells 
adherent to the elastomeric base of the plate are subjected to the same elongation as the 
base (curved arrows). C. Vacuum is released and Flex I plate resumes neutral position. 
Cells were cycled at 10% deformation and 1 Hz (0.5 s deformation alternating with 0.5 s 
in the neutral position). 
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In order for cells to be stretched in vitro they must be grown on a deformable surface. 
These substrates are either rectangular (uniaxial) or circular (biaxial) in design and range 
from plastic culture dishes (Banes et al., 1985) to silicone rubber membranes (Ives et al., 
1986) to elastin membranes (Leung et al., 1976). Rectangular surfaces are stretched 
mechanically while circular systems rely on vacuum deformation. The chief difficulties 
encountered are the maintenance of sterility and consistent levels of stretch and largely 
for these reasons the vacuum system has emerged as the model of choice. An early study 
using a circular system was carried out using vacuum pressure to deform aortic tissues 
from swine and dogs (Thibault and Fry, 1983). Subsequently, vacuum pressure was used 
to deform rigid culture dishes (Banes et al., 1985) and more recently circular dishes with 
elastomeric bottoms have been used (Harris et al., 1990) (Figure 5). Despite the fact that 
plating efficiency and the growth rate of some cell types on these flexible bottomed plates 
was decreased relative to those cultured on polystyrene tissue culture surfaces, the level 
of stretch can most easily be controlled in this system (Gilbert et al., 1994). Although 
studies using cyclic stretch are in no way a complete simulation of the complex in vivo 
environment due to the study of isolated biomechanical forces and cell types, the use of 
such cell culture systems may allow a more physiological study of systems under 
pulsatile stretching (Langille, 1993). Using similar systems, cyclic stretch has been show 
to exert important effects on phenotypic expression and growth of a number of cell types 
in vitro including vascular cells (Sumpio, 1989); fibroblasts (Banes et al., 1985); bone 
(Hasegawa et al., 1985) and epithelial cells (Brunnette, 1984). These studies have shown 
that physical deformation is perceived differently by different cell types and is not a 
generalised cell response (Sumpio and Banes, 1988b ). Of all cells in the body normally 
subjected to mechanical deformation EC and SMC within the arterial wall are prototype. 
In these cells the forces experienced are relevant to the regulation of cell morphology and 
function. Following this, I endeavour to use a commercially available vacuum-based 
cyclic stretch apparatus to investigate the effect of cyclic stretch on VEGF 
communication between vascular SMC and EC. 
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Methods and Materials 
1. Cell Culture 
Bovine Endothelial Cells 
Thoracic aortas of calves were removed aseptically and placed in phosphate buffered 
saline (PBS) with 200 U/ml penicillin and 200 µg/ml streptomycin and transferred on ice 
to the tissue culture facility. After removal of side vessels, fat and the adventitia to 
eliminate other cell types, the vessels were opened in a laminar flow hood and bovine 
aortic EC were obtained by the standard laboratory technique of gently scraping the 
internal surface of the aorta (Sumpio et al. , 1987). Cells were maintained in Dulbecco's 
modified Eagles (DME) high glucose medium/Ham's F-12 1: 1 (with 50 mM HEPES 
buffer, pH 7.2 and lOmM L-glutamine and NaHC03) supplemented with 10% vol/vol 
heat-inactivated foetal bovine serum (FBS), 5 µg/ml deoxycytidine/thymidine, antibiotics 
(penicillin 100 U/ml, streptomycin 100 µg/ml) and antimycotic (amphotericin B 250 
ng/ml) . The cells were incubated at 37°C in a humidified 5% CO2 incubator until 
confluent. Cells were seeded at low density and in many cases cultures were clonal. EC 
were identified by their typical closely opposed polygonal "cobblestoned" morphology of 
confluent monolayers seen at 1 OOx magnification under phase contrast microscopy and 
maintenance of density-dependent inhibition after serial passage. Cells isolated in this 
way have previously been shown to be free of other cell types (Sumpio et al. , 1987). At 
confluency, EC were subcultured using 0.01 % trypsin for detachment. Passages 2-4 were 
used in subsequent experiments. Cells were seeded at densities corresponding to 
confluency (6x 104 cells/cm2) , as determined by using a Coulter cell counter. They were 
subsequently grown in specialised Flex I plates for the application of cyclic stretch and 
quiescence induced by using 0% FBS and Ix insulin, transferrin, selenium (ITS) 
supplement (final concentrations: insulin 10mg/L, transferrin 5.5 mg/Land selenium 5.0 
µg/L) (Libby and O'Brien, 1983) for 24 hrs prior to experiment. The EC must be induced 
to quiesce to approximate the in vivo condition where they are non-proliferative and non-
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migratory (Couffinhal et al., 1997). If the cells are in a proliferative phenotype during the 
experiment then results may be due to increases in cell number rather than the stimulus 
being tested. In addition the use of serum-free medium ensures that the EC are not 
stimulated to by growth factors in the serum. Media with 0% FBS with lx ITS was found 
to be effective in inducing quiescence of SMC with maintenance of high cell numbers 
(see below) and when the same conditions were applied to endothelial cell culture they 
were found to be as effective. 
Bovine Smooth Muscle Cells 
SMC were isolated using standard laboratory technique (Sumpio and Banes, 1988b; 
Ross, 1971). After complete removal of the endothelial layer by mechanical scraping, 
two-millimeter sections of the aortic wall were removed and placed in a 25 ml culture 
flask with medium consisting ofDME (with 25 mM HEPES buffer, pH 7.2 and 2 mM L-
glutamine and 44 mM NaHC03) supplemented with 10% heat-inactivated FBS, 
antibiotics (penicillin 100 U/ml, streptomycin 100 µg/ml) and an antimycotic agent 
(amphotericin B 250 ng/ml). The sections were then incubated at 37°C in a humidified 
5% CO2 incubator until smooth muscle cell outgrowth was detected. Uniform populations 
of SMC were identified by their characteristic morphology and undulating "hill and 
valley" confluent monolayer in culture as seen at 1 OOx magnification under phase 
contrast microscopy (Sumpio and Banes, 1988b). Cultures isolated in this way were 
previously determined to be free of contaminating fibroblasts and EC by staining with an 
anti-a-actin antibody, which stains for the smooth muscle cell-specific protein a-actin 
(Powell et al., 1997). Cells were allowed to grow to confluency before subculture using 
0.01 % trypsin. Passages 2-4 were used in subsequent experiments. Cells were also seeded 
at confluency (5x 104 cells/cm2) in specialised Flex I plates for the application of cyclic 
stretch and quiescence induced by culture in 0% FBS + lx ITS (final concentrations: 
insulin 10mg/L, transferrin 5.5 mg/Land selenium 5.0 µg/L) (Libby and O'Brien, 1983) 
for 24 hrs prior to experiment. It was necessary to induce quiescence in SMC in 0% FBS 
to establish a baseline for detection of VEGF as serum has been shown to upregulate 
VEGF mRNA expression in SMC (Williams et al., 1995). This is possibly due to the 
47 
presence of growth factors in commercial FBS. Furthermore, the SMC must be induced 
to quiesce to approximate the in vivo condition where they are non-synthetic and non-
proliferative. If the cells are in a synthetic / proliferative phenotype during the experiment 
then results may be due to non-specific cytokine expression or increases in cell number 
rather than the stimulus being tested (Namiki et al. , 1995). Equal numbers of SMC were 
seeded in media with 0.5% FBS or 0% FBS with or without ITS to determine the 
conditions best suited to induce quiescence but allowing maximal cell adherence. After 
24 hours the plates were examined under phase contrast microscopy and washed 2x with 
PBS to remove floating cells. Adherent SMC were then resuspended by incubation with 
0.01 % trypsin and counted using a Coulter counter. 
Rat Smooth Muscle Cells 
Passage 1 rat aortic SMC were purchased from the American type culture collection 
(ATCC) and cultured with DME (with 25 mM HEPES buffer, pH 7.2 and 4 mM L-
glutamine, 0.1 mM sodium pyruvate and 18 mM NaHC03) supplemented with 10% 
vol/vol heat-inactivated FBS, antibiotics (penicillin 100 U/ml, streptomycin 100 µg/ml) 
and antimycotic (amphotericin B 250 ng/ml). These cells were allowed to grow to 
confluency before subculture using 0.01 % trypsin. Passages 2-4 were used in subsequent 
experiments. Cells were seeded at confluency (5x 104 cells/cm2) , as determined using a 
cell counter, in specialised Flex I plates for the application of cyclic stretch and 
quiescence induced using the same conditions and supplements used for bovine SMC. 
2. In Vitro Application of Cyclic Strain to Cultured Cells 
Apparatus 
The stress unit ( described in detail by Banes et al. , 1985) consists of a vacuum manifold 
with recessed ports connected by vacuum lines to a regulator solenoid valve that is 
controlled by a computer with a timer program. The timer controls the duration and 
frequency of the applied stress. Cells were cultured on collagen-coated 25 mm 6-well 
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culture plates with a flexible elastomer bottom, Flex I plate, that could be deformed to a 
known percentage elongation by controlling the level of vacuum (Figure 5). The collagen 
coating may improve plating efficiency of EC and other cell types on the elastomeric 
surface (Sumpio et al., 1987) by providing a substrate to which the cells can readily 
attach (Watanabe and Dvorak, 1997). Since the cells were found by microscopic 
examination to remain attached to the surface of the dish they presumably experienced 
the same force that was applied to the plate bottom (Sumpio et al., 1987). Although the 
mechanical stress applied to adherent cells varies with the position of the cells in the 
culture plate due to the nature of stretch application, with a gradient of increasing stress 
from the centre of the dish to the periphery, an average strain can be calculated (Gilbert et 
al., 1994). 
Stretch conditions 
For these experiments the membrane bottoms were subjected to 150 mm Hg (20 kPa) of 
vacuum, which produces an average strain of 10% on attached cells, at a rate of 60 
cycles/min (lHz) (0.5 s deformation alternating with 0.5 sin the neutral position (Figure 
5)). Ten percent stretch is used as it is within the range of percentage deformation 
experienced by the walls of arteries (Awolesi et al., 1995; Lee and Wilson, 1986) and 
allows comparison with other studies and lHz used as it is the approximate physiological 
rate of stretch. Unstretched cells grown on identical collagen-coated Flex I plates were 
used as negative controls. Cells in stretched and control plates were checked at 1 OOx 
magnification under phase contrast microscopy after induction of quiescence to confirm 
that the cells maintained the integrity and confluence of the monolayer. In addition, each 
plate was viewed after the experiment to determine whether the cells had remained 
adherent to the plates during the experiment. Plates in which the majority of the cells 
were not adherent after induction of quiescence or after the experiment were discarded. 
Fluid agitation and vibratory oscillations encountered by cells due to the application of 
cyclic stretch, which may have artifactual effects on cells during the course of the 
experiment (Leung et al., 1976), are found to be minimised by the use of this vacuum 
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deformation system (Birukov et al., 1995; Davis et al., 1994). The use of this system also 
allows comparison of the results with the findings of other groups using the same system. 
EC were subjected to cyclic strain for time intervals up to 2 hours in accordance with 
expected time courses of receptor phosphorylation recorded in the literature (Hu et al., 
1998). Smooth muscle cells were subjected to up to 24 hrs of stretch following the 
expected time course of cytokine expression (Gruden et al., 1997). The use of quiescent 
cells and short time points (Wilson et al., 1993)should minimise bias due to cell 
proliferation during the experiment. 
3. RNA Extraction and Northern Blot Analysis 
Experimental Set-up 
Quiescent bovine and rat SMC were subjected to cyclic stretch to determine the effect of 
cyclic stretch on VEGF expression. Control and experimental cells were seeded 
identically on 4 Flex I plates. One plate remained unstretched and served as a negative 
control for any effects of culture of SMC under cyclic stretch while another plate was 
subjected to cyclic stretch as described above. Bovine bFGF was added to a further plate 
of SMC at the published value of 10 ng/ml as a positive control for expression of VEGF 
(Stavri et al., 1995a). (In addition, the concentration dependence of bFGF as a positive 
control for induction of VEGF mRNA was determined to check the suitability of the 
published concentration of lOng/ml for further experiments.) TNF-a is not known to 
stimulate VEGF production in SMC and thus was added at 10 ng/ml to the final plate of 
SMC to control for any response of the SMC to the process of addition of cytokines. 
Time Courses 
Cells were stimulated by cyclic stretch and bFGF for 4 hours following the demonstration 
in a 24 hour time course of VEGF mRNA expression that the maximal induction of 
VEGF mRNA due to both of these stimuli occurred at 4 hours. 
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RNA Extraction 
Smooth muscle cell RNA was extracted by the guanidium isothiocyanate method using 
TRIZOL as per the manufacturers instructions. Briefly, after washing the cells twice with 
PBS, 1 ml of TRIZOL per 10 cm2 of culture plate surface area was added to the cells and 
the lysate homogenised through a pipette before sitting for 5 minutes at room 
temperature. Chloroform (0.2 ml per ml of TRIZOL used in sample preparation) was 
added, the solution shaken vigorously and left at room temperature for 15 minutes. It was 
then centrifuged at 12,000 g for 15 minutes at 4°C. The upper aqueous phase was 
transferred to a fresh tube and 0.5 ml of isopropanol per ml of TRIZOL used in sample 
preparation added. This was mixed, allowed to stand at room temperature for 10 minutes 
and centrifuged at 12,000 g for 10 minutes at 4°C. The supernatant was removed and the 
pellet washed in at least 1 ml of 75% ethanol per 1 ml of TRIZOL used in sample 
preparation before centrifuging at 12,000 g for 5 minutes at 4°C. The pellet was dried 
using a pipette to the point of removing all drops of ethanol and resuspended in an 
appropriate volume of DEPC-treated water. For the concentrations of RNA required for 
this study, the RNA from one 30 ml six-well Flex I plate was resuspended in 15 µl of 
DEPC-treated water. 
Gel Electrophoresis 
RNA (10-20 µg, as determined by ultraviolet (UV) spectrophotometry) was mixed with 
3x volume of formamide sample loading buffer (appendix 1) per volume of RNA 
solution and incubated for 15 min at 65°C. Following this, 1.5 µl of 1 mg/ml ethidium 
bromide was added to each sample and the RNA was electrophoresed through a 1 % 
agarose/2% formaldehyde gel. The purity and integrity of the mRNA was checked by UV 
spectrophotometry and by the appearance of the RNA after gel electrophoresis. If RNA 
degradation was visualised as a smeared sample in gel electrophoresis or if protein 
contamination was detected as a ratio of absorbencies at 260 nm / 280 nm of less than 1, 
the experiment was discarded. The gel was photographed under UV, cut to an appropriate 
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size and rinsed once for 15 minutes in ddH20 and twice in 20x SSC with an inversion of 
the gel before the last rinse. 
Northern Blotting and Membrane Fixation 
Hybond-N nylon membrane was cut to fit the gel and soaked in lOx SSC prior to transfer. 
The gel was placed on a paper wick, the ends of which lay in 500 ml of 1 Ox SSC. The 
membrane was placed on the gel, all bubbles removed and overlaid with blotting paper, 
towelling and a weight. Drawing of the 1 Ox SSC by the blotting paper without passing 
through the gel was prevented by surrounding the gel/membrane interface with plastic 
wrap. Transfer was carried out overnight. 
After RNA transfer, the gel and membrane were viewed on a UV lightbox to check for 
completeness of transfer by visualisation of the 18S and 28S rRNA bands, the membrane 
was photographed and the 18S and 28S rRNA bands marked on the membrane. The RNA 
was then fixed to the membrane by 3 exposures of UV crosslinking at 254 nm for 120, 
150 and 150 seconds respectively before the membrane was sealed in a plastic 
hybridisation bag and stored at 4°C until probing. 
Prehybridisation and Probe Preparation 
Before probing, the membrane was briefly wet in 2x SSC in a sealable plastic 
hybridisation bag before 1 ml/25 cm2 of membrane of hybridisation solution was sealed 
in the bag and the membrane preincubated at 42°C for 2 hours. During this time the 
radiolabelled murine probe for VEGF and human probe for glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were prepared. There is a very high sequence homology 
between the murine and bovine VEGF cDNA and the human and bovine GAPDH which 
allow the cross-species use of probes. GAPDH was chosen as a ubiquitously expressed 
gene against which to compare changes in VEGF expression due to the maintenance of 
steady levels of GAPDH expression under conditions of cyclic stretch and cytokine 
stimulation of bovine vascular cells in culture (Awolesi et al., 1995; Williams et al., 
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1995). The constancy of the GAPDH signal for different samples was also used as a 
check for the efficiency of transfer and equality of RNA loading. 
To 50 ng of probe DNA (as determined by UV spectrophotometry at 260 nm) 45 µl of TE 
was added, boiled for 2 minutes to eliminate secondary structure, placed on ice and pulse 
centrifuged at 12,000 g to collect the condensate from the roof of the tube. This volume 
was placed with the pellet in the Ready-To-Go kit and thoroughly mixed. A 5 µl aliquot 
of a-32P dCTP was added to the random prime reaction and mixed and the tube incubated 
at 37°C for 15 minutes. During this incubation the storage buffer in a G-25 Sephadex 
column was drained by centrifugation at 1100 g for 2 minutes. The DNA solution was 
then pulse-centrifuged at 12,000 g and the entire volume placed in the centre of the 
Sephadex column. The column is placed in a collection tube and spun at 1100 g for 4 
minutes to pass the DNA through the column and remove any unincorporated a-32P dCTP 
nucleotides. The degree of incorporation of the a-32P dCTP into the eluant radiolabelled 
probe is then determined by measuring the disintegrations per minute (DPM) emitted by 
1 µl of the probe in a scintillation counter. 
Hybridisation, Washing and Autoradiography 
A volume corresponding to either lx 106 DPM of the probe for VEGF mRNA or 0.5x 106 
DPM of the probe for the more prevalent GAPDH mRNA per ml of hybridisation 
solution used in the prehybridisation stage was boiled for 2 minutes with 0.5 µl of ssDNA 
and 20 µl of TE. The solution was then placed immediately on ice and pulse-centrifuged 
at 12,000 g before addition to the prehybridisation solution. The membrane was 
hybridised with the probe overnight at 42°C. 
After hybridisation, the membrane was removed from the hybridisation bag and washed 
twice in 100 ml of 3x SSC/0.1 % SDS at 55°C with shaking for 15 minutes. Progress and 
efficiency of washing was checked by scanning the blot with a Geiger-Muller counter. 
The washes were selected to result in a signal of up to 4000 counts per minute (CPM). 
The membrane was drained of the wash solution, sealed in a new hybridisation bag and 
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placed between two sheets of autoradiographic film. On the outside of these films 
intensifying screens were placed to amplify the signal. Autoradiography was carried out 
at -80°C for between 1 and 4 days. The length of exposure was determined by the specific 
probe, count by Geiger-Muller counter and progress of exposure as monitored by 
developing of one of the films. Developing was carried out in an automatic developer. 
The optical density of hybridisation signals on developed films were analysed using a 
scanning densitometer for quantification of steady state mRNA levels. The sizes of the 
hybridising bands for VEGF and GAPDH were confirmed, by comparison with the 
marked positions of the 28S and 18S rRNA bands, at the published sizes of 4.2 kilobase 
(kb) (Williams et al. , 1995) and 1.2 kb (Awolesi et al. , 1995) respectively. 
Stripping 
Membranes probed for VEGF were stripped by washing in 100 ml of boiling 0.1 % SDS 
before subsequent hybridisation for GAPDH. After the membrane was placed in the 
solution, it was allowed to cool to room temperature with shaking and the efficiency of 
the stripping checked by scanning the blot with a Geiger-Muller counter. If necessary, the 
stripping was repeated until a count below 500 CPM was obtained. After stripping, the 
membrane was placed directly into an appropriate volume of hybridisation solution at 
42°C for hybridisation. 
Species-Specificity Pilot Study 
The species specificity of the smooth muscle cell response to cyclic stretch was 
determined using a pilot study which duplicated the above work in every aspect except 
using rat aortic SMC in place of bovine aortic SMC. 
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4. Conditioned Medium and Migration Assay 
Experimental Set-up 
To investigate the release by SMC of soluble chemotactic factors for endothelial cell 
migration, assays were carried out using conditioned media from SMC on EC made 
quiescent as above (0% FBS and lx ITS for 24 hours) . EC were exposed to the following 
variables of smooth muscle cell media: conditioned media from SMC stretched for 4 
hours; media from unstretched SMC, which served as the negative control for any effects 
of cyclic stretch on the release of factors by the SMC; the conditioned media from SMC 
to which bFGF at 10 ng/ml had been added for 4 hours served as the positive control for 
VEGF conditioned media; unconditioned smooth muscle cell medium (0% FBS and lx 
ITS), which was used to control for any cellular effects on the medium during the 24 
hours of induction of quiescence and the time course of the experiment. Migration values 
were all standardised against the values obtained using unconditioned smooth muscle cell 
media. Although the use of 0% FBS in the media may result in increased random 
chemokinesis as compared to the use of 10% FBS (Waltenberger et al., 1994), this should 
be corrected for by standardising against the negative controls. 
Smooth muscle cell were seeded and quiescence induced for 24 hours using the same 
conditions as used previously (0% FBS and lx ITS for 24 hours) before being treated 
with bFGF at 10 ng/ml, stretched or unstimulated for 4 hours. Cells were examined under 
phase contrast microscopy following induction of quiescence and after each treatment to 
ensure adherence and if the cells were damaged the plates were discarded. After the 
treatment, media were collected on ice, spun down at 12,000g at 4°C to clear any cellular 
debris and stored at -80°C until use in the migration assay. Clarity and pH of the media 
were also checked to screen for contamination or pH alteration stemming from smooth 
muscle cell exposure. 
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Antibody Abrogation 
In order to determine the role of VEGF in the chemotactic response of EC to smooth 
muscle cell conditioned media, the above set of experiments were duplicated with anti-
human VEGF antibody at 50 µg/ml added to the media of the second set of experiments 
for 20 minutes at room temperature in order to neutralise any VEGF in the media. Due to 
the conservation of the VEGF structure between species, it is reasonable to assume that 
the high concentrations of the polyclonal anti-human VEGF antibody will cross-react 
with any bovine VEGF released by the SMC. 
Endothelial Cell Migration Assay 
For the migration assay, a blind-welled chemotaxis chamber was used which consists of a 
bottom plate containing wells and a matching top plate separated by a polycarbonate 
membrane with 8 µm pores (Figure 6). This pore size allows the exchange of molecules 
and migrating EC between the two chambers. The interface between the plates is sealed 
by a gasket which overlays the filter. Before placement of the filter, gasket and top plate 
and sealing of the apparatus, 30 µl of unconditioned media or media from unstimulated 
control SMC, stretched SMC and bFGF-stimulated SMC were placed into the bottom 
plate. Following this, the filter and gasket are laid on the bottom wells, sealing the 
apparatus and 50 µl of the quiescent endothelial cell culture at lx 106 cells/ml were placed 
into the wells in the top plate. The chamber was placed in a cell culture incubator for 4 
hours to allow the EC to migrate through the filter. Four hours is short enough to 
minimise the effects of proliferation due to factors in the smooth muscle cell conditioned 
medium while long enough to allow for the upregulation of the molecular mechanisms 
behind migration (Senger et al., 1996) and has been used in other endothelial cell 
migration studies (Ikeda et al., 1995; Rosen et al. , 1990). At the end of this time, the filter 
was removed and any surface cells scraped off the top surface, on which the EC were 
seeded using a cotton swab, followed by fixing in 70% ethano\ at -20°C for 20 minutes 
before staining with haemotoxylin overnight. In this way, any cells passing through the 
membrane at the time of fixation were bound and could be counted by microscopy. The 
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filters were destained in ddH20, placed on a microscope slide and overlaid with glycerol 
and a coverslip before counting for quantification of endothelial cell migration. Migratory 
activity for each well was recorded as the average count of 5 random fields at 400x 
magnification for each experimental value. Each experiment was repeated 6 separate 
times. 
ELISA 
VEGF Enzyme-linked Immunosorbant Assay (ELISA) was carried out using a polyclonal 
antibody raised in rabbits against the N-terminal portion of the mouse VEGF protein. 
This anti-VEGF polyclonal antibody has been found to be permissively reactive across-
species, reacting with both rat and mouse protein (Claffey et al., 1996). It was hoped that 
this lack of species specificity and the conserved nature of the portion of the VEGF 
protein against which the antibody is designed will allow the detection and quantification 
of the bovine VEGF in conditioned media samples from SMC. Although the mRNA 
expression levels of VEGF may fluctuate with time, the level of VEGF in the media is 
expected to increase over time without degradation as found in other studies (Katoh et al., 
1995; Visweswaran et al., 1997), allowing the analysis of the cumulative VEGF 
production after 24 hours. It was hoped that by 24 hours the levels of VEGF would be 
sufficient to allow quantitation of VEGF secretion by the SMC. Media from SMC treated 
with bFGF at 10 ng/ml for 24 hours served as the positive control while media from 
unstimulated SMC served as a negative control. Smooth muscle cells were stretched for 
24 hours. Media samples were collected on ice from experimental and control cells and 
any cellular material removed by centrifugation at 12,000 g for 5 minutes at 4°C before 
storage at -80°C until use in the ELISA. The ELISA was set up as follows (Yeo et al., 
1992): A microtitre well was coated with an antibody raised in rabbit against the C-
terminal of mouse VEGF, washed thoroughly with TBS-T and blocked with haemoglobin 
solution. After another wash, the media dilutions were placed in the well and incubated at 
20°C for 2 hours with shaking. After further washing, the anti-VEGF N-terminal antibody 
was added and the solution further incubated for 2 hours at 20°C and washed. The anti-
VEGF N-terminal antibody was labelled with Eu3+, which dissociates on addition of a 
57 
detection reagent to form a highly fluorescent chelate that can be detected by an ELISA 
reader and compared to the results obtained with a series of human VEGF standards. In 







Figure 6. Schematic diagram of the chemotaxis chamber used in the migration assay. 
When the apparatus is sealed, EC seeded in the top well which are induced to migrate 
towards the SMC conditioned medium in the bottom well are trapped in the 8µm porous 
membrane and counted after staining. The count gives an indication of the levels of 
chemotactic factors in the conditioned media. 
59 
5. lmmunoprecipitation and Western Blot Analysis 
Experimental Set-up 
To test whether cyclic stretch was able to bring about KDR phosphorylation in the 
absence of the VEGF ligand, quiescent EC were subjected to periods of cyclic stretch. 
Quiescent cells were used to approximate the non-proliferative cell state in vivo. 
Unstretched EC, with and without the addition of human recombinant VEGF at 50 ng/ml 
for 20 minutes (Waltenberger et al., 1994; Nor et al. , 1999; Gerber et al., 1998), served as 
positive and negative controls for the phosphorylation of KDR respectively. 
Time Courses 
The time course of phosphorylation of the VEGF receptor KDR (Flk-1) was found by 
examining protein isolated from identically seeded cells at time intervals following the 
start of cyclic stretch. A preliminary 3 hour time course of KDR phosphorylation, 
demonstrated that the maximal 3.4 fold induction of KDR phosphorylation that occurred 
after 2 hours (Figure 13 C - Experiment 1) was followed by a slight decrease to 3.0 fold 
at 3 hours (timepoint not shown in Figure 13 C). Thus in subsequent repeats cells were 
stimulated by cyclic stretch for up to 2 hours. Similarly, protein isolated after 10 minutes 
of cyclic stretch in another preliminary experiment exhibited only 1.4 fold 
phosphorylation compared to protein isolated from unstretched EC (timepoint not shown 
in Figure 13 C). This was very similar to the value of 1.0 fold phosphorylation found at 
30 minutes in this experiment (Figure 13 C - Experiment 4) therefore in subsequent 
experiments samples were taken at 30 minute intervals. 
Protein Isolation 
To isolate protein from each sample, EC were washed twice in cold PBS before 
harvesting by scraping in 100 µl of EBC lysis buffer supplemented with 1 mM PMSF, 1 
mM NaV03, 10 µg/ml aprotinin and 10 µg/ml leupeptin. Lysates were centrifuged at 
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12,000 g for 1 minute to remove cellular debris and the supernatant transferred to a fresh 
tube. Samples were stored at -80°C until quantification. Protein quantification was 
performed using the Bradford assay and 2 µls of protein were added to 998 µl of ddH20 
and mixed well before addition of 1 ml of the assay reagent. The change in colour was 
compared to a range of bovine serum albumin (BSA) protein standards using a 
spectrophotometer at 595 nm. Between 300 and 500 µg of each protein sample was 
diluted to a total volume of 500 µl in EBC buffer for subsequent immunoprecipitation. If 
less than 300 µg of protein was available the experiment was discontinued. 
lmmunoprecipitation 
4 µg of anti-KDR (anti-Flk-1) antibody was added to each sample, mixed thoroughly and 
rotated at 4°C overnight. Due to the cross-species reactivity of the anti-KDR antibody, it 
is reasonable to assume that the high concentrations of the polyclonal anti-mouse KDR 
antibody will cross-react with any bovine Flk-1 expressed by the EC. During this time the 
protein A-Sepharose beads were prepared. For each sample, 40 µl of a 50% protein A-
Sepharose bead slurry in 70% ethanol was washed 3x in EBC buffer to remove the 
storage ethanol and resuspended as a 50% slurry in EBC buffer. A 20 µl aliquot of this 
solution was added to each sample, mixed thoroughly and rotated at 4°C for 2 hours. 
The beads were then pelleted by centrifugation at 12,000 g at 4°C for 1 minute and the 
pellet washed 3x in NET-N supplemented with 1 mM PMSF, 1 mM NaV03, 10 µg/ml 
aprotinin and 10 µg/ml leupeptin. The pellet was resuspended in 20 µl of protein sample 
buffer, boiled for 5 minute, pulse centrifuged at 12,000 g and 4°C and stored on ice until 
electrophoresis. 
Gel Electrophoresis 
Samples were electrophoresed on a 5% non-reducing SDS polyacrylamide gel with a 
high molecular weight protein marker before overnight electrophoretic transfer to a 
nitrocellulose membrane at 4°C. The gel was stained with a Coomassie-based dye to 
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ensure complete transfer and equivalent loading in gel lanes while the membrane was 
blocked in 10% fat-free milk in tris-buffered saline-Tween-20 (TBS-T) for 1 hour at 4°C 
with shaking to prevent non-specific binding of the antibody. Transfer efficiency was 
also determined by observation of the transfer of the prestained molecular weight marker 
from the gel to the membrane and if transfer was poor, the blot was discarded. Similarly, 
if the protein samples ran in a streak during gel electrophoresis, indicative of protein 
degradation, rather than as discrete bands, the samples were discarded. The membrane 
was then probed with the anti-tyrosine phosphorylation antibody (PY-20) at 1 :2500 
dilution in 10% fat-free milk in TBS-T for 1 hour to detect tyrosine phosphorylation 
levels of Flk-1. After this time the membrane was washed in TBS-T at 4°C for 20 
minutes followed by two washes for 5 minutes to remove any unbound antibody. The 
PY-20 antibody is conjugated to a horseradish peroxidase enzyme, which produces a 
light signal detectable by film after exposure to enhanced chemiluminescence (ECL) 
reagents. 
Visualisation 
ECL reagents were prepared as per the manufacturers instructions and washed over the 
membrane for one minute before the membrane was drained, blotted dry and placed 
between two sheets of plastic wrap. ECL film was exposed to the wrapped membrane for 
up to 10 minutes although the majority of results could be seen after 10-30 seconds of 
exposure. The 210 kiloDalton (kDa) immunoreactive band corresponding to the KDR 
receptor protein was determined by comparison with the molecular weight marker and by 
subsequent exposure to an anti-KDR antibody (see below - Stripping and Reprobing). 
The optical densities of immunoreactive signals on developed films were analysed using 
a scanning densitometer for quantification of phosphorylation levels. 
Stripping and Reprobing 
To probe for KDR, membranes were stripped in a high salt buffer with 7% P-
mercaptoethanol at 65°C for 30 minutes before washing as previously and blocking in 
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10% fat-free milk in TBS-T for 1 hour at 4°C with shaking. The membrane was then 
labelled with the anti-KDR antibody as primary antibody at 1:2500 dilution in 10% milk 
in TBS-T for 1 hour. After this time the membrane was washed in TBS-T at 4°C as 
before. The membrane was then labelled with the secondary antibody, an anti-rabbit IgG 
peroxidase conjugate, at 1 :2000 in 10% milk at 4°C for 1 hour. Washes were performed 
as before to remove any unbound secondary antibody before detection of bound antibody 
was performed using the ECL protocol as above. The size of bands detected on the film 
was found by comparison with the molecular weight marker and used to identify the 210 
kDa protein as KDR. The optical densities of immunoreactive signals on developed films 
were once again analysed using a scanning densitometer for quantification of KDR 
levels. These values were used to correct for loading differences between samples and to 
ensure that KDR expression remained constant throughout the experiment. The KDR 
receptor is highly expressed in quiescent EC (Gerber et al., 1999) and no positive control 
for the presence of the receptor is therefore necessary. Blots in which a 210 kDa band 
was not found after probing with both PY-20 and anti-KDR were discarded. 
6. RT-PCR 
Reverse Transcription 
To examine the feasibility of using reverse transcriptase-polymerase chain reaction (RT-
PCR) to measure expression of the cytokines VEGF, PDGF-B, TGF-~ and bFGF in SMC 
stretched for 4-24 hours, total RNA from stretched SMC, as isolated above (RNA 
Extraction and Northern Blotting - RNA Extraction), was reverse transcribed into DNA 
for PCR as follows: 
2 µg of RNA were mixed with 0.5 µg of Oligo-dT primer and DEPC-treated water to a 
total volume of 12 µl in a thin-walled polymerase chain reaction (PCR) tube. The mixture 
was placed at 68°C for 10 minutes in order to remove any secondary structure in the RNA 
before being placed on ice. Appropriate volumes of the following reagents were added in 
a total reaction volume of 20 µl to reach final concentrations of: lx reverse transcriptase 
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buffer; 10 mM dithiothreitol (DTT); 0.5 mM each of dATP, dCTP, dGTP and dTTP; 0.25 
U/µl of RNAse inhibitor and finally 2.5 U/µl of reverse transcriptase (RT). Negative 
controls to establish the RNA as the sole source of any DNA present in the reaction 
mixture were set up in parallel except the RT was replaced by an appropriate volume of 
DEPC-treated water. The solutions were thoroughly mixed and heated to 37°C for 10 
minutes and 42°C for 50 minutes before the reaction was stopped by heating to 94°C for 2 
minutes (to denature the RT and RNA) and placed on ice. The reaction was further halted 
and the concentration of nascent DNA adjusted for PCR by the addition of 20 µl of 
DEPC-treated water to the reaction mixture. 
Polymerase Chain Reaction 
2 µl of the RT reaction were amplified in a fresh thin-walled PCR tube in Ix PCR buffer, 
using final concentrations of 2.5 U Taq DNA polymerase; 0.2 mM each of dATP, dCTP, 
dGTP and dTTP; 2 mM of sense and antisense primers (Table 1) and DEPC-treated water 
to total reaction volume of 50 µI. Cycle temperatures and numbers were adjusted for the 
specific thermal cycler and Taq DNA polymerase used in this study until a distinct PCR 
DNA product band for each cytokine, of the published molecular weight as confirmed by 
comparison with a common DNA molecular weight ladder, was obtained on gel 
electrophoresis (see below - Gel Electrophoresis). The primers used for VEGF are able to 
amplify all of the isoforms of this cytokine, allowing the determination of which isoforms 
are being expressed. Primers for P-actin and hypoxanthine phosphoribosyl transferase 
(HPRT) mRNA expression were also used to determine the feasibility of using these 
genes as controls. The p-actin gene has been shown to maintain constant expression 
under a variety of stimuli making it a suitable control (Ninomiya et al., 1992). HPRT was 
included as its expression has been specifically shown to remain unaltered during VEGF 
upregulation (Iizuka et al., 1994) and its robust response and high molecular weight in 
comparison to P-actin allow it to be run on the same percentage gels as the cytokines. The 
reaction was performed in a PCR Express thermal cycler. Cycle parameters were 
generally as follows: Samples were taken from ice to a preheated block at 94°C for a 1 
minute melting step followed by a 1 minute annealing step at the temperature indicated in 
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table 1, followed by a 1 minute extension step at 72°C except in the case of HPRT which 
was elongated at 65°C due to the primer design. The melting, annealing and elongation 
steps were cycled 30 times before a final extension at the appropriate extension 
temperature for 10 minutes. This final step allowed any products in which extension was 
not complete during the cycling to reach their full length. 
Gel Electrophoresis 
Products were electrophoresed with a 100 base pair (bp) DNA ladder on a 2% agarose gel 
containing 1 µl /ml ethidium bromide and photographed on an UV transilluminator. 
Negative controls from the RT step, as mentioned above, were run in parallel to each 
sample. 
7. Statistical Analysis 
Results are expressed as mean (± standard deviation) for the indicated number of 
independent observations (n). Densitometric values obtained for VEGF mRNA and KDR 
phosphorylation signals were normalised over standards for GAPDH and KDR levels 
respectively to correct for loading differences in studies involving gel electrophoresis. 
This adjustment was therefore not necessary for the results obtained from the migration 
assay or ELISA procedure. Following this adjustment, values in all studies were 
normalised to the individual unstretched control for each experiment and data were 
expressed as fold of the unstretched control. Statistical comparison of the differences 
between means of control and experimental expression of VEGF mRNA as determined 
by northern blotting and protein levels as determined by ELISA were made using paired 
one-tailed Student's t-tests. Comparison of the differences between experimental means 
of KDR phosphorylation levels and the control mean were made using a one-tailed 
Student' s t-tests. Comparison between migration results and their respective antibody-
abrogated controls was made with a 2-sample t-test with distinct variances. The degree of 
statistical significance of the differences of the means is reflected by their p values, which 
are indicated in the text. 
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Sequence Sense Primer Antisense Primer Anneal 
(Reference) Temp. 
VEGF ATG CGG ATC AAA ATC TGG TTC CCG AAA 57°C-
(Nicol et al. , CCTCACC CCCTG 60°C 
1997) 
PDGF-B CCG CAC CAA CGC TTT GGC TCG CTG CTC 62°C 
(Holt et al. , CAACTTCC CTGGG 
1994) 
TGF-~ (Dahiya GCC CTG GAC ACC AGG CTC CAA ATG TAG 64°C 
et al. , 1996) AACTATTGCT GGGCAGG 
bFGF GCA AAA ACG GGG CCA GTT CGT TTC AGT 65°C 
(Sheu et al. , GCT TCT TCC TGC G GCC ACA TAC CAA 
1996) 
~-actin ATC ACC ATT GGC TTG AAG GTA GTT TCG 65°C 
(Ninomiya et al. , AATGAGCG TGGAT 
1992) 
HPRT (Iizuka et AAT TAT GGA CAG CGT GGG GTC CTT TTC 56°C 
al. , 1994) GAC TGA ACG TC ACCAGCAAG 
Table 1. Primers and annealing temperatures used in RT-PCR. Cycle temperatures and 
numbers were adjusted for the specific thermal cycler and Taq DNA polymerase used in 
this study until a distinct band for each gene, of the published molecular weight, was 
obtained. The optimum annealing temperature found is listed. 
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Rat aortic smooth muscle cells (product number CRL-1444) were obtained from 
American Type Culture Collection (ATCC), Manassas, VA, USA. Tissue culture media 
Dulbecco ' s modified Eagle ' s medium (DME) (product number D-5648) for SMC, 
deoxycytidine (product number D-0776), thymidine (product number T-1895), bovine 
bFGF (product number F-3133), HEPES (N-[2-hydroxyethyl] piperazine-N'-[2-
ethanesulfonic acid]) buffer (product number H3375), sodium pyruvate (product number 
P-4526) and insulin, transferrin, selenium (ITS) supplement (product number I-3146) 
were obtained from Sigma chemical company St. Louis, Missouri, USA. Tissue culture 
media Dulbecco' s modified Eagle' s medium (DME)/F12 (product number 32500-019) 
for EC, antibiotic/antimycotic (product number 15240-039), trypsin-EDTA (product 
number 45300-019), magnesium and calcium free phosphate buffered saline (PBS) 
(product number 14190-201) were obtained from Gibco BRL Grand Island, New York, 
USA. Foetal bovine serum (FBS) from Hyclone Logan, Utah, USA. Flexercell Stress 
Unit and Flex I collagen-coated culture plates (product number P-1001 C) were obtained 
from Flexcell International Corporation, Hillsborough, North Carolina, USA. Cell 
counter was obtained from Beckman Coulter Incorporated. Fullerton, California, USA. 
RNA extraction and northern blotting 
TRIZOL (product number 15596-026) was obtained from Gibco BRL Grand Island, New 
York, USA. Formaldehyde (product number FI635), formamide (product number 
F9035), single stranded salmon sperm DNA (ssDNA) (product number D-7656), 
Denhardts solution (product number D2532), Diethyl Pyrocarbonate (DEPC) (product 
number D5758) and Dithiothreitol (DTT) (product number D5545) were obtained from 
Sigma chemical company St. Louis, Missouri, USA. Hybond-N nylon membrane for 
nucleic acids (product number RPN303N) and Ready-To-Go DNA random 
oligonucleotide primed nucleotide labelling beads deoxycytidine 5 '-triphosphate ( dCTP) 
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(product number 27-924001) were obtained from Amersham Pharmacia Biotech 
Piscataway, New Jersey, USA. BioMax MS autoradiographic film for northern blotting 
(product number 8377616), BioMax MS intensifying screens (product number 8827438) 
and X-OMAT automatic developer were obtained from Kodak, Rochester, New York, 
USA. Gel photographic film (product number T-667) and camera (product number DS-
34) were obtained from Polaroid Cambridge, Massachusetts , USA. Scanning 
Densitometer was manufactured by Molecular Dynamics, Sunnyvale, California, USA. 
Quickspin Sephadex G-25 fine Column (product number 1273922) was obtained from 
Boehringer Mannheim now Roche Molecular Biochemicals Indianapolis, Indiana, USA. 
Easytides Deoxycytidine 5' triphosphate (a-32P dCTP) (product number NEG513S) was 
obtained from NEN Lifesciences Boston Massachusetts, USA. Pancake Geiger-Muller 
survey meter (Product number 3-90) was obtained from Ludlum Measurements 
Incorporated. Sweetwater, Texas, USA. Scintillation counter and spectrophotometer were 
manufactured by Beckman Coulter Incorporated. Fullerton, California, USA. 
Migration assay 
Anti-human VEGF antibody (product number AF-293-NA) was obtained from R&D 
Systems Inc. Minneapolis, Minnesota, USA. Reusable chemotaxis chamber ( 48 well) 
(product number AC48) and Poretics Polycarbonate 8 µm membrane (product number 
PFB8) were obtained from Neuro Probe Incorporated. Gaithersburg, Maryland, USA. 
lmmunoprecipitation and western blotting 
Anti-Flk-1 (Anti-KDR) antibody (SC-504) was obtained from Santa Cruz 
Biotechnologies, Santa Cruz, California, USA. Anti-tyrosine phosphorylation antibody 
(PY-20) (product number Pl 1625) was obtained from Transduction Laboratories Inc. 
Lexington, Kentucky, USA. Human VEGF (293-VE) was obtained from R&D Systems 
Inc. Minneapolis, Minnesota, USA. Hybond-ECL nitrocellulose membrane for proteins 
(product number RPN2020D), protein A Sepharose CL-4B (product number 17-0963-03) 
for immunoprecipitation, ECL chemiluninescence detection reagents (product number 
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RPN2 l 09), anti-rabbit immunoglobin G (lgG) peroxidase conjugate (product number 
NA934) and film (product number RPN2103H) were obtained from Amersham 
Pharmacia Biotech Piscataway, New Jersey, USA. Bradford protein quantification assay 
(product number 5000002) and high range molecular weight marker (product number 
1610309) were obtained from Bio Rad Laboratories, Hercules, California, USA. 
Phenylmethylsulphonyl fluoride (PMSF) (product number P7626) was obtained from 
Sigma chemical company. St. Louis, Missouri, USA. GelCode Coomassie-based dye was 
obtained from Pierce chemical company. Rockford, Illinois, U.S.A. Scanning 
densitometer was manufactured by Molecular Dynamics, Sunnyvale, California, USA. 
Spectrophotometer was manufactured by Beckman Coulter Incorporated. Fullerton, 
California, USA. 
RT-PCR 
Primers for PCR for VEGF (Nicol et al., 1997), PDGF-B (Holt et al., 1994), TGF-~ 
(Dahiya et al., 1996), bFGF (Sheu et al., 1996), ~-actin (Ninomiya et al., 1992) and 
Hypoxanthine phosphoribosyl transferase (HPRT) (Iizuka et al., 1994) were made by 
Department of Medical Biochemistry University of Cape Town Medical School, Cape 
Town, South Africa. DNA ladder (100 bp ) (product number 15628-019), Oligo-dT 
reverse transcription primer (product number 18418-012) were obtained from Gibco BRL 
Grand Island, New York, USA. Gel photographic film (product number T-667) and 
camera (product nur~ber DS-34) were obtained from Polaroid Cambridge, Massachusetts, 
USA. dATP, dCTP, dGTP, dTTP mix (product number 1277049), RN Ase inhibitor 
(product number 799017) and Taq DNA polymerase with Taq buffer (product number 
1146173) were obtained from Boehringer Mannheim now Roche Molecular 
Biochemicals Indianapolis, Indiana, USA. M-MuLV Reverse transcriptase and reverse 
transcriptase buffer (product number 253S) were obtained from New England 
Biotechnology. Beverly Massachusetts, USA. PCR thermal cycler PCR Express (product 
number HBPX) was manufactured by Hybaid Franklin, Massachusetts, USA. 
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9. Appendix of solutions 
RNA solutions: 







pH to 7.0 
Autoclave and store in dark 
lOxMOPSB 
200 mM MOPS (pH 7.0) 
50 mM NaOAc (pH 7.0) 
lOmMEDTA 
store in dark 
RNA gel 




Make up fresh 
RNA electrolysis buffer 
lxMOPB 
Make up fresh 
4x RNA sample buffer 




Make up fresh 
Hybridisation Solution 
5x Denhardts Solution 
5x SSPE 
0.1% SDS 
0.1 mg/ml ssDNA 
50% formamide 




0.2 M NaH2P04 
SDS 
10% SDS 





denatured at 65°C for 30 min 
and 42°C for 120 min 
Store at 4°C 
20x SSC 
3 MNaCl 
0.3 M NaCitrate 








40 mM Tris.Acetate 
2 mM Na2EDTA.2H20 
DNA gel 
made up in lx TAE 
1% agarose 
Protein Solutions: 
4x Separating gel 
1.5 M Tris 
0.4% SDS 
pH to 8.8 
Filter and store at 4°C 
4x Stacking gel 
0.5 M Tris 
0.4% SDS 
pH to 6.8 
Filter and store at 4°C 
2x Sample buffer 




0.001 % bromophenol blue 
5x Protein Electrophoresis buffer 
125 mM Tris 
1 M glycine 
5%SDS 
pH to 8.8 
Store at 4°C 
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Transfer buffer 
25 mM Tris 
0.19 M glycine 
20% methanol 
Store at 4°C, use 3x 
lOx TBS-T 
0.2 M Tris 
1.37 MNaCl 
0.01 % Tween-20 
pH to 7.6, 
Store at 4°C 
EBC lysis buffer 
50 mM Tris 
120 mM NaCl 
0.5% NP40 
pH to 7.4 
add PMSF to 1 mM, NaV03 to 1 mM, 
aprotinin to 10 µg/ml and leupeptin to 10 
µg/ml before use. 
NET-N 




add PMSF to 1 mM, NaV03 to 1 mM, 
aprotinin to 10 µg/ml and leupeptin to 10 
µg/ml before use 
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Results 
1. Optimisation of Conditions for Induction of 
Quiescence and Application of Cyclic Strain 
Smooth muscle cells were grown with 0.5% FBS and 0%FBS with and without lx ITS 
supplement to determine the optimum conditions for induction of quiescence with 
maximal cell adherence. Adherence of SMC grown under the above low serum contitions 
was compared to cells grown with 10% FBS as positive control using a cell counter. As 
shown in Figure 7, the best conditions for induction of quiescence with high cell 
adherence in bovine SMC were found to be with media containing 0% FBS with lx ITS 
supplement. Cells grown under these conditions showed 94% adherence compared to 
only 84% adherence by SMC cultured in FBS-free media without ITS. Examination of 
cultures under microscopy prior to resuspension of the cells concurred with the cell count 
data. The same conditions used for bovine SMC were found to be excellent for induction 
of quiescence with the maintenance of adhesion in both bovine EC and rat SMC. 
In each of the experiments performed, morphological examination of cultured cells under 
phase contrast microscopy before the experimental treatment showed that EC and SMC 
maintained the confluence and integrity of the monolayer after conditions used to induce 
quiescence. Plates in which cells had bunched or the monolayer was detached were 
discarded. The same examination after the experiment demonstrated that the cells had 
remained adherent to the culture plates throughout the experiment. This demonstrated 
that the treatments used were not destructive to the cells and that, where applicable, the 
cells were subject to the forces applied to the culture plates. If a disruption of adherence 
was noted, the plate was discarded. In addition, SMC which were subjected to cyclic 
strain were noted to orientate perpendicularly to the radial direction of cyclic strain 
(Figure 8) after longer time periods of cyclic stretch as noted in previous studies (Sumpio 
and Banes, 1988) although this was accompanied by some cell loss. This indicates that 
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the 10 % level of stretch used was capable of influencing the physiology of adherent 
SMC and EC. 
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Figure 7. Optimisation of culture conditions for induction of quiescence. Bovine SMC 
were seeded at confluency on Flex I plates in media with 0.5% FBS or 0% FBS with or 
without ITS to determine the conditions which best induced quiescence but allowed 
maximal cell adherence. After 24 hours the plates were examined under phase contrast 
microscopy and washed 2x with PBS to remove floating cells. Adherent SMC were then 
resuspended by incubation with 0.01 % trypsin and counted using a Coulter counter. 
Results are expressed as a percentage of adherent cells grown in 10% FBS. These results, 
which were corroborated by microscopy, show that SMC may be induced to adopt the 
quiescent phenotype with 0% FBS and lx ITS with minimal loss of cells. The same 
conditions were found to be suitable for induction of quiescence in EC. 
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Figure 8. Photomicrographs taken at lOOx magnification indicating morphological 
effects of cyclic stretch on SMC (Courtesy of I. Mills, Yale University School of 
Medicine, New Haven, USA) A: Unstretched SMC with a random alignment. B: SMC 
align perpendicularly to axis of stretch after 24 hours of 10%cyclic stretch. Axis of 
stretch, the centre and periphery of the dish and a smooth muscle cell are indicated in 
panel B. Cells exposed to shorter time points exhibited less dramatic alignment in 
proportion to the period of stretch experienced. This figure is representative of neither the 
degree of alignment nor the confluency of the SMC on the Flex I plates after 4 hours. As 
shown in panel B, a limited loss of adherence may be seen after 24 hours of cyclic 
stretch. However, this was not observed for 4 hours of cyclic stretch. 
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2. VEGF Expression in Smooth Muscle Cells under 
Cyclic Stretch 
Optimisation of Controls 
VEGF expression in bovine aortic SMC under cyclic stretch was determined by northern 
blotting. Control and experimental cells were seeded identically on Flex I plates with 
bFGF at 10 ng/ml added as a positive control for VEGF expression while unstretched 
cells served as the negative control for the effects of cyclic stretch. VEGF mRNA 
expression induced by bFGF at 10 ng/ml and 50 ng/ml was statistically indistinguishable 
(p > 0.05) after 3 hours (Figure 9). Furthermore, after 6 hours bFGF was found to bring 
about the same induction ofVEGF mRNA expression at 10 ng/ml and 50 ng/ml (data not 
shown). Thus, bFGF at a concentration of 10 ng/ml was considered sufficient to induce 
VEGF mRNA expression in SMC for the 4 hour time period of the experiments and at a 
suitable level for a positive control. Addition of TNF-a, which is not known to induce 
VEGF expression in SMC, did not result in a significant alteration of VEGF mRNA 
expression from the levels observed in unstretched controls, thus demonstrating that the 
response to bFGF was specific and not due to the process of cytokine addition. 
Optimisation of RNA Extraction, Northern Blotting and Autoradiography 
RNA isolation from each 30 cm2 Flexcell I plate yielded at least 10 ng of RNA of 
adequate integrity and purity for northern blotting as determined by UV spectroscopy and 
gel electrophoresis. Neither RNA degradation nor protein contamination was detected in 
any of the experiments considered (see Methods and Materials - RNA Extraction and 
Northern Blot Analysis - Gel Electrophoresis). In each experiment, the transfer of the 
mRNA to nylon membrane by northern blotting was found to be complete by comparison 
of the gel and membrane under UV radiation. Only membranes which displayed the 18S 
and 28S rRNA bands and whose corresponding gels did not contain visible amounts of 
RNA after transfer were subsequently probed. Probing the membrane for VEGF mRNA 
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displayed a 4.2 kilobase (kb) band corresponding to the published molecular weight of 
VEGF mRNA and probing the same blot for GAPDH displayed a band corresponding to 
the published size of GAPDH mRNA at 1.2 kb for each experiment (Figures 9, 10 and 
11 ). Comparison of the densitometric values obtained after scanning the GAD PH bands 
indicated that mRNA loading and northern blot transfer was equal for all samples in each 
experiment. 
VEGF mRNA Expression 
In each experiment a weak VEGF mRNA signal was noted in samples from cells which 
were treated with neither bFGF nor cyclic stretch, indicating a low basal level of VEGF 
expression by these cells. As these cells were in the quiescent phenotype, this expression 
is due to neither serum factors nor switching by the SMC to the synthetic phenotype but 
rather a phenomenon of differentiated cells which has been observed previously in vivo 
(Couffinhal et al. , 1997). 
A time course measuring VEGF mRNA expression under cyclic stretch after various time 
intervals showed the upregulation of VEGF mRNA expression to be maximal, at greater 
than 3 fold of the expression in unstretched controls, after 4 hours. By 24 hours the 
expression of VEGF mRNA due to cyclic stretch had dropped slightly to 90 % of the 
expression from cyclic stretch at 4 hours (Figure 10). The induction of VEGF mRNA 
expression in the positive control - by addition of bFGF at 10 ng/ml - was also found to 
peak at around 4 hours and to drop to 80% of this peak value by 24 hours (Figure 10). 
These results show that the increase in VEGF mRNA expression shown at 4 hours is 
maintained, with a slight decrease, until 24 hours. Therefore, further experiments were 
carried out over a 4 hour time period. 
Seven independent experiments, conducted with different preparations of SMC, in which 
application of cyclic stretch, RNA extraction, transfer and probing met stringency criteria 
were included in the study and their results are summarised in Figure 11. These 
experiments demonstrated an increase in VEGF mRNA expression to 3.3 fold(± 1.5) of 
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unstretched controls after 4 hours. This was of a similar magnitude to the VEGF mRNA 
expression induced by bFGF at 10 ng/ml for 4 hours (Figure 11 ). 
Species-Specificity Pilot Study 
In order that the species specificity of this response could be investigated, a pilot study 
was undertaken in which rat aortic SMC were treated with the same regimen of cyclic 
stretch and positive control ofbFGF at 10 ng/ml as the bovine cells. Rat SMC were found 
to exhibit averages of 5 fold (n = 1) and 2. 7 fold (n = 2) increases in VEGF mRNA 
expression over unstretched controls to these stimuli respectively, indicating that the 
smooth muscle cell response to cyclic stretch in terms of VEGF mRNA expression may 




1 2 3 
... .. . :-· . . .· '. ' . 
























bFGF Concentration (ng/ml) 
Figure 9. Northern blot showing VEGF mRNA expression in response to different 
concentrations of bFGF. The figure is a typical autoradiographic result of 5 experiments. 
A: VEGF. Total RNA of SMC probed for VEGF mRNA. The arrow represents the 
location of the 28S rRNA band. A band corresponding to the VEGF mRNA can be seen 
at low constitutive levels in untreated SMC in lane 1. Lane 2 and 3 contain mRNA from 
SMC stimulated for 3 hours with bFGF at 10 ng/ml and 50 ng/ml respectively. B: 
GAPDH. The same blot stripped and probed for GAPDH mRNA. The consistency of the 
band density in all lanes indicates equal mRNA loading and transfer as well as uniform 
probe hybridisation. The arrow represents the location of the 18S rRNA band. C: 
Densitometric analysis of the levels of VEGF mRNA expression corrected against 
GAPDH mRNA expression levels and expressed as a fold of untreated controls. Mean 
increases in VEGF mRNA expression due to bFGF at 10 and 50 ng/ml were 
























bFGF 4 Hours Cyclic Stretch 4 bFGF 24 Hours Cyclic Stretch 24 
Hours Hours 
Figure 10. Northern blot showing change in VEGF mRNA expression due to both bFGF 
and cyclic stretch stimulation at 4 and 24 hours. A: VEGF. Total RNA of SMC probed 
for VEGF mRNA. The arrow represents the location of the 28S rRNA band. Comparison 
of the migration of the VEGF mRNA bands seen in lanes 1-6 with the migration of the 
28S rRNA band indicates the size of the VEGF mRNA to be 4.2 kb. A band 
corresponding to the VEGF mRNA can be seen at low constitutive levels at 4 and 24 
hours in unstretched SMC in lanes 1 and 4 respectively. Lanes 2 and 3 contain mRNA 
from SMC stimulated with bFGF at 10 ng/ml for 4 hours and 4 hours of 10% cyclic 
stretch respectively and each indicate an increase in VEGF mRNA expression over the 
unstretched control. Lanes 5 and 6 contain mRNA from SMC stimulated with bFGF at 10 
ng/ml for 24 hours and 24 hours of 10% cyclic stretch respectively and show a slight 
decrease in VEGF mRNA expression relative to the expression at 4 hours. B: GAPDH. 
The same blot stripped and probed for GAPDH mRNA. The arrow represents the location 
of the 18S rRNA band. Comparison of the migration of the GAPDH mRNA bands seen 
in lanes 1-3 with the migration of the 18S band indicate the size of the GAPDH mRNA to 
be 1.2 kb. The figure represents a typical autoradiographic result. C: Densitometric 
analysis of the levels of VEGF mRNA expression corrected against GAPDH mRNA 
expression levels and expressed as a fold of unstretched controls. VEGF mRNA 
expression due to both bFGF and cyclic stretch can be seen to decrease slightly between 
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Figure 11. Northern blot showing an increase in VEGF mRNA expression due to both 
bFGF and cyclic stretch stimulation. The figure is a representative autoradiographic result 
for all 7 experiments. A: VEGF. Total RNA of SMC probed for VEGF mRNA. The 
arrow represents the location of the 28S rRNA band. Comparison of the migration of the 
VEGF mRNA bands seen in lanes 1-3 with the migration of the 28S rRNA band indicates 
the size of the VEGF mRNA to be 4.2 kb. A band corresponding to the VEGF mRNA 
can be seen at low constitutive levels in unstretched SMC in lane 1. Lane 2 and 3 contain 
mRNA from SMC stimulated with bFGF at 10 ng/ml for 4 hours and 4 hours of 10% 
cyclic stretch respectively and each indicate a dramatic increase in VEGF mRNA 
expression. B: GAPDH. The same blot stripped and probed for GAPDH mRNA. The 
consistency of the band density in all lanes indicates equal mRNA loading and transfer as 
well as uniform probe hybridisation. The arrow represents the location of the 18S rRNA 
band. Comparison of the migration of the GAPDH mRNA bands seen in lanes 1-3 with 
the migration of the 18S band indicate the size of the GAPDH mRNA to be 1.2 kb. The 
figure represents a typical autoradiographic result. C: Densitometric analysis of the levels 
of VEGF mRNA expression corrected against GAPDH mRNA expression levels and 
expressed as a fold of unstretched controls. Both bFGF and cyclic stretch stimulated cells 
upregulated VEGF mRNA expression in SMC to a statistically significant degree over 
unstimulated controls at the 99% confidence interval (bars represent standard deviation, * 
indicates p < 0.005, n = 7). 
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3. Activity of VEGF Released by Smooth Muscle Cells 
Optimisation of Controls 
VEGF has been demonstrated to have effects on diverse aspects of endothelial cell 
physiology including migration and survival. To determine the biological activity on EC 
of VEGF released by SMC, the culture media from quiescent SMC - both unstretched 
and stretched for 4 hours - were analysed for their ability to induce migration in quiescent 
EC in an in vitro chemotaxis assay. Unconditioned smooth muscle cell media was used as 
a negative control while the media from SMC exposed to bFGF at 10 ng/ml for 4 hours 
was chosen as a positive control. The pH and clarity of media collected from all SMC 
was found to be similar to that of unconditioned media indicating that smooth muscle cell 
conditioning had not led to pH changes or contamination. 
Both at assembly of the migration chamber (Figure 6) and after the execution of the assay 
each well was inspected for air-bubbles obstructing the interface of the EC and the test 
media. If a bubble was found in a well of any of the variables in a given experiment the 
entire experiment was discarded. On these criteria, 6 independent experimental repeats 
were included in this study and migration analysed by counting fixed and stained filters. 
Antibody Abrogation 
In addition to the above controls, anti-VEGF antibody was added to a duplicate repeat of 
conditioned media from each condition to neutralise any VEGF in the media. 
Comparison of endothelial cell migration induced by the conditioned media in the 
presence and absence of the anti-VEGF antibody will establish the proportion of the 
endothelial cell migration that is due to VEGF. This is important as it demonstrates 
whether VEGF plays a part in the endothelial migration due to smooth muscle cell 
conditioned media and also quantifies the contribution of VEGF to the migratory 
response, establishing a baseline for comparing the results. As shown in Figure 12, the 
increases in endothelial cell migration due to conditioned media from stretched, bFGF-
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stimulated and unstretched SMC were not completely inhibited by the addition of the 
anti-VEGF antibody. This indicates the possible involvement of other factors in the 
migratory response of EC to media. However, the statistically significant (p < 0.05) 
decrease in the migration increases following addition of anti-VEGF in all samples 
indicates that VEGF may be a chief factor involved. 
In one of the 6 experimental repeats mentioned above the migration values induced by 
anti-VEGF antibody treated media from bFGF- and stretch-stimulated SMC were 
respectively 4.1 and 6.4 fold higher than that of the average migration induced by the 
same antibody-treated samples in the other experiments. This result was possibly due to 
failure of the antibody and the repeat was considered aberrant and not considered. The 
results of the remaining 5 experiments are considered below and shown in Figure 12. 
Endothelial Cell Migration 
All media conditioned by SMC were shown to induce migration of EC (Figure 12). 
Conditioning of media by unstimulated SMC resulted in an 8.3 (± 2.4) fold increase in 
endothelial cell migration compared to unconditioned media. This dropped to 3.2 (± 1.3) 
fold with the addition of anti-VEGF antibody, indicating that the majority of the 
endothelial cell migration response to media from unstimulated SMC resulted from the 
presence of VEGF in the media. Conditioned media from SMC exposed to bFGF at 10 
ng/ml to for 4 hours resulted in endothelial migration to 8.2 (± 3.8) fold of unconditioned 
media (5.5 (± 3.0) fold with anti-VEGF). These data show that bFGF did not induce 
release of endothelial cell chemotactic molecules by the SMC into the conditioned 
medium to a greater extent than unstretched controls alone. In addition, comparison of 
results with and without anti-VEGF antibody indicate that VEGF contributed only 40% 
to the endothelial migration response to conditioned media from SMC treated with bFGF. 
Cyclic stretch for 4 hours was, by contrast, found to stimulate the production of soluble 
factors by the SMC which increased endothelial cell migration to 14.6 (± 2.8) fold of the 
level of unconditioned media. This value was diminished to 6.7 (± 3.0) fold with anti-
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VEGF antibody, indicating that VEGF contributed to 55% of the endothelial migratory 
response. The relevance of the results is covered in the discussion section of this work. 
ELISA 
In order to determine the levels of VEGF released by SMC under cyclic stretch, a pilot 
ELISA study (n = 3) was carried out over 24 hours on the conditioned culture media of 
SMC. The media from bFGF-stimulated SMC served as a positive control and results 
were compared to human VEGF standards to quantify the VEGF concentration (Table 2). 
In this way bFGF and cyclic stretch were found respectively to induce average secretion 
of 8.7 ng/ml and 7.1 ng/ml of VEGF into the media over 24 hours. By comparison, 
cumulative levels of VEGF secretion by unstimulated SMC during the course of 
induction of quiescence and the experiment were approximately 6.0 ng/ml. This value is 
high in comparison to the levels secreted by stimulated cells. Nevertheless, VEGF levels 
in the media were corrected against control media from unstimulated SMC to determine 
the relative expression due to bFGF and cyclic stretch. In the bFGF positive control the 
levels of VEGF corresponded to a statistically significant (p < 0.05) 1.5 (± 0.2) fold 
average increase of VEGF over unstimulated cells. However, in media from SMC 
stretched a statistically insignificant (p > 0.05) increase in average VEGF levels of 1.2 (± 
0.2) fold of the levels of unstimulated controls was found (Table 2). These apparently 
contradictory results and the possible mechanisms behind them are discussed in the 
discussion section of this work. 
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Figure 12. Graph showing endothelial cell migration in response to media from SMC. 
Results are standardised against the EC migratory response to unconditioned smooth 
muscle cell media and expressed as a fold of this response (bars represent standard 
deviation, n = 5). Endothelial cells migration was increased in response to media from 
unstretched SMC, bFGF treated SMC and SMC exposed to cyclic stretch. The high 
chemotactic response to media from unstretched control cells may be due to the release of 
chemotactic factors such as VEGF and bFGF by these cells over time during induction of 
quiescence. This is supported by the inability of media from bFGF-stimulated SMC to 
increase the VEGF-mediated migratory response of EC over the response due to media 
from unstretched control SMC. The relevance of these findings is addressed in the 
discussion section of this work. The statistically significant reduction in migration (* 
indicates p < 0.05) due to the addition of a VEGF-neutralising antibody in all cases 
indicates that although not alone, VEGF may be a chief mediator of the chemotactic 
response of EC to the conditioned media of unstretched and stretched SMC. It also 
demonstrates that VEGF is released by the SMC in a biologically active form at sufficient 
levels to elicit a response by the EC. An increase in VEGF secretion into the media of 
SMC due to cyclic stretch is consonant with the increase in VEGF expression due to the 
cyclic stretch noted at the mRNA level above. 
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Media Sample Unstimulated lOng/ml bFGF 24 10% Cyclic stretch 
Hrs 24Hrs 
VEGF concentration 6.0 8.7 7.1 
(ng/ml) 
Fold VEGF Production 1 1.5 (± 0.2) * 1.2 (± 0.2) 
(n=3) 
Table 2. VEGF protein levels in smooth muscle cell conditioned media as determined by 
ELISA. VEGF protein was found in all smooth muscle conditioned media. The level of 
VEGF secretion in unstimulated SMC correlates with the constitutive expression in 
unstimulated SMC demonstrated in this work by northern blot and previously shown in 
vivo (Couffinhal et al., 1997). However, the high concentration found in these cells after 
24 hours may mask the release of VEGF due to bFGF and stretch during this time. Thus, 
although the concentration of VEGF in the media is increased by both the addition of 
bFGF and cyclic stretch, only the increase due to bFGF is statistically relevant at the 95% 
confidence interval (* Denotes p < 0.05). 
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4. Effect of Cyclic Stretch on KDR Phosphorylation in 
Endothelial Cells 
Optimisation of Controls 
Although VEGF released by SMC under cyclic stretch in vivo may influence the adjacent 
EC, a number of studies suggest that it is possible for VEGF receptors on EC to be 
phosphorylated by cyclic stretch in the absence ofVEGF from SMC or EC. If KDR (Flk-
1) is activated purely as a mechanoreceptor by cyclic stretch then this may affect the 
endothelial response to locally-released VEGF. To further investigate whether KDR is a 
mechanoreceptor quiescent EC were stretched on Flex I plates, proteins extracted and 
KDR phosphorylation determined by immunoprecipitation for KDR and immunoblotting 
with an anti-tyrosine phosphorylation antibody PY-20. Quiescent cells were used as they 
mimic the non-secretory, non-proliferative phenotype found in vivo and cells in this 
phenotype are not expected to release VEGF (Namiki et al., 1995; Couffinhal et al., 
1997). 
VEGF at the published value of 50 ng/ml (Waltenberger et al., 1994; Nor et al., 1999; 
Gerber et al., 1998) was added to unstretched EC as a positive control for KDR 
phosphorylation while unstretched cells served as the negative control for the effects of 
cyclic stretch. VEGF at 50 ng/ml was found to increase KDR phosphorylation to an 
average maximum of 12.3 fold of unstretched controls by 20 minutes of exposure. This 
concentration and time was thus considered appropriate for a positive control for KDR 
phosphorylation. Blots which showed no phosphorylation of KDR in response to VEGF 
were discarded. 
Optimisation of Protein Isolation, lmmunoprecipitation and Gel Electrophoresis 
Protein isolation from each plate yielded 300 - 500 µg of protein for immunoprecipitation 
as determined by the Bradford assay. If less than 300 µg of protein was available the 
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experiment was discontinued. Similarly, if the protein samples ran in a streak during gel 
electrophoresis, indicative of protein degradation, rather than as discrete bands, the 
samples were discarded. Following electrophoresis, the protein transfer to the 
nitrocellulose membrane was found to be thorough in all experiments by staining the gel 
and observation of the transfer of the prestained molecular weight marker. 
Visualisation 
Bands obtained in immunoblotting were compared with the prestained molecular weight 
marker and found to be at the published value of 210 kDa for KDR (Brogi et al., 1996). 
The identity of KDR was further confirmed by stripping the same blot and probing with 
an antibody specific for KDR. Although a band of the same size and shape was present 
when immunoblotting with KDR, as confirmed by comparison with the molecular weight 
marker, there were unfortunately a high number of background bands after stripping and 
reprobing of the blot (Figure 13 B). These extra bands may be due to inter-species cross-
reactions by the antibody or high non-specific binding after stripping. However, the 
constancy of band densities for KDR over time indicated that the levels of KDR 
expression remained constant under cyclic stretch and did not contribute to changes in 
levels of KDR phosphorylation (Figure 13 B). Only blots which showed visible bands at 
210 kDa after probing with both PY-20 and the anti-KDR antibody were analysed by 
densitometry. 
KOR Phosphorylation 
Time courses for phosphorylation of KDR determined that values of phosphorylation 
before 30 minutes were similar to the values at 30 minutes (1.4 fold of unstretched 
controls at 10 minutes) and were found to plateau at approximately 3 fold of that of 
unstretched cells after 180 minutes. Therefore, further experiments were carried out 
between 30 and 120 minutes. Four independent experiments (assigned 1 - 4), conducted 
with distinct preparations of EC, met the stringency criteria in terms of application of 
cyclic stretch, response to VEGF, isolation of sufficient undenatured protein, efficient 
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transfer and identification of a signal for KDR following immunoblotting and their results 
are summarised in Figure 13. Experiment 1 displayed an initial decrease in 
phosphorylation compared to unstretched controls (fold phosphorylation < 1 fold of 
unstretched controls) to 90 minutes followed by an increase in phosphorylation to greater 
than 3 fold of unstretched values at 120 minutes (Figure 13 C). Experiment 2 followed a 
similar trend to experiment 1 although phosphorylation levels at 30 and 60 minutes were 
both higher (greater than 3 .5 fold of unstretched controls) than those found at the same 
time intervals in experiment 1. Although these results are included in the study they 
appear to be anomalous when compared to the low phosphorylation values at 30 and 60 
minutes obtained in the other experiments and the values from experiment 2 lead to the 
large standard deviation in the mean of all the experiments at 30 and 60 minutes (Figure 
13 C). Experiments 3 and 4 followed the same initial decrease followed by an overall 
increase in phosphorylation over time as seen in experiment 1 although the response at 90 
and 120 minutes in experiment 4 was lower than that seen in the other experiments 
(Figure 13 C). This may be due to an unobserved difference in the cells following 
induction of quiescence, which resulted in a muted or delayed response. This result 
appears to deviate from the robust increase in phosphorylation observed at 90 and 120 
minutes in the other experiments and the values from experiment 4 mutes the mean 
increase in phosphorylation for all the experiments. Furthermore, this result diminishes 
the statistical significance of the differences of the mean responses at 90 and 120 minutes 
from unstretched controls (120 minutes relevant at the 95% confidence interval (p < 0.05) 
and 90 minutes relevant at the 93% confidence interval (p < 0.07) without values from 
experiment 4). As demonstrated by the mean values for the 4 experiments (Figure 13 C), 
cyclic stretch appears to induce an initial statistically irrelevant decrease in receptor 
phosphorylation followed by a modest increase in KDR phosphorylation to 2.5 fold of the 
unstretched control which is only statistically significant at the 94% confidence interval 
(p < 0.06 n = 4). Both the biological relevance of the trends observed and whether the 





0 4 .... ... 
Cl 3.5 -='-... 
3 0 
.c 







































• Expt 1 
• Expt 2 
• Expt 3 
- Mean 
• Expt 4 
Figure 13. Effect of cyclic stretch on KDR phosphorylation in EC. A: Immunoblot with 
PY-20 for KDR (Flk-1) phosphorylation. Arrows indicate the position and size of the 
molecular weight marker standards. The 209 kDa band corresponding to KDR is just 
above the 205 kDa molecular weight marker. Bands for KDR were identified by their 
molecular weight of approximately 210 kDa as determined by comparison with the 
molecular weight marker and by subsequent probing with anti-KDR antibody. Lanes: 1. 
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Cell lysate of unstretched negative control; 2. Cell lysate of EC stimulated with VEGF at 
50 ng/ml for 20 minutes demonstrates a IO-fold increase in KDR phosphorylation as 
compared with the unstretched control; 3 to 6. contain cell lysates of EC subjected to 30, 
60 , 90 and 120 minute of cyclic stretch respectively. The figure represents a typical 
result. Phosphorylation can be seen to decrease slightly relative to the unstretched control 
at 30 and 60 minutes but to increase dramatically at 90 and 120 minutes to reach 3 fold of 
unstretched values. B: Immunoblot with anti-KDR antibody. The same blot was stripped 
and probed with anti-KDR antibody. Although there is a high background after stripping, 
for reasons covered above, the constancy of band density in all lanes of the blot 
demonstrates that protein loading is equal for all samples. Thus, the increase in KDR 
phosphorylation in stretched EC observed in A occurs without an increase in KDR levels. 
C : Densitometric analysis of the levels of KDR phosphorylation over time for 4 
experiments expressed as fold of KDR phosphorylation in unstretched controls and 
corrected against KDR protein levels. Results for each experiment are elaborated on in 
the text. Despite the outlying values at 30 and 60 minutes in experiment 2 (A ) and the 
muted response at all time points in experiment 4 ( + ), the overall trend, as portrayed by 
the mean value for the four experiments (red line), is an increase in KDR phosphorylation 
in response to cyclic stretch over time to a 2.5 fold response at 120 minutes. This 
response is statistically relevant compared to unstretched controls at the 94% confidence 
interval (vertical bars represent standard deviation, * indicates p < 0.06, n = 4). 
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5. RT-PCR Determined Cytokine Expression in Smooth 
Muscle Cells under Cyclic Stretch 
Optimisation of RT-PCR and Controls 
Contractile cells such as SMC are known to produce a variety of cytokines under 
conditions of cyclic stretch. Accordingly, a pilot study to determine the feasibility of 
using RT-PCR to determine the expression ofVEGF, PDGF-B, TGF-P and bFGF mRNA 
in SMC under cyclic stretch for 4-24 hours was carried out as described above (Methods 
and Materials - RT-PCR) using published primers. The results of gel electrophoresis of 
PCR products, which are summarised in Figure 14, indicate a distinct DNA product band 
for VEGF, TGF-P and bFGF at the published molecular weight (as confirmed by 
comparison with a common DNA molecular weight ladder). This demonstrates that the 
primers and conditions listed above (Methods and Materials - Table 1) are suitable for 
RT-PCR analysis of expression of these cytokines in SMC under cyclic stretch. In all 
cases, no DNA band was obtained in controls in which RT was excluded, indicating that 
PCR products were not due to unspecific binding of the primers (Figure 14 A, lane 2). 
This indicates the expression of VEGF, bFGF and TGF-P mRNA by SMC after 4-24 
hours of cyclic stretch. 
Cytokine Expression in Smooth Muscle Cells under Cyclic Stretch 
Following gel electrophoresis, VEGF PCR DNA products were visualised as two bands 
(Figure 14 A, lane 3), determined to be 312 bp and 180 bp in size, which represent the 
VEGF 165 and VEGF 12 1 isoforms respectively. This expression confirms the expression of 
VEGF mRNA by SMC under cyclic stretch found in northern blots and mentioned above 
(Results - VEGF Expression in Smooth Muscle Cells under Cyclic Stretch - VEGF 
mRNA Expression). The band corresponding to the PCR DNA product of amplification 
with primers to bFGF was found to be of the published value of 300 bp (Figure 14 B, 
lane 2). TGF-p PCR DNA products were similarly detected at 161 bp (Figure 14 C, lane 
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2). PDGF-B PCR DNA products were not detected despite exhaustive manipulation of 
conditions for reasons which were not due to experimental failure but possibly cellular 
considerations covered in the discussion section of this work. In addition, 100 bp PCR 
DNA products following RT-PCR carried out to detect ~-actin mRNA from under 
varying conditions of cyclic stretch were found to be constant (Figure 14 D, lanes 2-6). 
This ideally suits its use as a control against which to standardise the expression of 
cytokine mRNA under cyclic stretch. Finally, HPRT PCR DNA product was found to be 
expressed at its published value of 378 bp, allowing it to be used as an alternative 
standardising control (Figure 14 E, lane 2). These results demonstrate that VEGF, bFGF 
and TGF-~ mRNA are expressed by SMC under cyclic stretch and RT-PCR can be used 
to determine the expression of these cytokines and appropriate controls by SMC under 
cyclic stretch. 
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Figure 14. DNA gels of products ofRT-PCR performed on RNA from SMC under cyclic 
stretch. Gels are representative of results obtained. Band sizes, as confirmed by 
comparison with DNA ladders in lane 1 in each gel, are indicated in base pairs (bp) by 
arrows. A: VEGF. Lanes: 1 100 bp DNA ladder; 2 no RT negative control (not shown for 
other cytokines); 3 PCR DNA product from SMC subjected to 4 hours of cyclic stretch 
showing two bands at 180 bp and 312 bp corresponding to mRNA for the VEGF 121 and 
VEGF165 isoforms respectively. B: bFGF. Lanes: 1 100 bp DNA ladder; 2 PCR DNA 
product from SMC subjected to 4 hours of cyclic stretch showing a band at 300 bp 
corresponding to the bFGF mRNA. C: TGF-p. Lanes: 1 100 bp DNA ladder; 2 PCR 
DNA product from SMC subjected to 4 hours of cyclic stretch showing a band at 161 bp 
corresponding to the TGF-p mRNA. D : P-actin. Lanes: 1 100 bp DNA ladder; 2 and 3 
PCR DNA product from unstretched control SMC primed in the RT reaction by random 
primer and oligo-nucleotide primer respectively; 4-6 PCR DNA product from SMC 
subjected to 1, 24 and 8 hours of cyclic stretch respectively. E: HPRT. Lanes: 1 100 bp 
DNA ladder; 2 PCR DNA product from SMC subjected to 4 hours of cyclic stretch 
showing a band at 378 bp corresponding to the HPRT mRNA. 
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Discussion 
1. Experiments conducted and Induction of Quiescence 
This study investigates the role which cyclic stretch might play in VEGF expression by 
SMC in a compliant environment. The time course and magnitude of VEGF mRNA 
expression due to cyclic stretch were measured by northern blotting. In addition, the 
levels of VEGF secreted into the medium by SMC under cyclic stretch and the biological 
activity on EC of secreted VEGF were investigated using an ELISA and migration assay 
respectively. 
Furthermore, following observations of KDR receptor phosphorylation in response to 
shear stress (Chen et al. , 1999), the effect of cyclic strain on KDR phosphorylation was 
investigated by immunoprecipitation and western blotting of stretched EC to determine 
whether KDR acts as a mechanoreceptor for cyclic stretch. This may affect KDR-
mediated endothelial response to locally-released VEGF. 
For these experiments low passage number bovine aortic SMC and EC were plated on 
collagen-coated elastomer plates and subjected to 10% repetitive strain at 1 Hz. In order 
to best approximate the in vivo situation, where the majority of the SMC are found in the 
quiescent I contractile phenotype, cells used in these experiments were induced to quiesce 
by culturing them in 0% FBS prior to the experimental procedure. The removal of serum 
has the added benefit of creating a common experimental baseline as commercially 
available FBS contains an undefined mixture of hormones, nutrients and other 
components, which may lead to SMC stimulation and experimental variation. This is 
especially important when using bovine cells and FBS. Serum is unphysiological for 
SMC, which are never exposed to serum in vivo, however, serum starvation in culture is 
also an unphysiological environment for SMC and leads to increased proteolysis (Libby 
and O'Brien, 1984) because specific factors in serum are necessary to maintain SMC 
viability in culture. Therefore, the supplementation of smooth muscle media with some of 
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these factors in ITS supplement (Libby and O'Brien, 1983) allows a cellular phenotype 
which approaches that found in the artery without a large loss in viability (Figure 7). In 
the experiments in this study this means that SMC under cyclic stretch are not stimulated 
by factors in the media and are in the contractile phenotype. The very limited expression 
of growth factors and non-proliferative characteristics of SMC in this phenotype ensure 
that any VEGF expression arises froID: the stimulus being tested and neither from 
activated smooth muscle cell secretion nor an increase in cell numbers. Furthermore, the 
absence of extraneous factors in the media allows the easy detection of the released 
VEGF by ELISA and endothelial migration assay. 
In like manner, the maintenance of EC in the quiescent phenotype by the use of serum-
free culture both ensures that EC are physiologically close to the state found in vivo and 
that they are not subject to stimulation by other factors found in serum. However, as with 
SMC, ITS supplements are required for survival as unsupplemented serum-free culture of 
EC has been shown to lead to apoptosis (Gerber et al., 1998). In this study the 
maintenance of EC in the quiescent phenotype ensures that endothelial migration in the 
migration assay is due to factors in the smooth muscle cell-conditioned serum and that 
phosphorylation of the KDR receptor in the cyclic stretch experiments does not occur due 
to factors released by active EC. Furthermore, non-proliferative quiescent cells will not 
bias results as there will be a minimal increase in cell numbers during the experiment. 
2. VEGF Expression in Smooth Muscle Cells under 
Cyclic Stretch 
Time Course of VEGF Expression 
The experimental conditions were based on the work of Gruden et al (1997) and Seko et 
al ( 1999), which previously demonstrated the upregulation of VEGF in other contractile 
cell types under cyclic stretch. Quiescent SMC were exposed to various periods of cyclic 
stretch followed by northern blot analysis to determine the expression of VEGF mRNA 
98 
by these cells. Unstretched SMC served as a negative control while bFGF was added as a 
positive control for VEGF expression. VEGF mRNA expression in aortic SMC was 
found to increase due to cyclic stretch to greater than 3 fold of unstretched controls at 4 
hours (Figures 10 and 11) and decrease slightly thereafter to 90% of this value by 24 
hours. This time course of VEGF mRNA expression in SMC under cyclic stretch is 
consistent with the VEGF mRNA expression profiles over time which were shown in 
other studies to be induced in SMC by serum (Williams et al. , 1995), cytokines (Brogi et 
al., 1994; Pedram et al., 1997), or other known VEGF inducers (Namiki et al., 1995). The 
time course of VEGF expression found in SMC is also similar to the time course of 
VEGF expression induced by cyclic stretch in contractile mesangial cells (Gruden et al., 
1997). The similarity in VEGF expression due to cyclic stretch between SMC and 
mesangial cells, which are the smooth muscle cell-like pericyte adjacent to the 
endothelium in the kidney, further underlines their functional and structural similarities 
(Schlondorff, 1987). 
The VEGF expression response of SMC to the bFGF positive control in this work 
followed a similar pattern of expression to that obtained due to cyclic stretch. This pattern 
was also consistent with previous findings in other work (Stavri et al., 1995a) although 
the addition of 10 ng/ml of bFGF has previously been shown to increase VEGF mRNA in 
a similar time course although more rapidly and robustly in rabbit aortic SMC (Stavri et 
al., 1995a). The consistent response in bovine cells to bFGF at 10 ng/ml throughout our 
experiments indicates that this difference in levels of VEGF mRNA expression may be 
specific to the species or experimental set-up used. Preliminary experiments with rat 
SMC showed similar patterns of VEGF mRNA expression due to bFGF at 10 ng/ml and 
cyclic stretch indicating that the production of VEGF in response to bFGF at 10 ng/ml 
and cyclic stretch may be a common response for both bovine and rat SMC. 
Possible Mechanisms behind VEGF Expression 
The increase in VEGF mRNA expression due to cyclic stretch noted in this study may be 
due to the direct action of biomechanical forces on SMC such as noted in studies using 
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SMC and other contractile cells (Gruden et al., 1997; Wilson et al., 1993; Li et al., 1997a; 
Seko et al., 1999) and EC subjected to shear stress (Cucina et al., 1998). Alternatively, 
given the large number of cytokines which have been shown to induce VEGF expression 
in SMC (Brogi et al., 1994; Stavri et al., 1995a; Stavri et al., 1995b), it is possible that 
this VEGF expression may be a secondary result under the autocrine mediation of other 
cytokines such as bFGF, PDGF-B and TGF-~ (Seko et al., 1999). However, such a 
mechanism would simply shift the basis of the response into the next link of the chain, 
meaning that stretch induced upregulation of these cytokines leads to the upregulation of 
VEGF. 
It is worthwhile noting that the VEGF mRNA expression responses by SMC to bFGF and 
cyclic stretch in this study are similar in both magnitude and time course (Figures 10 and 
11). Furthermore, preliminary RT-PCR analysis showed that bFGF mRNA may also be 
expressed by SMC under cyclic stretch (Figure 14), although whether it was expressed 
prior to 4 hours was not investigated. As bFGF has previously been shown to induce the 
rapid expression ofVEGF (Stavri et al., 1995a), these findings leave the question open as 
to whether bFGF is indirectly the trigger for the VEGF mRNA upregulation by SMC in 
response to cyclic stretch in the present study. Although the 4 hour time course of 
expression of VEGF under cyclic stretch demonstrated here appears to be too short for 
novel bFGF transcription and translation followed by induction of VEGF expression, 
cyclic stretch may induce release of bFGF stores from intact cells or from the basement 
membrane produced in vitro (Stiemer et al., 1993). This mechanism has been proposed 
for the release of TGF-~ by stretched myocardial cells (Li et al., 1997a). Another possible 
mechanism of release for bFGF is from damaged cells (Stavri et al., 1995a) although no 
visible damage to the monolayer was seen after application of cyclic stretch for 4 hours. 
It is unfortunate that without the complete controls the results from RT-PCR for bFGF do 
not demonstrate that bFGF expression results from cyclic stretch. However, other studies 
have shown bFGF to be released from SMC stretched at higher than physiological levels 
(Cheng et al., 1997). Basic FGF has been shown to be released by SMC after only 15 
minutes of cyclic stretch at 14% (Cheng et al., 1997) and low levels of bFGF (10 ng/ml) 
have previously been shown to induce dramatic VEGF expression by 1 hour (Stavri et al., 
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1995a). Therefore an autocrine mechanism for upregulation of VEGF mRNA by cyclic 
stretch involving bFGF would fit within the 4 hour time course noted for stretch-induced 
VEGF mRNA expression in this study. 
Furthermore, according to the time course for stretch- and bFGF-induced expression of 
VEGF mRNA in the present study, VEGF mRNA upregulation in response to both 
stimuli had diminished by 24 hours. Therefore, it is possible that, if bFGF is involved in 
mediation of the increased expression of VEGF by SMC, this effect diminishes as the 
time of exposure approaches 24 hours. This hypothesis agrees with another study that 
observed that bFGF was not involved in the smooth muscle cell response to cyclic stretch 
after 48 hours, although shorter time periods were not considered in their study (Wilson 
et al., 1993). However, VEGF expression has very recently been demonstrated in SMC in 
the absence of bFGF expression (Feng et al. , 1999) and in response to levels of cyclic 
stretch (4%) which do not result in significant bFGF release (Cheng et al., 1997) 
indicating that VEGF expression due to cyclic stretch may occur independently of bFGF 
expression at low levels of stretch. In addition, the distinct patterns of VEGF protein 
secretion in stretch- and bFGF-stimulated SMC after 4 hours, - demonstrated by 
endothelial cell migration studies (Figure 12) - indicate that, although the magnitude of 
VEGF mRNA upregulation by the two stimuli in this study may be similar at 4 hours, the 
mechanisms underlying the upregulation may be distinct. More work is required to 
determine whether bFGF plays a significant role in the induction of VEGF expression at 
the physiologically relevant 10% cyclic stretch. 
PDGF, is an alternative candidate for mediating the VEGF mRNA upregulation in 
response to cyclic stretch in SMC. A marked upregulation in release of PDGF-A and 
PDGF-B by SMC under cyclic stretch has been previously demonstrated (Wilson et al. , 
1993) and 10 ng/ml of PDGF-BB has been shown by other groups to induce VEGF 
mRNA expression by 3 hours (Brogi et al. , 1994; Williams et al. , 1995). Therefore, an 
autocrine mechanism for the stretch-induced expression of VEGF mRNA expression 
involving the release of PDGF-B could occur within the 4 hour increase in VEGF mRNA 
expression found in the present study. However, the preliminary RT-PCR data did not 
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show PDGF-B mRNA expression in SMC under cyclic stretch for 4 hours despite 
exhaustive manipulation of conditions used. However, without appropriate controls it is 
difficult to interpret this finding. Cross species hybridisation for this assay is probable 
due to high sequence homology (Herren et al. , 1993; Lindner et al. , 1995) so the lack of 
expression may be due to the predominant expression of the PDGF-A isoform by the 
cells due to differences in smooth muscle cell origin (Malek et al. , 1993) or because the 
time of stretch is shorter than the 24 hours of cyclic stretch previously shown to cause 
PDGF-B mRNA expression (Wilson et al. , 1993). It is possible that PDGF-B may not be 
expressed by SMC under cyclic stretch after 4 hours and may therefore play no role in the 
expression of VEGF seen at this time. It is hoped that with the appropriate controls, 
quantitative RT-PCR can determine the role, if any of PDGF-B in autocrine control of 
VEGF expression. Another possible mechanism for VEGF expression due to cyclic 
stretch is via mediation of the PDGF receptor-a. The activation of the PDGF receptor-a 
by cyclic stretch, which has been shown by another group to occur before 30 minutes in 
the absence of either PDGF ligand (Hu et al. , 1998), may initiate smooth muscle cell 
responses, such as increased VEGF expression, normally initiated by the activation of the 
receptor by PDGF-B and may lead to the induction of VEGF mRNA by SMC under 
cyclic stretch in this study. 
VEGF mRNA has also been shown by other groups to be rapidly upregulated in response 
to cyclic stretch in contractile cardiac myocytes under the mediation of TGF-p (Li et al. , 
1997a; Seko et al. , 1999) and it is possible that a similar mechanism occurs with SMC, 
where as little as 1 ng/ml of TGF-phas been shown to induce the expression of VEGF 
after 3 hours (Brogi et al., 1994). Given the rapid rise in TGF-P levels following cyclic 
stretch it has been hypothesised to be released from cellular stores by cyclic stretch rather 
than produced by the induction of novel TGF-p transcription (Li et al. , 1997a). In this 
study, preliminary analysis using RT-PCR showed that TGF-P mRNA was expressed by 
SMC under 4 hours of cyclic stretch (Figure 14) although this data does not directly 
demonstrate that TGF-P expression is due to stretch. However, VEGF expression under 
cyclic stretch has been recently shown to occur in the absence of TGF-p in mesangial 
cells (Groden et al. , 1999), indicating that TGF-P is not central to the expression of 
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VEGF in all contractile cells under cyclic stretch. It is hoped that quantitative RT-PCR 
can show whether TGF-~ plays a role in VEGF upregulation due to cyclic stretch in 
aortic SMC. 
Levels and Activity of VEGF Released 
Smooth muscle cells exposed to cyclic stretch for 4 hours were shown to upregulate the 
expression of VEGF mRNA by 3.3 (± 1.5 p < 0.005) fold ofunstretched controls (Figure 
11 ). Although the magnitude of this response is lower than the response previously found 
to occur in response to serum or hypoxia in other studies (Brogi et al., 1996; Stavri et al., 
1995b; Williams et al., 1995), it is similar to the response induced by TGF-~ (Brogi et al., 
1994), PDGF-B (Stavri et al., 1995b) and endothelin (Pedram et al., 1997). Furthermore, 
the similarities between SMC and mesangial cells with respect to time course of stretch-
induced VEGF expression noted above are found with respect to the magnitude of VEGF 
mRNA expression (Gruden et al., 1997). Once again, the similarity in magnitude of 
responses between SMC and mesangial cells is consistent with their functional and 
structural similarities (Schlondorff, 1987). Although the isoforms of VEGF expressed by 
stretched SMC in my work could not be determined by northern blotting, they were later 
shown by pilot RT-PCR experiments to be VEGF, 21 and VEGF 165 (Figure 14). These 
isoforms are freely soluble and have been shown to be capable of inducing endothelial 
cell migration (Ferrara and Davis, 1997). Levels of released VEGF shown to elicit 
proliferative and migratory responses in EC in other studies have been shown to result 
from 2 - 3 fold induction in VEGF mRNA in SMC (Ferrara et al., 1991; Pedram et al., 
1997). Furthermore, levels of VEGF previously shown to influence endothelial cell 
migration and proliferation, in a dose dependent manner (Waltenberger et al., 1994) have 
also been previously shown to be sufficient to reduce endothelial cell apoptosis and 
thereby increase endothelial cell survival (Gerber et al., 1998; Nor et al., 1999). However, 
the link between VEGF mRNA expression and an effect on endothelial physiology 
cannot be inferred from other work. Thus, the 3.3 fold upregulation of VEGF mRNA in 
SMC under cyclic stretch found in this work, needed to be directly shown to be capable 
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of inducing sufficient VEGF production to effect endothelial cell behaviour and thus 
survival. 
In order to determine whether the increase in VEGF expression by SMC under cyclic 
stretch found at the mRNA level resulted in the secretion of VEGF at biologically 
significant levels, conditioned media of SMC under cyclic stretch were used in an 
endothelial cell migration assay. Smooth muscle cells subjected to cyclic stretch for 4 
hours released soluble factors into their media, which increased endothelial cell migration 
by greater than 14 fold of unconditioned media. However, after correction against the 
relatively high secretion of endothelial cell chemotactic factors by unstretched SMC 
(inducing approximately 8 fold the endothelial cell migration of unconditioned media), 
the dramatic release of endothelial cell migratory factors by stretched SMC only 
represents a 1.8 fold increase in secretion of endothelial cell migratory factors brought 
about by subjecting them to cyclic stretch. Furthermore, as can be seen in Figure 12, the 
addition of anti-VEGF antibodies does not completely attenuate the endothelial cell 
migration response to media from unstretched and stretched SMC inferring that other 
factors contributing to endothelial cell migration may be released by both unstretched and 
stretched SMC in this study. Addition of anti-VEGF antibodies showed that the relative 
contributions of other factors to endothelial cell migration in media from stretched and 
unstretched SMC were both found to be approximately 40% of the total migration. Basic 
FGF has been shown to be released by SMC due to cyclic stretch (Cheng et al., 1997) and 
is likely to contribute to endothelial migration in this experiment. However, as also 
shown in the data and confirmed by Yoshida et al (1996), VEGF is twice as powerful at 
inducing endothelial migration and the two cytokines are not synergistic. This is 
confirmed by the preliminary RT-PCR data from the present study which demonstrates 
the expression of the endothelial cell chemotactic factor bFGF by SMC under cyclic 
stretch (Figure 14) although cyclic stretch is not directly demonstrated to lead to bFGF 
expression. Taken together these findings lends weight to the theory presented above that 
VEGF production in SMC under cyclic stretch may be accompanied by or mediated by 
the production of other factors. Calculating the approximately 60% contributions of 
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VEGF alone to the total induced endothelial cell migration, stretch is shown to induce a 
1.6 fold increase in VEGF-mediated endothelial cell migration after 4 hours. 
The levels of endothelial cell migration induced by the stretched smooth muscle cell 
conditioned media in my study are consistent with migration values previously reported 
in response to VEGF (Pedram et al., 1997; Senger et al. , 1996) and other cytokines (Ikeda 
et al., 1995; Rosen et al., 1990) in other studies over the 4 hour time interval. 
Furthermore, the endothelial cell migratory response due to media from stretched SMC in 
this work correlates with the expression of VEGF mRNA in a similar way to that found 
by other groups. Greater than 3 fold VEGF mRNA expression in SMC due to application 
of endothelin has previously been shown to result in greater than 3 fold secretion of 
VEGF protein by the SMC which was capable of inducing 1.8 fold migration in EC over 
4 hours (Pedram et al., 1997). Similarly, PDGF-B stimulation of VEGF mRNA in EC 
was followed by an approximately 3 fold secretion of VEGF into the media which 
induced an approximately 2 fold increase in VEGF-mediated endothelial cell migration 
(Wang et al., 1999). The increases in VEGF-induced endothelial cell migration over 4 
hours in the present study are furthermore found to correspond to the levels of VEGF 
found in the media. 
Following the demonstration of VEGF mRNA expression by SMC under cyclic stretch 
and the release of levels of VEGF into the medium which caused migration of EC, 
attempts were made to quantify the levels of VEGF secreted. Surprisingly, the ELISA 
pilot study to determine the cumulative levels of VEGF secreted into the media after 24 
hours of stretch found only a modest 1.2 fold increase in VEGF. Although this small 
increase is not representative of the increase in VEGF mRNA expression after 4 hours, 
this low level of secretion is consistent with some findings by other groups. Seko et al 
showed greater than 3 fold upregulation in VEGF mRNA by cardiac myocytes to lead to 
only a 1.7 fold increase in VEGF protein over 24 hours (Seko et al., 1999). However, the 
1.2 fold increase in VEGF expression due to cyclic stretch in the present study is 
statistically indistinguishable from unstretched controls (p > 0.05) indicating that cyclic 
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stretch may have no effect on the release of VEGF after 24 hours. In light of the 3 .3 fold 
increase in VEGF mRNA shown at 4 hours due to cyclic stretch this is surprising. 
The divergence between mRNA expression at 4 hours and protein secretion at 24 hours 
may arise from long-term basal but constitutive expression of VEGF by the SMC during 
24 hours of induction of quiescence and 24 hours of experiment on the collagen-coated 
Flex I plates. Although the 0% FBS in the culture medium should minimise VEGF 
expression, a low level of VEGF expression was observed in unstretched cells (Figures 
9,10 and 11) and expression of VEGF by SMC seeded on collagen has been reported 
previously (Nicosia et al., 1997). In the present study, the secretion of high levels of 
approximately 6 ng/ml of VEGF into the medium by unstimulated SMC during 24 hours 
of induction of quiescence and the 24 hour course of the experiment may swamp the 
VEGF secretion response to stretch-stimulation. This may account for the low fold 
increase in protein secreted by stretched cells as compared to unstretched cells. VEGF 
has little effect on SMC and therefore would not be detected and down-regulated in the 
absence of mediating EC. The gradual release of cumulatively high levels of VEGF by 
unstimulated SMC in culture would also explain the high (approximately 8 fold) VEGF-
mediated migration response to media from unstretched SMC found in this study and 
mentioned above. Levels of VEGF at 6 - 7 ng/ml are consistent with reported levels 
previously shown to be necessary to bring about endothelial cell migration (Senger et al., 
1996) at an approximate 1.3 fold increase in over 6 hours (Waltenberger et al., 1994). 
Furthermore, a study which related the 2 - 4 ng/ml ( or 2 - 4 ng of VEGF I I 06 SMC) 
produced by VEGF-transfected SMC after 48 hours to the induced endothelial cell 
migration demonstrated a greater than 3 fold increase in migration after 72 hours 
(Visweswaran et al. , 1997). If the measured VEGF of the supernatant in the present work 
are related to cell number, the approximately 6 ng/ml of VEGF found in unstretched 
SMC was equivalent to 17 ng / 106 SMC. While, the differences in VEGF expression and 
induced migration between my study and the one involving VEGF-transfected SMC may 
be due to experimental differences in time courses of both expression and migration and 
different migration assays, it may also be due to high VEGF secretion over time by SMC 
coated on collagen. By comparison with the findings of others, it appears that the levels 
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of VEGF secretion are very high in unstretched controls given the consistently low 
VEGF mRNA expression found over the 24 hour time period in preliminary time course 
experiments. Thus, the gradual release of high levels of VEGF during induction of 
quiescence and the experiment by unstretched and stretched SMC seeded on collagen 
appears to be the most likely reason for the high levels of VEGF and the lack of a 
distinctive VEGF secretory response to cyclic stretch at 24 hours. 
However, an alternative reason for the low fold increase in VEGF secretion in stretched 
cells compared to unstretched cells at 24 hours in this study may be a decrease in VEGF 
secretion over time after the production at 4 hours found by the endothelial cell migration 
assay. Other studies using mesangial cells under cyclic stretch have shown a profile of 
VEGF protein secretion that lags behind the mRNA expression (Groden et al., 1997). 
They showed an initial 2.4 fold peak increase in VEGF mRNA expression after 6 hours 
which drops to basal levels by 12 hours and was only subsequently followed by a delayed 
3 .1 fold increase in secreted VEGF protein levels after 12 hours which returned to basal 
levels by 24 hours. In the present study - while the modest values of VEGF protein in the 
media at 24 hours from stretch-stimulated SMC are similar to previously reported values 
- they do not approach the robust 3 fold increase seen at the mRNA level in response to 
cyclic stretch when considered as a fold of unstretched controls. Rather, it may be the 
case that a short-lived increase in levels of secreted VEGF that has decreased by 24 hours 
has occurred similar to the VEGF expression profile of mesangial cells in response to 
cyclic stretch. A more thorough ELISA determination of levels of VEGF protein 
secretion over shorter time periods needs to be carried out to further characterise the 
secretion of VEGF resulting from the increase in VEGF mRNA expression after 4 hours 
of stretch. This may indicate whether the small fold increase in VEGF secretion in 
stretched cells over unstretched cells is due to high levels of secretion by unstretched 
cells or to an increase in VEGF expression by SMC under cyclic stretch which has started 
to wane by 24 hours. 
In vivo other mechanisms may contribute to VEGF secretion. Smooth muscle cell 
numbers in the wall of a prosthetic vascular graft are likely to be far lower than those in 
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confluent culture, making the contribution of stimuli which induce VEGF expression, 
such as cyclic stretch, more pronounced over long-term baseline secretion. In addition, 
the binding of VEGF by heparin in the basement membrane in vivo may stabilise VEGF 
released by SMC (Park et al., 1993). Thus, even if the release of VEGF by SMC under 
cyclic stretch proves to be a transient event, sequestering and stabilisation by heparin 
binding would serve to prolong the activity of VEGF released by SMC under cyclic 
stretch in the environment of a compliant graft. 
The cumulative VEGF secretory response due to bFGF in this study (l.5 fold compared 
to values from unstimulated controls as determined by ELISA experiments on 
conditioned media) is also modest. Although the increase in VEGF in the media of 
bFGF-stimulated SMC at 24 hours is significantly (p < 0.05) greater than VEGF in 
unstretched controls, it is a far cry from the 3 fold increase in expression after 4 hours at 
the mRNA level and indistinguishable (p > 0.05) from the low increase in levels of 
VEGF expression in stretched cells at 24 hours noted above. As with the response to 
cyclic stretch, the low levels of increase in VEGF levels in the media at 24 hours 
compared to unstimulated SMC may be due to high levels of VEGF secreted gradually by 
the unstimulated cells for reasons mentioned above. These high values of VEGF may 
swamp any increase in VEGF expression due to bFGF. Alternatively, the secretion of 
VEGF due to bFGF may decline as the time of exposure approaches 24 hours as seen in 
PDGF-B and TGF-~ stimulated SMC (Brogi et al., 1994). As noted above with respect to 
the VEGF secretion response to cyclic stretch, more ELISA analysis is required in future 
studies to better characterise the VEGF secretion due to bFGF over time. 
The fold increase in VEGF-mediated endothelial cell migration by conditioned media 
from bFGF-treated SMC over unstimulated controls found at 4 hours in this study is also 
surprisingly low considering the fold increase in VEGF mRNA expression at this time 
compared to unstimulated controls. Despite the similar (approximately 3 fold) increase in 
VEGF mRNA expression levels at 4 hours by SMC stimulated with bFGF and cyclic 
stretch, there appears to be a difference in VEGF secretion after 4 hours as evidenced by 
differences in VEGF-mediated endothelial cell migration. Although the medium from 
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stretched SMC induces a 1.6 fold increase in VEGF-mediated migration compared to 
unstimulated controls (see above), endothelial cell migration in response to the 
conditioned medium of bFGF-stimulated SMC was almost the same as to the media from 
unstimulated controls. This infers that bFGF does not lead to an increase in VEGF 
secretion over untreated SMC after 4 hours. Once again, the low relative increase in 
VEGF secretion over untreated SMC may be due to the high background levels of VEGF 
released by untreated SMC during induction of quiescence. Alternatively, although 
previously shown to act more rapidly in rabbit SMC in other studies (Stavri et al., 1995a), 
VEGF secretion due to bFGF in bovine SMC in this study may occur after the 4 hour 
peak VEGF mRNA expression. Whatever the explanation behind the lack of increase in 
VEGF-mediated migration at 4 hours in this study, the migration results indicate a 
difference in VEGF secretion after 4 hours between bFGF-stimulated and stretch-
stimulated SMC although the increase in VEGF mRNA expression at this time is similar. 
A possible reason for the difference in protein secretion at 4 hours by stretched and 
bFGF-treated SMC found in this study may be distinct post transcriptional regulation of 
VEGF mRNA processing. Low levels of VEGF mRNA expression were noted in 
unstretched smooth muscle cell controls (Figures 9, 10 and 11) consistent with the 
demonstrations of basal levels of VEGF mRNA expression by unstimulated SMC in 
other studies (Couffinhal et al., 1997; Ferrara et al., 1991). Considering the constitutive 
expression in the present work it is possible that steady state VEGF mRNA may be 
rapidly increased due to cyclic stretch by a post-transcriptional mechanism to increase the 
half-life of the mRNA rather than as a result of increased transcriptional activation of the 
VEGF gene. Such a mechanism has been shown by other groups to be behind the 
increase in VEGF mRNA steady state levels due to hypoxia (Levy et al., 1996). 
However, mRNA stabilisation is a complex and poorly understood mechanism and the 
time-consuming expression of additional factors, which protect the mRNA from 
degradation, may take longer than the time course of expression found in the present 
study. Alternatively, cyclic stretch may alter the control of translation of the VEGF 
mRNA or release of VEGF from the cells, resulting in accelerated protein secretion. 
Either mechanism would account for the rapid production of levels of VEGF protein over 
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4 hours of cyclic stretch capable of increasing endothelial cell migration found in this 
study. Future work could use nuclease protection assays and conditioned media ELISA 
studies at shorter time courses to determine the role, if any, of mRNA stabilisation in the 
regulation of VEGF expression in response to cyclic stretch. 
The increased VEGF mRNA steady state levels in SMC due to bFGF treatment in this 
study could, by contrast, result from transcriptional induction and leads to a more gradual 
albeit more long term response as seen in studies by another group (Stavri et al., 1995a). 
Basic FGF has been shown by other groups to have profound effects on SMC behaviour 
(D'Amore and Smith, 1993; Slavin, 1995) and it is possible that the stimulatory effects of 
bFGF on SMC may reduce or delay the secretion of VEGF into the media in this study. 
The addition of anti-VEGF antibodies failed to completely inhibit the endothelial cells 
migratory response to media from bFGF-stimulated cells in this study, in a similar 
fashion and at similar levels to the attenuations observed in the endothelial cells 
migratory responses to anti-VEGF treated media samples from stretched and unstretched 
SMC (Figure12). This indicates that factors other than VEGF may play a role in 
endothelial cell migration due to conditioned media from bFGF-treated cells in this study 
although the bFGF - added to the smooth muscle cell media - has been shown to 
contribute to endothelial cell migration by other studies (Montesano et al. , 1986) and may 
influence endothelial cell migration in this study. 
Previous studies have shown that the levels of VEGF required to induce proliferation 
(Weatherford et al. , 1996) and migration (Wang et al. , 1999) in EC are similar to those 
required to increase endothelial cell survival by reducing apoptosis (Gerber et al., 1998; 
Nor et al. , 1999). Thus, considering the values of VEGF secreted by SMC under cyclic 
stretch in this study, in terms of both concentration after 24 hours and biological activity 
after 4 hours, it appears that SMC under cyclic stretch secrete sufficient VEGF to 
promote endothelial cell survival. Following the development of a number of 
commercially available in vitro apoptosis assays, the direct anti-apoptotic effect on EC of 
conditioned media from stretched SMC could be tested in future studies. 
110 
Our pilot RT-PCR study indicates that VEGF may not be the only cytokine whose 
expression is found in SMC under cyclic stretch (Figure 14). Although the results are too 
preliminary to draw any conclusions from, future quantitative studies may elucidate the 
diverse downstream possibilities of VEGF, bFGF and TGF-p expression by SMC under 
cyclic stretch and the effect which cyclic stretch has on control of their expression. 
Furthermore, although many similarities exist between the physiologies and functions of 
SMC and pericytes (Nicosia and Villaschi, 1995), they have been shown to differ in their 
responses to cytokines such as PDGF-B and TGF-p (D'Amore and Smith, 1993). In the 
scenario of capillaries migrating through a fibrin network within the wall of an implanted 
synthetic vascular graft, the support cell for the EC would be the pericyte. Pericytes have 
been shown in other studies to be instrumental in VEGF-mediated endothelial cell 
survival in capillaries (Benjamin et al., 1998; Goede et al., 1998; Reynolds and Redmer, 
1998). VEGF has also been shown to be produced by the specialised mesangial pericyte 
(Schlondorff, 1987) under cyclic stretch (Groden et al., 1997). However, no work has 
investigated the effect of cyclic stretch on microvascular pericyte function. The isolation 
and culture of pericytes by a number of groups (Antonelli-Orlidge et al., 1989; D'Amore 
and Smith, 1993; Kim et al., 1998; Nicosia and Villaschi, 1995; Swinscoe and Carlson, 
1992; Nehls et al., 1994) has enabled the in vitro study of this cell type although they are 
an ill-defined group of cells (Shepro and Morel, 1993), which is elusive to isolate and 
phenotypically unstable in culture. It would nevertheless be worthwhile to determine the 
effect of cyclic stretch on pericyte expression of VEGF and other cytokines such as the 
angiopoietins and TGF-P which have been shown to be important in capillary 
stabilisation (Darland and D'Amore, 1999). This may provide an in vitro indication of 
how stretch-induced pericyte production of these cytokines would affect the transmural 
migration of capillaries within a healing compliant porous prosthetic vascular graft. 
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3. Effect of Cyclic Stretch on KDR Phosphorylation in 
Endothelial Cells 
Time Course of KOR Phosphorylation 
The migratory and anti-apoptotic effects of VEGF on EC are mediated by the endothelial 
cell-specific receptor KDR (Gerber et al. , 1998; Waltenberger et al., 1994). Recently, 
biomechanical forces have been shown by other groups (Hu et al., 1998; Osawa et al. , 
1997; Yano et al. , 1996a) to result in phosphorylation of receptors in vascular cells in the 
absence of their respective ligands. This has led to speculation that these receptors may 
possess a dual role as receptors for their ligand cytokines and as mechanoreceptors for 
biomechanical forces (Hu et al. , 1998). It has been previously proposed that receptor 
phosphorylation in response to biomechanical forces may initiate signalling pathways and 
thus responses usually triggered by the cytokine ligand (Hu et al. , 1998). As KDR is 
highly and constitutively expressed by EC in vivo (Couffinhal et al. , 1997; Quinn et al., 
1993) it was considered worthwhile investigating any effect of cyclic stretch on its 
expression and activity. This was carried out by immunoprecipitation and western 
blotting of stretched EC for KDR and KDR phosphorylation using unstretched EC as a 
negative control and VEGF-stimulated EC as a positive control for KDR 
phosphorylation. It was hoped that this would give an indication of the ability of EC 
under cyclic stretch to respond to the VEGF released by SMC under cyclic stretch. 
Alteration of KDR expression by EC or KDR phosphorylation due to cyclic stretch may 
occur in vivo which might alter the effects of VEGF and levels of VEGF required to 
influence the EC. 
For this study, KDR was chosen over Flt-1 due to the involvement of KDR in the anti-
apoptotic effect of VEGF on EC (Gerber et al., 1998). In addition, KDR has been shown 
to work as a mechanoreceptor for shear stress and it is possible that this function extends 
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to the detection of cyclic stretch (Chen et al. , 1999). Although the results do not indicate 
a statistically significant change in KDR phosphorylation up to 120 minutes due to cyclic 
stretch at the 95% confidence interval (p > 0.05), this appears to be due to the 
contribution of a few outlying results and the overall trend in KDR phosphorylation is too 
pronounced to assume that stretch has no biological effect on phosphorylation of KDR 
over time (Figure 13). Therefore, some of the possible implications of the results are 
considered below. The results demonstrate an initial minor decrease in KDR 
phosphorylation in stretched EC to 60 minutes under cyclic stretch followed by an overall 
increase, although there was some variation between individual experiments, to an 
average of 2.5 fold of unstretched controls at 120 minutes. One important finding of this 
study is that KDR expression by the EC, which has previously been shown in other 
studies to be changed due to other stimuli (Brogi et al., 1996; Mandriota et al. , 1996), was 
not altered due to cyclic stretch over time (Figure 13B). This is consistent with in vivo 
observation of constitutive expression of the receptor in the elastic artery (Quinn et al. , 
1993) and indicates that any KDR-mediated response to VEGF by the EC may occur 
within an environment under cyclic stretch. 
Levels of KOR Phosphorylation 
Given that the high (50 ng/ml) VEGF concentrations used in this study as a positive 
control for KDR phosphorylation caused an average 12.3 fold increase in KDR 
phosphorylation after 20 minutes, the 2.5 fold upregulation ofKDR phosphorylation after 
120 minutes represents a dramatic response. Other studies using human umbilical vein 
EC (HUVEC) have previously confirmed this degree of KDR phosphorylation to result 
from to 1 - 10 ng/ml of VEGF (Waltenberger et al. , 1994). This range of VEGF 
concentration has furthermore been shown to be sufficient to lead to dose dependent 
VEGF-mediated reductions in apoptosis in HUVEC via the phosphorylation of KDR 
(Gerber et al. , 1998; Nor et al., 1999). As there is only one tyrosine phosphorylation site 
on the KDR receptor (Heldin, 1995; Kroll and Waltenberger, 1997) it is thus possible that 
any phosphorylation response will initiate similar signal transduction responses to VEGF-
mediated phosphorylation. Therefore, it is conceivable that the values of phosphorylation 
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observed in this study after 120 minutes may be sufficient to affect the response to VEGF 
in EC under cyclic stretch. However, the differences in time courses and magnitudes of 
the response to VEGF (12.3 fold increase at 20 minutes) and cyclic stretch (2.5 fold 
increase at 120 minutes) observed in this study seem to infer that the two phosphorylation 
responses would only affect each other if VEGF was added at a later period than used in 
the present study. In any case, considering the diversity of endothelial cell responses to 
cyclic stretch (Sumpio, 1989; Sumpio et al. , 1988a) and the number of signalling 
pathways triggered by KDR phosphorylation (Kroll and Waltenberger, 1997), further 
work is required to determine if the possible KDR phosphorylation under cyclic stretch 
noted here leads to altered response of EC to VEGF. 
Possible Mechanisms behind KDR Phosphorylation 
Although the response of KDR phosphorylation seen by EC under cyclic stretch in this 
study is of a similar magnitude to the responses seen in other receptors subject to 
biomechanical forces by other groups (Hu et al. , 1998; Osawa et al., 1997; Yano et al., 
1996a), the time course of phosphorylation is late compared to the rapid profile of 
phosphorylation found in most responses to biomechanical forces by other receptors. 
PECAM phosphorylation in EC under shear stress (Osawa et al. , 1997), the 
phosphorylation of the PDGF receptor-a by cyclic stretch in SMC (Hu et al. , 1998) and 
focal adhesion kinase phosphorylation in EC due to cyclic stretch (Y ano et al. , 1996a) all 
occur in under 30 minutes. Although it seems unlikely in the light of the finding of these 
studies, it cannot be ruled out that the initial lag in KDR phosphorylation up to 90 
minutes in the present study may be due to a period of adjustment to the force regimen by 
the EC after which phosphorylation responses are seen. However, considering the 
relatively high (1.8 fold) initial values of KDR phosphorylation found after 10 minutes of 
stretch in preliminary time course experiments, the ensuing decrease in phosphorylation 
until 90 minutes followed by a subsequent increase in phosphorylation appears to be 
more consistent with a biphasic response to stretch in which an initial phosphorylation 
response to stretch up to 30 minutes is followed by a second and more pronounced 
response after 90 minutes. The initial response may be better characterised by future 
114 
studies analysing KDR phosphorylation before 30 minutes but the delayed response 
raises questions as to whether the KDR phosphorylation after 90 minutes shown in this 
study is directly due to cyclic stretch or is mediated by the stretch-induced release of 
VEGF consistent with an autocrine loop. 
Although other studies have shown VEGF to be expressed in other cell types under cyclic 
stretch (Groden et al., 1997; Seko et al., 1999), expression in cultured EC has previously 
been found to be undetectable (Williams et al., 1995) and information on expression of 
VEGF secretion by EC under cyclic stretch is lacking. However, future ELISA studies on 
conditioned media from stretched EC and anti-VEGF antibody-inhibitory studies on EC 
under stretch may show whether cyclic stretch leads to production of VEGF in EC after 
90 minutes by a novel mechanism. Alternatively, placenta growth factor (PlGF) may be 
released by the EC due to cyclic stretch and influence the interaction of VEGF with 
KDR. This factor has been shown to potentiate the activity of low levels of VEGF in an 
autocrine manner though to be brought about by displacing Flt-1 bound VEGF (Park et 
al., 1994) allowing it to interact with KDR. If VEGF is not involved in the KDR 
phosphorylation observed in this study, it is possible that the activation of KDR 
represents a direct later response to cyclic stretch by EC. Such a response has been 
demonstrated in other studies by the PDGF receptor-a in SMC, which was found to be 
phosphorylated by stretch without PDGF-B release up to 4 hours in SMC. In EC, longer 
time courses of surface protein phosphorylation due to cyclic stretch have been shown in 
other studies - such as by paxillin, which is phosphorylated after 4 hours (Yano et al., 
1996a) - and it is possible that the response by KDR observed in my work follows a 
similar late pattern. If this is the case, the mild (and statistically insignificant (p > 0.05) 
compared to unstretched controls) decrease in phosphorylation before 90 minutes in the 
this study may represent nothing more than transient minor fluctuations in KDR 
phosphorylation seen over time in culture. It is hoped that future work can determine 
whether the statistically insignificant (p > 0.05) difference between KDR phosphorylation 
levels over time in stretched EC and unstretched controls truly indicates that KDR 
phosphorylation does not occur due to cyclic stretch or whether the perceived increase in 
phosphorylation of KDR after 90 minutes noted in this study is biologically relevant. If 
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the phosphorylation of KDR over time due to cyclic stretch is a genuine and functionally 
relevant response, it will be left to determine whether it is inhibitory, additive or 
synergistic to the anti-apoptotic effects of physiological levels of VEGF on the EC. A 
further role of KDR activation may be the release of NO by EC (Kroll and Waltenberger, 
1999). Thus locally released VEGF from stretched SMC may also induce production by 
EC of the smooth muscle cell-relaxing molecule NO (van der Zee et al., 1997) to 
complement the levels already induced in EC by cyclic stretch (Awolesi et al., 1995), 
providing a compensatory pathway to alleviate pathologically high levels of stretch. 
Furthermore, it is hoped that future inhibitor studies will outline the regulation of signal 
transduction events following KDR phosphorylation in EC under cyclic stretch and thus 
determine whether the response shown in this study affects the expression of cellular 
signalling molecules, such as Bcl-2 and the caspases (Nor et al., 1999), associated with 
increased endothelial cell survival in response to VEGF. 
Concluding Remarks 
VEGF was once hypothesised to be involved in smooth muscle cell proliferation in 
intimal hyperplasia by increasing the vascularity of the vessel wall (Ferrara et al., 1991). 
However, constitutive expression of VEGF by SMC (Couffinhal et al., 1997) and the 
VEGF receptor KDR by EC (Quinn et al., 1993) have since been shown in arteries in vivo 
and appear to be indispensable to correct vessel function. An important function of this 
ligand-receptor expression is the dose-dependent anti-apoptotic role of VEGF in 
endothelial maintenance (Nor et al., 1999). VEGF has been shown to be instrumental in 
increased vascularity of prosthetic grafts (Masuda et al., 1997) and maintaining the 
endothelial layer (Benjamin et al., 1999) responsible for superior graft performance (Zilla 
et al., 1999). However, EC and accompanying SMC / pericytes are largely excluded from 
contemporary grafts due to a number of factors and consequently healing is poor (Davids 
et al., 1999). It is hoped that, amongst other developments, improved graft porosity will 
allow a higher level of cellular infiltration into the grafts. However, it is most likely that 
the levels of VEGF secretion seen in the native artery (Couffinhal et al., 1997) will not be 
achieved because of decreased cell density, which is due to the presence of the polymer 
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scaffold and fibrous scarring. In addition, as shown in this study, there is a contribution of 
mechanical stimulation to the production of VEGF by the SMC and this functional 
stimulation is lacking in stiff contemporary grafts. It therefore appears that the production 
of VEGF by SMC in a porous vascular prosthesis can never be as high as the levels in the 
artery. In order to improve the functional production of VEGF by SMC within the walls 
of a synthetic vascular graft the design of the prosthesis should minimise the volume of 
scaffold in the wall. In addition, it should be determined whether pulsatile stretching can 
raise the levels of VEGF secretion from the basal levels observed in static culture and at 
least asymptotically lead to levels of VEGF required for physiological maintenance. This 
will give an indication of whether the beneficial effects of compliance on the release of 
cytokines are sufficient to lead to improved healing. If it can be shown that stretching 
significantly influences levels of maintaining VEGF, spontaneously healing grafts would 
need to be physiologically compliant. 
This study justifies this demand by showing that cyclic stretch increases the expression of 
VEGF by SMC under the possible mediation of other factors. This increased VEGF 
expression leads in tum to increased secretion of VEGF at sufficient levels to increase 
endothelial cell migration. The levels of VEGF required to affect endothelial cell 
migration have previously been demonstrated to be approximately equal to those 
sufficient to improve endothelial cell survival. This implies that the levels of VEGF 
secreted by the SMC are biologically relevant. The secretion of VEGF may then diminish 
slightly over time, although the levels of VEGF secretion by unstretched controls in my 
model made assessment of later secretion responses difficult. Furthermore, despite 
inducing similar VEGF mRNA expression responses, bFGF and cyclic stretch elicit 
different responses in terms of secretion of VEGF protein. This points to possible 
differences in the molecular mechanisms behind the increase in VEGF expression due to 
bFGF and cyclic stretch. Finally, cyclic stretch did not alter the expression of the KDR 
receptor although it is possible that cyclic stretch may influences the ability of the EC via 
this receptor to react to VEGF released locally by SMC. A greater understanding of the 
effect of cyclic stretch on VEGF-mediated communication between SMC and EC should 
provide information about the mechanical properties which optimise this interaction 
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which can then be integrated into the design of future spontaneously healing vascular 
prostheses. 
However, VEGF is not the only cytokine produced by SMC under cyclic stretch. Wilson 
et al (1993) show secretion of PDGF-BB and PDGF-AA by stretched SMC. Both of these 
isoforms are chemotactic for SMC (Ross et al. , 1990), which may aid in recruitment of 
additional SMC to· the walls of a compliant graft. However, the mitogenic action of 
PDGF-BB may lead to unrestrained proliferation of SMC. Thus, the beneficial effects of 
the increased production of VEGF on endothelial cell survival are balanced against the 
possibility of increased PDGF-mediated smooth muscle cell proliferation associated with 
intimal hyperplasia (Golden et al. , 1991 ; Jawien et al. , 1992). However, in vivo, other 
factors , such as the direct phosphorylation of PDGF receptor-a by cyclic stretch (Hu et 
al. , 1998) which may alter the response of SMC to locally released PDGF via this 
receptor, might attenuate any proliferative effects of PDGF released by the SMC. 
Stabilisation of the SMC under conditions of cyclic stretch may also occur via the 
differentiating effects of cyclic stretch on smooth muscle cell phenotype (Reusch et al. , 
1996). The majority of SMC in the compliant artery, which have been shown to produce 
VEGF (Couffinhal et aL, 1997), are found in this quiescent contractile state without overt 
proliferation (Mills and Sumpio, 1997). Thus cyclic stretch in vivo may promote the 
establishment of a stable population of SMC in the pores of a compliant graft. 
Furthermore, the maintenance of the endothelium by increased production of VEGF 
under cyclic stretch may in tum lead to the release of factors by the EC which halt 
proliferation of SMC (Axel et al., 1997; Couffinhal et al. , 1997). In vivo this stabilising 
function of EC will be additionally mediated by the biomechanical forces to which they 
are subjected and EC have been shown to decrease the production of PDGF-B (Malek et 
al. , 1993) and increase the production of TGF-~ (Cucina et al. , 1998) in response to shear 
stress. TGF-~ has been shown to be released by both EC and SMC in co-culture (Axel et 
al. , 1997) and to induce quiescence in both EC (RayChaudhury and D'Amore, 1991) and 
SMC (D'Amore and Smith, 1993) which reduces the release of cytokines. This thus 
represents a shift from the release of stimulatory factors to a release of factors involved in 
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inducing quiescent conditions (Axel et al., 1997). Finally, cyclic stretch in cardiac 
myocytes has been shown to lead to the release of VEGF via the mediation of TGF-~ 
released by these cells (Seko et al., 1999). It is therefore possible that, if a similar 
response occurs in SMC, cyclic stretch may mute any possible PDGF-mediated smooth 
muscle cell proliferative response in a dose-dependant way by the release of TGF-~. 
Thus, although the presence of SMC in a compliant envronment brings with it the 
possibility of increased production of PDGF-B (Wilson et al., 1993), with subsequent 
smooth muscle proliferation characteristic of intimal hyperplasia, this is not observed in a 
healthy compliant artery where the endothelial-smooth muscle interaction appears to lead 
to stabilisation of both cell types (Axel et al., 1997). Production of VEGF by SMC under 
cyclic stretch leads to stabilisation of the endothelium, which in tum releases factors 
leading to the stabilisation of the SMC. Thus, the use of compliant graft materials in 
vascular grafts, which allow the SMC and EC to experience a measure of the cyclic 
stretch that they are subject to in the native artery, may also approach the natural function 
of the native artery. 
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